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Scope of the thesis 
 
This thesis concerns studies of a two-component system (TCS) from Deinococcus 
radiodurans bacterium. TCSs work based on the activity of two proteins: the histidine 
kinase and the response regulator.  
Histidine kinases are responsible for several reactions of this mechanism: 
autophosphorylation, phosphotransfer and phosphatase activity. The mechanism is 
initiated by an autophosphorylation, induced by a signal from the environment. These 
proteins are composed of two domains: the dimerisation and histidine phosphorylation 
domain (DHpD), and the catalytic ATPase domain (CAD). 
The response regulator is activated by the histidine kinase, through a 
phosphotransfer reaction. The response regulators are composed by a receiver domain 
(RD) that will receive the phosphoryl group from the histidine kinase on the aspartate 
residue, and an effector domain which commonly consists of a DNA-binding domain 
(DBD). Upon phosphorylation of the RD of the response regulator the protein suffers a 
conformation change that increases its binding affinity to specific DNA region. 
The work focuses on the PhoR-PhoB system, a signalling mechanism that gets 
activated upon environmental phosphate starvation. The activation of PhoB response 
regulator, through phosphotransfer from PhoR histidine kinase, leads to activation of the 
last protein with consequent binding to a specific DNA sequence (Pho box), regulating 
the Pho regulon. 
The Pho system has been studied in different bacteria using different kinds of 
approaches. However, the knowledge of this system in D. radiodurans concerns the 
annotation of the genes that encode the two proteins of the mechanism: PhoR (DR2244) 
and PhoB (DR2245). 
 This thesis presents the structural characterisation of both full-length proteins and 
their domains, through small angle X-ray solution scattering (SAXS) analysis. 
Biochemical data and the X-ray structure of the PhoRCAD domain (resolution 2.25 Å) 
complement those studies. The biochemical data demonstrates the PhoR 
autophosphorylation activity as well as phosphoryl transfer activity to PhoBRD. 
 
 xii 
Âmbito da tese 
Esta dissertação refere-se ao estudo estrutural e bioquímico de um dos sistemas de 
dois componentes (TCS) de Deinococcus radiodurans. O TCSs baseia-se na actividade de 
duas proteinas: a quinase de histidina e o regulador de resposta.  
As quinases de histidinas efectuam diversas reacções destes sistemas como 
autofosforilação, transferência de fosfato e actividade de fosfatase. O mecanismo é 
iniciado pela autofosforilação da proteína, sendo esta reacção induzida por um sinal 
ambiental específico. Estas proteínas são compostas dois domínios: o domínio de 
dimerização e fosforilação de histidina (DHpD) e o domínio catalítico de ATPase (CAD). 
O regulador de resposta é activado através de uma reacção de fosfotransferência da 
quinase de histidina; sendo a proteína composta por domínio receptor (RD), que é 
fosforilado pela quinase de histidina, no aspartato; e pelo domínio effector que neste e na 
maioria dos casos consiste num domínio de ligação ao DNA (DBD). Após a fosforilação 
do regulador de resposta, a proteína sofre uma alteração conformacional, dimerizando e 
aumentando subsequente a sua afinidade de ligação a uma região específica do DNA. 
O estudo centra-se no TCS PhoR-PhoB, que é activado após uma limitação da 
concentração de fosfato no meio. A proteína PhoR activa a proteína PhoB através da 
tranferência do grupo fosfato com consequente aumento da afinidade de última proteína 
para uma região específica do DNA (Pho box), regulando a transcrição dos genes do 
regulão Pho.  
O sistema Pho tem sido alvo de numerosos estudos em diversas bactérias. No 
entanto, a informação relativa ao sistema em D. radiodurans resume-se apenas à anotação 
dos genes codificantes para proteínas PhoR (DR2244) e PhoB (DR2245). 
 Nesta tese, é apresentada a caracterização estrutural das proteínas em solução na 
sua forma integral bem como dos respectivos domínios; utilizando a técnica de difracção 
de raios-X de pequenos ângulos (SAXS). O estudo é complementado com análises 
bioquímicas e determinação de estrutura cristalografica do domínio PhoRCAD (resolução 
de 2.25 Å). Os resultados bioquímicos demonstram a autofosforilação in vitro da proteína 
PhoR, bem como a sua capacidade para transferir o grupo fosfato para o domínio PhoBRD. 
 xiii 
Abbreviations 
 
A280nm/A260nm- Ratio between absorption at 280 nm and absorption at 260 nm. 
ADP Adenosine-5'-diphosphate. 
AMP-PNP-  β,γ-Imidoadenosine 5′-triphosphate. 
AT- Adenine- thymine. 
ATP-  Adenosine-5'-triphosphate. 
bps-  Base pairs. 
Bfactor-  Atomic displacement parameters. 
BSA-  Bovine serum albumin protein. 
CAD-  Histidine kinase catalytic and ATP-binding domain.  
DBD-  Response regulator DNA- binding domain. 
DD-  Histidine kinase class II dimerisation domain. 
DHpD-  Histidine kinase class I dimerisation and histidine phosphorylation domain. 
DLS-  Dynamic light scattering. 
Dmax-  Maximum particle diameter size. 
DNA-  Deoxyribonucleic acid. 
DTT-  Dithiothreitol. 
EAL-  Response regulator c-di-GMP-specific phosphodiesterase effector domain. 
ED-  Response regulator effector domain. 
EDTA-  Ethylene diamine tetra acetic acid. 
GAF-  
 
cGMP- specific and stimulated phosphodiesterases, Anabaena adenylate cyclase and 
Escherichia coli FhlA. 
GC-  Guanidine-cytosine. 
GGDEF-  Response regulator diguanylate cyclase activity effector domain. 
HCA-  Hierarchical cluster analysis. 
HK- Histidine Kinase. 
HPt-  Histidine-containing phosphotransfer domain. 
IPTG-  Isopropyl-β-D-thiogalactopyranoside. 
IR-  Isomorphous replacement 
MAD- Multi-wavelength anomalous dispersion. 
MCPs-  Methyl-accepting chemotaxis proteins. 
MW-  Molecular weight. 
MR- Molecular replacement. 
NCS-  Non crystallographic symmetry. 
OD600-  Optical density measured at 600 nm. 
 xiv 
P2-  Histidine kinase class II recognition domain. 
P5-  Histidine kinase class II regulation domain. 
PAS-  Per which is period circadian protein, Arnt the Ah-receptor nuclear translocator protein
and Sim the single-minded protein. 
PC- Principle component. 
PCA- Principle component analysis. 
PCR-  Polymerase chain reaction. 
PEG-  Polyethylene glycol 
PhoBDBD-  PhoB response regulator DNA-binding domain. 
PhoBFL-  PhoB response regulator full length protein. 
PhoBRD-  PhoB response regulator receiver domain. 
PhoP-P-  Phosphorylated PhoP response regulator. 
PhoRA-   Active PhoR histidine kinase. 
PhoRCAD-  PhoR histidine kinase catalytic and ATP-binding domain. 
PhoRD-  Deactivated PhoR histidine kinase. 
PhoRDHpD- PhoR histidine kinase dimerisation and histidine phosphorylation domain. 
PhoRFL- PhoR histidine kinase full-length protein. 
PhoRI-  Inhibited PhoR histidine kinase. 
Pi-  Inorganic phosphate. 
Pit system-  Transport system. 
Pst system- Inorganic phosphote specific transport system. 
RD-  Response regulator receiver domain. 
Rg- Radius of gyration. 
Rmerge-  Merged R-factor. 
RNA-  Ribonucleic acid. 
RR-  Response regulator. 
SAD- Single-wavelength anomalous dispersion. 
SAXS-  Small angle X-ray scattering. 
T4 PNK-  T4 polynucleotide kinase. 
TCS- Two-component signal transduction system.  
TEV-  Tobacco etch virus protease. 
TLS-   Translation/Libration/Screw. 
TM-  Transmembrane.  
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1. Deinococcus radiodurans 
 
Deinococcus radiodurans, formerly Micrococcus radiodurans, is a bacterium of the 
Deinococcaceae family. This microorganism is resistant to extreme conditions such as 
exposure to desiccation, UV light, high doses of ionising radiation (10,000 Gy) and to 
numerous DNA damaging chemical agents (Moseley et al., 1983, Minton, 1994, Wang et 
al., 1995). The first strain was isolated in 1956 by A. W. Anderson from canned meat that 
had received sterilising doses of ionising radiation (Anderson, 1956). This microorganism 
is a non-pathogenic, Gram-positive, non-sporulating, non-motile, spherical and obligate 
aerobe (Murray, 1981, Murray, 1992). It usually grows as a cluster of four cells each of 1 
to 2 µm in diameter, producing red-pigmented colonies when the grown in a rich medium 
(Thornley et al., 1965, Work et al., 1968, Murray et al., 1983, Brooks, 1980, Embley T. 
M., 1987). Species belonging to this family form a characteristic eubacterial phylogenetic 
lineage, which is considered to be closely related to the Thermus genus (Makarova et al., 
2001). 
The genome of D. radiodurans has been sequenced (White et al., 1999) and 
consists of four genetic elements; a 2.64 Mbp chromosome, a 412 Kbp chromosome, a 
177 Kbp megaplasmid and a 45 Kbp plasmid (White et al., 1999) with an average 
guanine-cytosine (GC) content of 67 %. Microrganisms with a high GC content DNA 
have been proposed to have more stable genomes than those with a high adenine-thymine 
(AT) content DNA and it has been suggested that this enhanced stability of the DNA 
contributes to the high resistance to ionising radiation, UV radiation and other factors 
mentioned above for D. radiodurans (Kaplan et al., 1962). However, an experimental 
analysis of D. radiodurans resistance to X-ray or ultraviolet radiation gave conflicting 
results that contradict this high GC hypothesis (Moseley et al., 1964). X-ray survival rates 
were seen to decrease linearly with high GC content. The opposite result was obtained 
when UV radiation was used. Since D. radiodurans is resistant to both X-ray and UV 
radiations, it was concluded that the high GC content of D. radiodurans DNA did not 
have an effect on the resistance capacity of the bacterium (Moseley et al., 1964). 
Extensive genome analysis has shown that the majority of the proteins identified in 
D. radiodurans genome have homologues in Escherichia coli or in other bacteria which 
do not show the same resistance profile. However, D. radiodurans was shown to possess 
expanded protein families, protein families unique to D. radiodurans (Makarova et al., 
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2001) and DNA repair proteins that are more efficient than in other microorganisms 
(Tanaka et al., 2004). Taken together these characteristics may explain the high resistance 
capacity of this microorganism. 
D. radiodurans, like E. coli, has a well developed two-component signal 
transduction system, encoding for 23 histidine kinase domains and 29 receiver domains. 
These domains appear in different arrangements and, in addition to the fundamental 
domains usually found in these systems, extra domains such as GAF domains (cGMP- 
specific and stimulated phosphodiesterases, Anabaena adenylate cyclase and E. coli 
FhlA) and PAS domains (Per which is period circadian protein, Arnt the Ah-receptor 
nuclear translocator protein and Sim the single-minded protein), are found. 
The additional domains usually act as sensing domains that either detect stimuli 
from the environment (PAS domain) or regulate the signal events (GAF domain) 
(Aravind et al., 1997, Taylor et al., 1999). That these are found in D. radiodurans 
indicates that the bacterium possesses good panoply of signalling mechanisms that allow 
adaptation to different environmental conditions such as osmotic regulation, phosphate 
sensing or redox sensing. 
The study of D. radiodurans two-component signal transduction system activated 
upon inorganic phosphate starvation (PhoR-PhoB) is described in this thesis. 
 
2. The two-component signal transduction systems 
 
Sensing and responding to its environment is a critical survival strategy used by any 
living cell. Signal transduction systems mediate bacterial response to environmental 
stimuli such as nutrient depletion, pH, osmolarity conditions, or toxin production 
(Mitrophanov et al., 2008). Such systems are activated through an environmental stimulus 
and allow cells to produce the appropriate adaptative response to a new environmental 
condition. The adaptative response is specific to a given stimulus. Signal transduction 
mechanisms occur in a wide range of organisms from Bacteria, Archaea, eukaryotic 
microorganisms to plants (Gao et al., 2007). In higher organisms signal transduction 
systems are generally quite complicated involving a cascade of kinase proteins that 
recognise the stimulus and that are able to transport the information to the next protein in 
the signalling pathway. In prokaryotes and some eukaryotes these signals are transduced 
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using a relatively simple system named two-component signal transduction system (TCS) 
(Stock et al., 2000).  
The most basic TCSs consist of a histidine kinase sensor protein and a response 
regulator protein (Figure 1.1).  
 
 
Figure 1.1- Schematic diagram of a typical two-component signal transduction system 
(Koretke et al., 2000, Stock et al., 2000, Gao et al., 2007).  
The conserved histidine kinase contains the unique domains DHpD and CAD. The response regulator 
contains the RD with an aspartate residue and the effector domain (ED). 
 
In the most simplified scenario, histidine kinases are composed of three domains 
(Figure 1.1): an Input Domain that senses the stimulus, a Dimerisation Histidine 
phosphotransfer Domain (DHpD) responsible for protein dimerisation and activation, and 
a Catalytic and ATP-binding Domain (CAD) which allows the autophosphorylation of a 
conserved histidine residue in the DHpD. The most common response regulators are 
composed of two domains: a Receiver Domain (RD) in which the protein gets 
phosphorylated in an aspartate residue; and an Effector Domain (ED) which is in the 
majority of the cases is a DNA- binding domain (DBD), that will act to ensure that the 
cell adapts to the new environmental condition. 
 There are several indications that TCSs are not essential for microorganism 
survival, since their number varies dramatically through different species, and thus 
present some functional redundancy (Grebe et al., 1999). However, as TCSs are 
completely absent in humans, in which the signal transduction is based in a Ser/Thr/Tyr 
kinase cascades (Meyerson et al., 1992, Samet et al., 1998), this study important and 
possibly useful for the development of new therapeutic anti-microbial targets (Barrett et 
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al., 1998b, Barrett et al., 1998a, Macielag et al., 2000, Stephenson et al., 2004, Rasko et 
al., 2008). 
Detection of an environmental stimulus (Figure 1.1) is carried out by histidine 
kinases that autophosphorylate a conserved histidine residue located in the cytoplasmic 
region of this protein. Here, the γ-phosphoryl group of adenosine-5'-triphosphate (ATP) 
bound to the CAD of the histidine kinase is transferred to the histidine residue on the 
DHpD of the histidine kinase. The phosphoryl group is then transferred to the conserved 
aspartate of the response regulator leading to a conformational change that will impose a 
specific cellular response such as genes transcription regulation, enzymatic activity, 
interaction with proteins or RNA (Stock et al., 2000, Gao et al., 2007). 
The chemistry underlying the TCS mechanism involves three phosphotransfer 
reactions and two phosphoprotein intermediates Figure 1.2 (Parkinson, 1993). 
 
1. Autophosphorylation: HK-His + ATP  HK-His∼P + ADP 
 
2. Phosphotransfer: HK-His∼P + RR-Asp  HK-His + RR-Asp∼P 
 
3. Dephosphorylation: RR-Asp∼P + H2O  RR-Asp + Pi (in which the histidine 
kinase is also involved). 
 
In order to inactivate the system, the phospho-Asp residue is hydrolysed and the 
phosphoryl group released as inorganic phosphate. These reactions (Figure 1.2) require 
the presence of divalent metal ions, usually Mg2+ (Stock et al., 2000). 
Introduction 
Doctoral thesis of Sofia Caria 7 
 
 
Figure 1.2- Mechanism of histidine kinase autophosphorylation and His-Asp 
phosphorelay from histidine kinase to the response regulator (Koretke et al., 2000, Stock 
et al., 2000, Gao et al., 2007). 
The conserved histidine residue from the histidine kinase attacks the ATP bound to the CAD of the protein. 
The attack leads to phosphohistidine formation (A). By the interaction of the histidine kinase with the 
response regulator coordinated by a magnesium in the phosphoryl group is transferred to the response 
regulator, and a phosphoaspartate is formed (B and C). The phosphoryl group then released as inorganic 
phosphate to produce an inactivated system (C and D). This figure was produced using ACD/ChemSketck 
(Advanced Chemistry Development, 2006). 
 
More complex signal transduction systems can also be found in prokaryotes. Here, 
several histidine kinases are able to phosphorylate the same response regulator or, 
conversely, a single histidine kinase interacts with several response regulators. An 
example of the first case is the chemotaxis system in which CheA histidine kinase 
competitively phosphorylates the CheB or CheY response regulators (Li et al., 1995) in 
order to control the flagella motor of the bacteria. Even more complex systems, include 
the regulation of nitrate/nitrite-responsive gene expression in E. coli. Here, two histidine 
kinases NarX and NarQ, are able to phophorylate two response regulators NarL and NarP 
(Rabin et al., 1993). 
Eukaryotic type signalling in which the signalling is dependent on a cascade of 
reactions comprising different enzymes is also observed in some bacteria. An example of 
A B 
C D 
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this is the sporulation control system of B. subtilis. This complex mechanism starts with 
the phosphorylation of Spo0F (a response regulator) that can be affected by several 
histidine kinases; the phosphoryl group transfer is mediated by Spo0B (hybrid histidine 
kinase- HPt) to the Spo0A (final response regulator) leading to gene transcription 
regulation (Figure 1.3) (Burbulys et al., 1991). 
 
Figure 1.3- A more complex phosphorelay system dependent on a hybrid histidine 
kinase.  
Upon sporulation induction KinA and KinB histidine kinases are phosphorylated. The phosphoryl group is 
transferred to the aspartate of the Spo0F response regulator. The signal is transduced to the final Spo0A 
response regulator via Spo0B hybrid histidine kinase. 
 
Besides the regulation and adaptation to a new condition, the TCSs can be inter-
linked, in that one TCS is required for the regulation of protein expression of another 
system. This behaviour has been described in B. subtilis, were a clear integration between 
the systems controlling phosphate (PhoR-PhoP), aerobic and anaerobic respiration (ResE-
ResD) and sporulation (KinA/B-Spo0A) is observed (West et al., 2001). The Pho and the 
Res systems are co-regulated; phosphorylated PhoP (PhoP-P) is needed for the expression 
of ResD and vice versa (Sun et al., 1996).  
Until recently it was thought that autophosphorylation of the histidine kinases 
always occurs in a trans fashion between the monomers that form the histidine kinase 
dimer as shown for E. coli EnvZ and NtrB (Yang et al., 1991, Ninfa et al., 1993, Stock et 
al., 2000). However, recent studies on a Thermotoga maritima histidine kinase and on 
Staphylococcus aureus PhoR (Casino et al., 2009) demonstrated that in these systems 
autophosphorylation occurs in a cis fashion, requiring that the T. maritima histidine 
kinase and the S. aureus PhoR autophosphorylate their own DHpD, with the DHpD of 
both subunits are making up the histidine kinase dimer. These results show that 
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autophosphorylation can occur either in cis or trans fashion, the choice of mechanism 
being governed by structural differences in the histidine kinase DHpD (Figure 1.4). 
 
 
Figure 1.4- Histidine kinases autophosphorylation mechanisms.  
The autophosphorylation mechanism can occur in a trans (A) or a cis (B) fashion depending of the histidine 
kinase. 
 
In both trans or cis cases the histidine phosphorylation reaction occurs at one of the 
nitrogen atom in the imidazole ring, creating a phosphoramidate bond. In principle, 
phosphorylation can occur on either N1 or N3 (Figure 1.2), however, in all histidine 
kinases so far characterised only N3-phospho-His has been observed. Phosphohistidines 
are suitable as phospho-donors, due to their large standard-free energy of hydrolysis 
(Table 1.1) (Matthews, 1995, Klumpp et al., 2002), which is independent of their 
environment.  
 
Table 1.1- Standard Gibbs free energy of hydrolysis of phosphorylated amino-acid 
residues (Stock et al., 1990). 
∆GºHydrolysis Ϧ (kcal mol-1) Phosphorylated 
residue Intrisic  Proteins  
Phosphohistidine1 -8 to -10 -12 to -14 
Phosphoserine2 -3 -6.5 
Phosphotyrosine4,5 ND -9.5 
Phophoaspartate6 -10 to -13 2 
Ϧ 
- Standard free energies for the reactions: X-P + H2O  X + Pi. 
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 That phosphohistidines have a high negative ∆GºHydrolysis, favouring the 
unphosphorylated protein, implies that the flux of phosphoryl groups is relevant for the 
histidine kinase activity rather than the stoichiometry of the reaction (Stock et al., 1990).  
Phosphoryl transfer from the histidine kinase to the response regulator produces 
stable acyl phosphate specie (phosphoaspartate in Table 1.1). The free energy of 
hydrolysis of the phospho-aspartate bound in response regulators is rather different from 
that observed for other acyl phosphates. This observation has led to the hypothesis that 
the response regulator undergoes a conformational change (Stock et al., 2000). 
 
2.1. Histidine kinases 
 
Histidine kinases contain conserved amino acid sequence motifs used for histidine 
kinase family classification (Fabret et al., 1999, Parkinson, 1992 #12). Six conserved 
sequence motifs (Table 1.2), also known as the histidine kinase boxes: H, X, N, D, F and 
G boxes (Grebe et al., 1999), are used for the protein classification depending on their 
position in the amino acid sequence (Dutta et al., 1999). 
 
Table 1.2- Histidine kinase box amino acid sequence motifs (Wolanin et al., 2002). 
Histidine kinase boxes Conserved aminoacid sequence Function 
H-box HExxxP Activation site (His) 
X-box Hydrophobic Dimerisation 
N-box NLxxxN Mg2+ interaction 
D-box DxGxG ATP binding 
F-box FxPF ATP-lid 
G-box GxGxGL ATP-lid 
 
Class I histidine kinases comprise the majority of histidine kinases. Here, the H-box 
which contains the phosphorylated histidine is found along with X-box in the DHpD 
(Figure 1.5-A). The N, D, F and G boxes are contained in the CAD. (Dutta et al., 1999).  
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Figure 1.5- General domain organisation in class I, II and hybrid histidine kinases 
(Bilwes et al., 1999, Mascher et al., 2006).  
A- Schematic representation of Class I histidine kinases. B- In hybrid histidine kinases two extra domains 
are present; the receiver domain (similar to the response regulators RD) and the histidine-containing 
phosphotransfer domain (HPt); C- Schematic representation of the Class II histidine kinase (CheA). Here, 
the P1 domain contains the H-box, the function of the P2 domain is the specific recognition of the response 
regulator partner (CheY). The C-terminal P5 domain is responsible for the interaction with CheW that 
receives the signal from the sensor. 
 
Class II histidine kinases, of which CheA is the only example (Bilwes et al., 1999), 
contains more subdomains than the class I histidine kinases (Figure 1.5-A). The 
additional domains in this class are the P1, the P2, the Dimerisation Domain (DD) and the 
P5 domain. The P1 domain contains the H-box; P2 is responsible for the interaction with 
the response regulator; DD assures dimer formation and contains the X-box. The CAD is 
A 
B 
C 
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similar to those of class I histidine kinase containing N, D, F and G boxes; whilst P5 
domain is the sensing domain that regulates the kinase activity.  
Macher et al. proposed that histidine kinases could be further divided in to three 
main groups based on the mechanism used for sensing environmental stimuli as 
schematically described in Figure 1.6 (Mascher et al., 2006). 
In the first group, the periplamic-sensing histidine kinases (Figure 1.6-A), the 
sensory domain is located between at least two transmembrane (TM) helices and the 
signal is transmitted to kinase domain in the cytoplasm of the bacterium. The majority of 
known histidine kinases are included in this group. The second group is characterised by 
the existence of 2 to 20 TM regions, of which two are linked by a shorter loop (20 to 50 
amino acid residues). The signal is detected either on the TM helices or on this short loop 
(Figure 1.6-B). Stimuli from within the membrane can be of several types such as 
mechanical stress on the cell envelope, other membrane bound proteins, electrochemical 
gradients and transport processes among others (Mascher et al., 2006). The third group of 
histidine kinases is the second most common in Nature, including histidine kinases that 
detect the signal via membrane-anchored or soluble proteins of which the input domain is 
found in the cytoplasmatic region of the protein (Figure 1.6-C).  
Those histidine kinases in which the sensing domain is absent require an auxiliary 
protein to initiate environmental alert (Figure 1.6-C). Examples include the NtrB kinase 
in where homotrimer sensor protein PII is required (Jiang et al., 1998), or CheA which 
requires the action of methyl-accepting chemotaxis proteins (MCPs) and interaction with 
the partner CheW (Grebe et al., 1998). 
In some cases the basic His-Asp phosphotransfer system is complex, including a 
second histidine that transports the signal to the aspartate present in the response 
regulator. This signal relay requires the existence of an extra domain- HPt - that conveys 
the phosphate for signal transfer, through an active-site histidine from one receiver 
domain to the second receiver domain (Kato et al., 1997). When the first receiver domain 
and the HPt-domain are encoded in a single polypeptide (Figure 1.5-B), the protein is 
referred to as a hybrid histidine kinase (Figure 1.6-C). 
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Figure 1.6- Schematic representation of histidine kinase groups based on signalling 
mechanism (Mascher et al., 2006).  
Histidine kinase groups; (A) Periplasmic-sensing histidine kinases, (B) Transmembrane-sensing histidine 
kinases that can either sense through the conjugation of the TM regions with the input domain or through 
membrane-spanning helices, (C) Cytoplasmic-sensing histidine kinases in which sensing occurs through 
interaction with other proteins. The environmental stimulus is represented by either an arrow or a star. The 
histidine kinase will then transfer the phosphoryl group to the response regulator promoting dimerisation 
and consequent binding to a promoter region of the DNA. 
 
2.1.1. Histidine kinase structural information 
 
Three-dimensional structural information is available for both class I and class II 
histidine kinases although this is more extensive for class I proteins (Table 1.3). 
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Table 1.3- Histidine kinase structures available on Protein Data Bank. 
 Structures Ligands 
Histidine 
kinase1 
 
T. maritima ThkA (pdb: 3a0r)  
T. maritima HK0853-CD (pdb: 3dge) 
T. maritima HK0853-CD (pdb: 2c2a) 
B. subtilis DesK (pdb: 3gie) 
T. maritima CheA (pdb: 1b3q) 
E. coli EnvZ2 
TrrA 
ADP, RR0468 
- 
- 
- 
- 
DHpD - - 
CAD 
T. maritima ThkA, (pdb: 3a0t) 
T. maritima ThkA, (pdb code: 3a0u) 
T. maritima ThkA (pdb code: 3a0w) 
T. maritima CheA (pdb: 1i58) 
E. coli NtrB (pdb: 1r62) 
E. coli PhoQ (pdb: 1id0) 
E. coli EnvZ, (pdb: 1bxd) 
M. tuberculosis PrrB (pdb: 1ysr) 
ADP- Mg2+  
BeF3-- Mg2+ 
- 
 ADPCP- Mg2+ 
- 
AMPPNP- Mg2+ 
ADPNP- Mg2+   
- 
1
- full cytoplasmic domain, 2- NMR model. 
 
Even though information on its activation signal is lacking HK0853-CD from  
T. maritima was the first histidine kinase for which structural information become 
available for the entire cytoplasmic portion (Marina et al., 2005). In solution this protein 
is a homodimer (Ninfa et al., 1993) and in the crystal structure two molecules related by 
crystallographic symmetry associated to form the dimer (Marina et al., 2005) (Figure 
1.7).  
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Figure 1.7- Orthogonal view of the crystal structure of the cytoplasmic portion of 
HK0853 class I histidine kinase from T. maritima.  
Crystallographic dimer of HK0853 cytoplasmic portion from T. maritima with 1.9 Å resolution. The 
monomers are represented in the structure in two different blues. Each monomer consists in a N-terminal 
DHpD comprising two α-helices and a C-terminal CAD made up of seven β-sheets and three α-helices. 
Conserved histidine residues presented in red and missing protein region in dashed lines. 
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Figure 1.8- Orthogonal views of the crystal structure of the cytoplasmic portion of ThkA 
class I histidine kinase from T. maritima.  
Crystallographic dimer of ThkA cytoplasmic portion from T. maritima with 3.8 Å resolution. The 
monomers are represented in the structure with two different blues with the PAS domains highlighted with 
two different greens. Each ThkA monomer consists of a N-terminal PAS domain composed of three  
α-helices covered by five β-sheets, a DHpD responsible for dimerisation and composed of two α-helices, a 
C-terminal the CAD comprising seven β-sheets, three α-helices and the ATP-lid (in yellow). 
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In each monomer the DHpD adopts a helical hairpin structure with the C-terminal 
CAD α/β domain connected to the DHpD by a linker region (Figure 1.7). Dimerisation 
occurs exclusively via interactions between the DHpDs of both monomers which 
associate to form a central four helix bundle structure. The phosphorylated His260 is 
found right after a kink, promoted by Pro265 in the first α-helix of the DHpDs, and is 
highly solvent exposed. The kink in the helix favours the access of the ATP-bound CAD 
to the histidine thus promoting its phosphorylation (Marina et al., 2005).  
The C-terminal CAD consists of a α/β sandwich in which a five stranded β-sheet 
are flanked by three α-helices. In the crystal, the orientation of the CAD is nearly 
orthogonal to the dimerisation interface (Figure 1.7). The small linker region between the 
domains allows the flexibility that is necessary for the autophosphorylation reaction to 
take place (Casino et al., 2009). 
The CAD presents a similar fold to those seen for the structures of the isolated CAD 
of the homologous proteins, PhoQ (Marina et al., 2001), EnvZ (Tanaka et al., 1998) or 
NtrB (Song et al., 2004). The region between residues 433 and 441 (F-box) was 
disordered in the HK0853-CD crystal structure but its location had previously been 
identified being involved in nucleotide binging in the PhoQ-AMPPNP crystal structure 
(Marina et al., 2001). For this reason the F-box is part of the ATP-lid (Table 1.2). The 
flexibility seen in the ATP-lid region in this crystal structure suggests that the presence of 
Mg2+ cation and of ATP γ-phosphate are required in order to lock this flexible region into 
place. 
Another class I histidine kinase with a known crystal structure is ThkA, also from 
T. maritima (Figure 1.8) (Yamada et al., 2009). This protein possesses an extra domain at 
the N-terminus - the PAS domain - presenting a similar fold to that of FixL from the 
FixL/FixJ O2 sensing system (Gong et al., 1998). The PAS domain adopts a left-handed 
glove like fold in which three α-helices are flanked by a five-strand β-barrel (Figure 1.8). 
In the FixL protein it was shown that the PAS domain acts as the sensing domain of the 
protein, but the structural analysis of ThkA PAS domain does not give a clear clue for its 
function. The PAS domain interacts with the CAD, and its presence results in a bending 
of the N-terminal helix of the DHpD. The rest of the structure maintains the overall fold 
described for HK0853 (Figure 1.7). However, the CAD is rotated 60º with respect to the 
DHpD. This results in the ATP-lid of the histidine kinase approaching the DHpD.  
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Yamada et al. also presented the structure of ThkA-CAD bound to ADP-Mg2+ 
(Yamada et al., 2009). Here, the ATP-lid of the domain is visible and locks the substrate 
inside the CAD core. 
Although a conserved fold can be found along the class I histidine kinases, the 
sequence identity is not as high as one would expect. In terms of sequence the variation is 
big being mainly conserved the residues that characterise the histidine kinases (see Figure 
1.9, Figure 1.10 and Table 1.4). 
 
Table 1.4- Deviations in Cα positions following the superposition of the crystal structure 
of class I histidine kinases. Amino acid sequence identity is also shown. 
Superpose T. maritima HK0853 rmsd (Å) Cα Seq. identity (%) 
T. maritima ThkA1 1.77 142 25 
M. tuberculosis PrrB 1.35 123 26 
S. typhimurium PhoQ  1.74 120 21 
E. coli NtrB 1.58 118 25 
1
 cytoplasmic region lacking the PAS domain 
 
As can be seen from Figure 1.10 and Table 1.4 the overall structures of class I 
histidine kinases is conserved with the biggest differences found being the relative 
orientation between the DHpD and CAD; and the length of the loops that connects them. 
From the differences can be seen if there are extra domains in the proteins.  
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Figure 1.9- Comparison of amino acids sequence of histidine kinase class I protein with known crystallography structure. 
The sequence comparison is done using the typical domains of the histidine kinases located in the cytoplasmatic region of the proteins. The typical domains are highlighted with a 
green box (DHpD) and with a pink box (CAD), the remaining boxes below each sequence alignment mark the conserved residue boxes typical of histidine kinases class I; H-box in 
blue, N-box in yellow, D-box in red, F-box in grey and G-box in purple. 
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Figure 1.10- The superposition of the crystal structure of a monomer of the cytoplasmic domains of HK0853 from T. maritima and crystal structure of 
monomers of others class I histidine kinases.  
A- The structure of a monomer of HK0853 T. maritima shown in blue. B- Superposition of known class I structures: HK0853 from T. maritima (in blue, pdb:2c2a), ThkA from  
T. maritima (in green, pdb: 3a0r), PhoQ from S. typhimurium (in yellow, pdb: 3cgz), PrrB from M. tuberculosis (in red, pdb:1ys3) and NtrB from E. coli (in purple, pdb: 1r62). 
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Figure 1.11- Crystal structure of the cytoplasmic domains of CheA 
class II histidine kinase from T. maritima.  
A- Crystallographic CheA∆289 dimer at 2.6 Å resolution. The monomers are 
represented in two different blues.  B- The structure viewed in a dimetric orthogonal 
from that shown in A. C- CheA P1 domain crystal structure at 0.98 Å resolution 
with conserved histidine residue (His 45) shown in red. D- CheA P2 crystal structure 
obtained at 1.9 Å resolution. 
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The full length structures of Class II histidine kinases are still unknown although 
structural information is available for several isolated domains. As previously mentioned, 
in class II histidine kinases, the H-box containing the conserved histidine residue (His45) 
that gets phosphorylated is not contained in the DHpD, but in the P1 domain at the N-
terminus of the protein (Figure 1.5 and Figure 1.11-B). The recognition domain (P2) that 
interacts with the respective response regulator partner (CheY) can be found between P1 
domain and the dimerisation interface (DD). The C-terminus contains the regulation 
domain (P5) that receives the signal from the environment by interaction with another 
protein (CheW) followed by a CAD-like domain, responsible for the binding of ATP.  
The crystal structure of isolated P1 domain of CheA from T. maritima (Quezada et 
al., 2004) presents a general up–down–up–down four-helix bundle fold (Figure 1.11-C) 
that resembles other phosphotransferase domains such as that seen for the ArcB hybrid 
histidine kinase (Kato et al., 1997). A P1 domain consisting of a four-helix bundle fold 
that had also been seen for the S. typhimurium CheA P1 domain (Mourey et al., 2001). 
ArcB receives the phosphate from the phosphoaspartate of a response regulator and not 
from ATP bound to the CAD. Although the phosphotranfers domains of ArcB and the P1 
domain of CheA share the histidine phosphorylation in a similar position, the 
environment around this residue is different in the two proteins. Glu67 in P1 domain is a 
Gln residue in the ArcB, modifying thus residue changes the negative electrostatic 
potential around the phosphorylated histidine. This leads to the conclusion that although 
sharing a common fold the different amino acid sequence composition of the two domains 
allows phosphorylation of the histidine to occur using different pathways (Quezada et al., 
2004). 
The structure of CheA P2 domain from T. maritima has also been determined (Park 
et al., 2004). When compared with the structures of the P2 domains of CheAs from 
different bacteria it is seen that, although there is a conserved fold, the same cannot be 
stated for the domain sequence. In reality the sequences of this domain is not well 
conserved between the species. The overall fold of the P2 domain consists of a α/β 
sandwich composed by three α-helices in one side and four β-strands in the other (Figure 
1.11-D). Crystal structures of the P2 domain CheA in complex with CheY, from different 
microorganisms demonstrate how a substitution of a specific residue can lead to different 
binding modes. (Gouet et al., 2001, Park et al., 2004). 
The crystal structure of the CheA construct - CheA∆289 - which lacks the P1 and 
the P2 domains but contains the DD, the CAD and the P5 domain is shown in Figure 1.11 
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(Bilwes et al., 1999). The DD is composed of two antiparallel α-helices that form a four- 
helix bundle motif upon dimerisation, resembling that of class I histidine kinases. 
Dimerisation occurs via interactions of two DDs which each present a similar fold that 
seen for DHpD in class I histidine kinases although they do not contain the 
phosphorylated histidine which is found, as mentioned above, in the P1 domain.  
The CAD domain also presents the conserved fold seen in class I histidine kinases, 
and with a flexible linker region containing several small α-helices linking this to the  
C-terminal P5 domain. 
 The C-terminal P5 domain is unique to class II histidine kinases, and responsible 
for the reception of the environmental signal through interaction with another protein of 
the pathway. Structurally the domain consists in two twisted five-strand β-barrels. This 
fold is similar to that observed for the SH3 domains of tyrosine kinases such as Src or to 
the PAS domain fold seen in some class I histidine kinases (Figure 1.8). This fold is 
considered common to proteins that interact with other proteins (Bilwes et al., 1999). 
 
2.2. Response regulators 
 
As previously mentioned in §2 of this chapter, response regulators are composed of 
two domains: a conserved N-terminal receiver domain (RD), which is phosphorylated at 
an aspartic acid residue by the histidine kinase; and a variable C-terminal effector domain 
(ED). The phosphorylation of the aspartate in the RD leads to a conformational 
stabilisation of the ED, activating the protein. Response regulators also possess an 
intrinsic autophosphatase activity that regulates the lifetime during which the protein is 
active. 
The conserved RDs of the response regulators have three activities. First, they 
interact with the phosphorylated DHpD of histidine kinases and catalyse phosphoryl 
transfer from the phosphorylated histidine of the DHpD to their aspartate. Second, they 
autodephosphorylate the aspartate; and finally, they regulate the activity of the ED in a 
phosphorylation-dependent manner (West et al., 2001). 
Response regulators can be associated to an ED or found in isolation (Table 1.5). 
Unlike the RD which is conserved, the variability of the ED response regulators in 
sequence, structure, and allows their classification.  
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 Isolated RD response regulators are not physically linked to an ED and are not able 
to play a direct role in regulating ED function. The majority of EDs linked to RDs are 
DNA binding domains. However, other types of EDs produce different responses that can 
be enzymatic, protein-protein interaction, or RNA-protein interaction. The different types 
of ED found in response regulators are represented in Table 1.5 (Galperin, 2006b, Gao et 
al., 2007). 
 Almost half of all Archea response regulators lack ED (Galperin, 2006a). Such 
response regulators are thought act either by intermolecular interaction, as is the case for 
CheY, previously mentioned in §2 of this chapter, or to work as phosphoryl shuttle 
proteins within the phosphorelay (Gao et al., 2007). More than half of all response 
regulator act through DNA-binding EDs which are subdivided into six families (Table 
1.5) depending on the domain fold.  
  
Table 1.5- Types of response regulators based on the different EDs contained. 
Response regulator  Subfamily Protein domains 
Stand-alone RD 
 (17 %)1 
- 
 
OmpR-like (30 %) 
 
NarL-like (17 %) 
 
NtrC-like (9 %) 
 
LytR-like (3 %) 
 
ActR-like (1 %) 
 
DNA-binding (63 %)1 
YesN-like (2 %) 
 
RNA-binding (1 %)1 AmiR/NasR-like 
 
Methylesterase (3 %) 
 
Diguanylate cyclase (1,5 %) 
 
c-di-GMP phosphodiesterase (1,5 %) 
 
c-di-GMP phosphodiesterase (2 %) 
 
Protein phosphatase (1 %) 
 
Enzymatic (13 %)1 
Histidine kinase (2 %) 
 
Protein-binding (3 %)1 CheW-like 
 
Others (3 %)1 - - 
1-
 Percentages obtained through a study performed by Michael Galperin in which approximately 9000 
bacterial response regulators were analysed (Galperin, 2006b). 
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The most common family is the OmpR which covers 30 % of all the DNA-binding 
response regulators. Here, the in which the protein dimerises after phosphorylation 
activation and binds to the DNA. 
Enzymatic response regulators can also be divided into six families (Table 1.5). The 
most common enzymatic response regulators possess a GGDEF (diguanylate cyclase 
activity) or an EAL domain (c-di-GMP-specific phosphodiesterase) EDs which are 
responsible for the synthesis or degradation of cyclic di-GMP, respectively (Romling et 
al., 2005). 
RNA-binding response regulators act by promoting transcription or inhibiting its 
termination process. Protein-binding response regulators act by binding to another 
response regulator of the process and more tightly regulate the transmission of the signal. 
As example of this the chemotaxis signalling system, in which CheW is fundamental for 
the regulation of CheY activity (Jimenez-Pearson et al., 2005).  
The biggest question following the classification of response regulators was to 
understand how a structurally conserved RD can regulate the different activities of 
different EDs (Galperin, 2006b). Two conformational states for response regulators were 
observed, one of which is stabilised as a result of aspartate phosphorylation. It was 
proposed that protein surface in the two conformations is different and that this property 
could be used to trigger different protein-protein interactions, thus explaining the 
regulation mechanism (Volkman et al., 2001). The two conformations were annotated as 
inactive and active, the latter stabilised by phosphorylation. 
 
2.2.1. Response regulators structural information 
 
The RDs of the different response regulator families have variable amino acid 
sequence identity but crystal structure analysis suggest a conserved α/β fold in which a 
central 5-stranded parallel β-sheet is flanked on both sides by amphipathic α-helices 
(Figure 1.12 and Table 1.6).  
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Figure 1.12- Crystal structure of the RD of PhoB response regulator from E. coli 
superposed with the crystal structures of RDs of response regulators with different EDs. 
PhoBRD from E. coli (in pink, pdb:1b00); TrrARD from T. maritima (in green, pdb:3a0r); PleD from  
C. vibrioides (in yellow, pdb: 2v0R); AmiR from P. aeruginosa (in blue, pdb: 3cgz); CheW from  
T. maritima (in red, pdb:1ys3). 
 
Table 1.6- Deviations in Cα positions following the superposition of the crystal structure 
of the RDs shown in Figure 1.12. Amino acid sequence identity is also shown. 
Superpose E. coli PhoBRD rmsd (Å) Cα Seq. identity (%) 
T. maritima TrrA 1.67 107 30 
C. vibrioides PleD 1.63 113 38 
P. aeruginosa AmiR 2 105 8 
T. maritima CheW 2.8 140 3 
 
The activate conformation of RDs was obtained by structure determination in the 
presence of beryllium fluoride (Figure 1.13) (Sola et al., 1999) which mimics the 
phosphoryl group binding to the active Asp of the RD. 
A major difference between the structures of inactive/active RDs is a change in 
conformation which implies different rotamers of the residues Thr83 and Tyr102 (Figure 
1.13-B). When the protein is inactive the residues leave the active site available for ATP 
entrance, whilst in the active the position of the Thr83 moves so that it forms a hydrogen 
bond with the phosphoryl group. The role shown for Tyr102 is to move to the space 
previously occupied by the side chain of Thr83. 
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Figure 1.13- Crystal structures of PhoBRD from E. coli in the active and inactive state 
(Gao et al., 2009).  
A- Stereo view of a superposition of the crystal structures of PhoBRD in its active (purple) and inactive 
(yellow) conformations. The residues presenting different conformations are shown in sticks. The beryllium 
fluoride is shown in green and the magnesium cation in the inactive conformation in cyan.  B- Zoom view 
of the active centre in stereo, with the residues displacement highlighted. 
 
 EDs vary in amino acid sequence, in fold and function (Figure 1.14 and 1.15). 
DNA-binding response regulators increase binding affinity to a specific DNA sequence in 
a phosphorylation dependent manner. Several fold are found for the DNA-binding EDs 
leading to a sub-classification of the family into OmpR-like (Figure 1.15-A), NarL-like 
(Figure 1.15-B), NtrC1-like (Figure 1.15-E), LytR-like (Figure 1.15-C), ActR-like (Figure 
1.15-D) and YesN-like (Figure 1.15-F). 
 
 
 
A 
B 
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 Although DNA-binding response regulators are the most representative family there 
are others families such as enzymatic (Figure 1.14-A), RNA-binding (Figure 1.14-B) and 
protein-binding response regulator (Figure 1.14-C) which, besides completely different 
functions, present different folds. 
 
Enzymatic 
 
RNA-binding 
 
Protein-binding 
 
Figure 1.14 - Crystal structures of response regulators with enzymatic, RNA-binding or 
protein-binding EDs.  
A- The ED of the enzymatic response regulator PleD (pdb code:2v0n), B- The ED of the RNA-binding 
response regulator AmiR (pdb code:1qo0) and C- The ED of the protein-binding response regulator CheW 
(pdb code:2ch4) (Wassmann et al., 2007, O'Hara et al., 1999, Park et al., 2006). 
  
 Recent genome sequenciations allowed the determination of putative response 
regulators through the conserved RDs and new EDs have been characterised. So the 
classification done so far can suffer modifications due to the constant evolution of 
structural knowledge in this subject. 
 
 
A B C 
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D E F 
 
 
 
Figure 1.15 - DNA-binding ED from different response regulators. 
In the DNA-binding EDs of response regulators several fold can be found. The ED of PhoB is a OmpR-like domain with a winged helix-turn-helix fold (A, pdb code:1gxp); 
the NarL ED has a helix-turn-helix motif (B, pdb code:1je8); the AgrA ED is a LytR-like domain, composed only by antiparallel β-strands (C, pdb code:3bs1); the NtrC4 ED 
is a ActR-like domain composed of five α-helices (D, pdb code 3e7l), the NtrC1 ED consists of an α/β subdomain typical of P-loop NTPases and an α-helical subdomain 
feature conserved to AAA+ ATPases (E, pdb code:1ny6); the YesN ED is composed by α-helices (F, pdb code: 2lsg).  
A B C 
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2.3. Histidine kinases- response regulators complexes and mechanism 
insight 
 
The structures described above for histidine kinases and response regulators in 
isolation have allowed the determination of protein domains folds as well as active site 
geometries and structural changes due to the presence of substrate (ATP in the case of the 
histidine kinases) or a compound that mimics the protein activation such as BeF3-. 
However, the determination of histidine kinases-response regulators structures in 
complex with each other was important for a better understanding of the mechanisms 
involved. The recent structures of the T. maritima HK0853-RR0468 complex (Casino et 
al., 2009) led to the discovery that the autophosphorylation can occur in trans or in cis 
fashion depending on the histidine kinase involved (previously mentioned in §2 of this 
Chapter) and allowed the mapping of interactions between a histidine kinase and a 
response regulator. 
In the structure of the HK0853-RR0468 protein-protein interactions were seen in 
three different regions (Figure 1.16): 
 
1- between the bottom of the four helix bundle of histidine kinase (DHpD 
helix α1 and α2) and the α1 helix and the β5-α5 loop of the response regulator; 
2- between the ATP lid and the α4-β4 loop of histidine kinase CAD and the 
β3-α3 loop of the response regulator; 
3- between the linker connecting DHpD and CAD from histidine kinase and 
the β4-α4 loop of the response regulator. 
 
The crystal structure also confirmed the suggestion (Skerker et al., 2008) that 
recognition specificity of the histidine kinases and the response regulators is determined 
by residues in these regions since many residues involved are not conserved in histidine 
kinases and response regulators (Casino et al., 2009). 
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Figure 1.16- Orthogonal views of the crystal structure of T. maritima histidine kinase 
HK0853 in complex with the cognate response regulator RR0468 (PDB code: 3dge) 
(Casino et al., 2009). 
Crystal structure obtained at 2.8 Å. The complex consists of a HK0853 dimer (shown in blue) bound to two 
RR0468 molecules (shown in pink). HK0853 His260 in green; RR0468 Asp53 in yellow.  
 
The determination of the histidine kinase/response regulator complex structure 
coupled with mutational studies allowed a mechanism for signal transduction to be 
proposed (Figure 1.17). 
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Figure 1.17- Mechanism for signal transduction recently proposed (Casino et al., 2009). 
1- Binding of ATP the the CADs of the histidine kinase; 2- Phosphorylation of the histidine residues 
contained in the DHpD of the histidine kinase. Subsequent binding of the response regulator partner induces 
a conformation change of the α-helices of the histidine kinase DHpD; 3- Phosphotransfer from the histidine 
residue of the histidine kinase to the aspartate of the response regulator. 
 
The structure of the T. maritima ThkA/TrrA complex at low resolution (3.8 Å) has 
also recently been published (Figure 1.18) (Yamada et al., 2009).  
 The arrangement of the complex is identical to that of the HK0853/RR0468 
complex, with the exception of the PAS domain that it is not present on the HK0853 
(Figure 1.16 and 1.18). This domain of ThkA is involved in of the three major 
interactions that stabilise the complex formation. The main interactions observed in the 
crystal structure are (Figure 1.18): 
 1- between the α1 helix and the β5-α5 loop of TrrA and α6 DHpD of ThkA. This 
is very similar to the interaction observed in HK0853/RR0468 complex (Figure 1.16); 
 2- between the β4-α4 loop of TrrA and α7 DHpD of ThkA. This is in a similar 
region to that observed in HK0853/RR0468 complex although, in that case, the 
interaction was accomplished via the loop connecting the histidine kinase DHpD to the 
CAD; 
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 3- between α4 of TrrA and β3-β4 and α5 of ThkA. This interaction is unique to 
ThkA/TrrA complex since it is accomplished through the PAS domain of ThkA that is 
not present in all histidine kinases. 
 
 
 
Figure 1.18- Orthogonal views of the crystal structure of T. maritima ThkA histidine 
kinase in complex with the TrrA response regulator (pdb code: 3a0r) (Yamada et al., 
2009).  
Crystal structure obtained at 3.8 Å. The complex consists of a ThkA dimer (coloured in blue and green) 
bound to two TrrA molecules (coloured in pink). The ThkA conserved His547 is shown in red and the 
conserved TrrA Asp52 in yellow. 
 
 As in the HK0853/RR0468 structure the conserved histidine (His547) of ThkA 
faces the conserved aspartate (Asp52) of TrrA giving insight to the phosphotransfer 
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mechanism (in red and yellow respectively in Figure 1.18). Once again it was observed 
that the interactions are determined mainly in the flexible regions of the proteins which 
present sequence variability. 
 
3. PhoR-PhoB - Phosphate signalling system 
 
For bacteria phosphorus is an essential nutrient and is involved in several pathways 
(Wanner, 1993). Its acquisition is achieved by the assimilation several phosphorus-
containing compounds that are then converted in ATP (Wanner, 1993). The most 
common source of phosphorous is inorganic phosphate (Pi) of which the assimilation is 
concentration dependent. Depending on the concentration, two different transport systems 
of Pi are activated. If there is a high inorganic phosphate concentration, the Pit system of 
transport system is active. In limiting Pi concentrations assimilation is carried out by the 
Pst transport system  (Rosenberg et al., 1977). 
In phosphate starvation conditions, transcription of the Pho regulon is activated, 
encoding proteins involved in the transfer of phosphate or other phosphorus-containing 
compounds, the pore proteins of the outer membrane, phosphomonoesterases, 
phosphodiesterases, proteins involved in the biosynthesis of cell wall components and in 
the utilisation of polyphosphates and phophonates (Table 1.7).  
The regulation of the expression of the genes in the Pho regulon is accomplished 
through the binding of the phosphorylated response regulator PhoB to their promoter 
regions (Hulett, 1996, Vershinina et al., 2002). The PhoB response regulator is 
phosphorylated by the PhoR histidine kinase.  
In the promoter regions of the Pho regulon members, there are recognisable 
elements for the PhoB and for the RNA polymerase σ70 subunit. The region of interaction 
of the RNA polymerase σ70 subunit is found between the -10 region of the promoter and 
the Pho box in E. coli can be found 10 nucleotides upstream the -10 region, assuring the 
binding of the PhoB protein (McCleary, 1996). When both conditions are accomplished 
and the PhoB is in its active form, phosphorylated, the transcription of the genes occurs 
(Vershinina et al., 2002). 
The E. coli PhoR/PhoB system acts on the transcription of 137 genes, inducing 118 
genes and repressing 19 genes (Vershinina et al., 2002, Baek et al., 2006). 
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Table 1.7- Genes of E. coli Pho regulon. 
 
Gene Product description 
amn1 AMP nucleosidase 
eda2 Aldolase 
phoA3 Alkaline phosphatase 
phoB3 DNA-binding response regulator 
phoE3 Outer membrane phosphoporin 
phoH3 Conserved protein with nucleoside triphosphate hydrolase 
phoR3 Histidine kinase 
phoU3 Chaperon-like PhoR/PhoB inhibitory protein 
pstA3 Pi transporter, membrane component 
pstB3 Pi transporter, ATP-binding component 
pstC3 Pi transporter, membrane component 
pstS3 Pi transporter, periplasmic-binding component 
ugpA3 Glycerol-3-phosphate transporter subunit 
ugpB3 Glycerol-3-phosphate transporter, periplasmic- binding component 
ugpC3 Glycerol-3-phosphate transporter, ATP-binding component 
ugpE3 Glycerol-3-phosphate transporter, membrane component 
ugpQ3 Glycerol-3-phosphate transporter, membrane component 
phnC3 Phosphonate transporter, ATP-binding component 
phnD3 Phosphonate transporter, periplasmic- binding component 
phnE3 Phosphonate transporter, membrane component 
phnF3 Transcription regulator 
phnG3 Carbon-phosphorus lyase complex 
phnH3 Carbon-phosphorus lyase complex 
phnI3 Carbon-phosphorus lyase complex 
phnJ3 Carbon-phosphorus lyase complex 
phnK3 Carbon-phosphorus lyase complex, ATP-binding component 
phnL3 Carbon-phosphorus lyase complex, ATP-binding component 
phnM3 Carbon-phosphorus lyase complex, membrane component 
phnN3 Carbon-phosphorus lyase complex, ATP-binding component 
phnO3 Carbon-phosphorus lyase complex, acyltransferase 
phnP3 Carbon-phosphorus lyase complex, phosphodiesterase 
psiE3 Phosphate starvation-inducible 
psiF3 Phosphate starvation-inducible 
yibD1 Glycosyl transferase 
ytfK1 Conserved protein 
appA4 Acidic phosphatase 
nuc4 5'-nucleotidase 
ppX4 Synthesis of polyphosphates 
ppK4 Utilisation of polyphosphates 
1
- (Baek et al., 2006), 2- (Murray et al., 2005), 3- (Wanner, 1996), 4- (Rao et al., 1999) 
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The genes regulated by the Pho system in E. coli include systems responsible for 
phosphate metabolism and conversion (Table 1.5). The Pho system regulates itself and 
the Pst phosphate transport (Wanner, 1996, Rao et al., 1999). 
The expression of proteins that deal with organic phosphate sources is also 
regulated by the Pho system. Such proteins are the Ugp's that include the UgpQ 
phosphodiesterase responsible for the hydrolysis of the phosphodiesters that are then 
transported into the cell through the Ugp integral membrane complex (Wanner, 1996). 
In B. subtilis the Pho regulon has some common features with that of E. coli. 
However, differences related to the bacilli physiology, like production of endospores.  
 
Table 1.8- Genes of B. subtilis Pho regulon (Vershinina et al., 2002). 
Gene Product description 
phoA Alkaline phosphomonoesterase 
phoB Alkaline phosphomonoesterase 
phoD Alkaline phosphomonoesterase/phosphodiesterase 
phoP DNA-binding response regulator 
phoR Histidine kinase 
pstA Pi transporter, membrane component 
pstB Pi transporter, ATP-binding component 
pstC Pi transporter, membrane component 
pstS Pi transporter, periplasmic-binding component 
tuaA Biosynthesis of teichuronic acid- sugar transferase 
tuaB Biosynthesis of teichuronic acid- polymer export 
tuaC Biosynthesis of teichuronic acid- sugar transferase 
tuaD Biosynthesis of teichuronic acid- UDP-glucose 6-dehydrogenase 
tuaE Biosynthesis of teichuronic acid- polymerization 
tuaF Biosynthesis of teichuronic acid 
tuaG Biosynthesis of teichuronic acid- sugar transferase 
tuaH Biosynthesis of teichuronic acid- sugar transferase 
tagA Teichoic acid biosynthesis- protein A 
tagB Teichoic acid biosynthesis- protein B 
tagD Glycerol-3-phosphate cytidylyltransferase 
tagE Polyglycerol phosphate glucosyltransferase 
tagF Polyglycerol phosphate glycero-phosphotransferase 
glpQ glycerophosphoryl diester phosphodiesterase 
glpT glycerol-3-phosphate permease 
ydhF Unknown  
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Thus, besides regulation the Pho and the Pst systems (Table 1.6) the B. subtilis Pho 
regulon also regulates the expression of genes involved in the synthesis of teichuronic 
acids (tua and tag operons), and other permeating phosphorus source compounds (glpT) 
and again phosphodiesterases (glpQ). 
Phosphate starvation is sensed by the Pho two-component system, usually annotated 
as PhoR-PhoB in gram negative bacteria (such E. coli) and PhoR-PhoP gram positive 
bacteria (such B. subtilis) (Vershinina et al., 2002). Although a Gram positive bacterium, 
the D. radiodurans response regulator that acts upon phosphate starvation was annotated 
as PhoB (DR2245). The PhoR-PhoB two-component system has been studied in several 
microrganisms including E. coli (PhoRB), B. subtilis (PhoRP), Mycobacterium 
tubercolosis (SenX3-RegX3) and Streptomyces coelicolor (PhoRP) (Hsieh et al., 2010, 
Hulett, 1996, Sola-Landa et al., 2005). For D. radiodurans no studies have been 
performed the only real knowledge available is that the D. radiodurans phoB response 
regulator gene (DR2245) is found in the same operon as phoR histidine kinase (DR2243) 
and a phoU gene (DR2242) (Figure 1.19) (Makarova et al., 2001). 
 
 
 
Figure 1.19- Pho operon of D. radiodurans.  
The Pho operon in D. radiodurans is composed of a phoU gene usually is present in Pst operons, a phoR 
gene that encodes for a histidine kinase and a phoB gene that encodes for the response regulator of a PhoR-
PhoB two component system. 
 
The organisation of the Pho operon in D. radiodurans is thus different from that 
found in E. coli where the phoU gene is in the Pst operon. In D. radiodurans another 
phoU gene (DRA0161) can be found in the pst operon. However, the phoU gene in  
D. radiodurans Pho operon is more similar to the E. coli gene. The D. radiodurans PhoB 
response regulator has a DNA-binding domain and acts as a transcription regulator. 
PhoR belongs to the most common class I family of histidine kinases described in 
§2.1 of this Chapter. In B. subtilis and E. coli, PhoR features transmembrane helices and 
PhoR was initially thought to be a periplasmic-sensing histidine kinase (Figure 1.6-A). 
However, when mutations removing the N-terminus transmembrane region were 
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performed PhoR presented similar activity in response to phosphate concentration 
(Scholten et al., 1993, Kern et al., 1999). Based on this information it has been proposed 
that PhoR is either a membrane-spanning or a cytoplasmic-sensing histidine kinase 
(Figure 1.6-B and C) (Mascher et al., 2006).  
The PhoR is fundamental in the phosphate sensing process with transcriptional 
activation or repression, depending on whether PhoR is inhibited, activated, or 
deactivated (Figure 1.20).  
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Figure 1.20- Mechanism for the Pho regulation E. coli (Hsieh et al., 2010).  
 
One of the most studied Pho systems is that from E. coli. Here, inhibition, 
activation and deactivation is dependent on the Pst system which is an ABC transporter 
system responsible for the transport of inorganic phosphate into the cell. 
The Pho system is activated through a negative input which is the limiting 
phosphate concentration in the environment ([Pi] < 4 µM). When there is a excess of 
phosphate in the environment ([Pi] > 4 µM), Pi binds to PstS leading to an inhibition of 
the Pho regulon (Figure 1.20-A). Here, the first system for phosphate is active. When 
inorganic phosphate concentration is low the PstS is unbound, leading to the activation of 
the PhoR histidine kinase. The PhoR will autophosphorylate and consequently transfer 
the phosphoryl group to the PhoB response regulator (Figure 1.20-B). That PhoB 
phosphorylation causes conformational changes to the response regulators has been 
observed through crystallographic structures in the presence and absence of BeF3- 
(Arribas-Bosacoma et al., 2007, Bachhawat et al., 2005). Upon PhoB activation its 
binding affinity to a specific DNA sequence (Pho box) will increase leading to the 
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activation or repression of several genes contained in the Pho regulon depending on the 
promoter region position of the Pho box. Once [Pi] returns to normal levels, Pi rebinds to 
PstS and PhoB is dephosphorylated thus deactivating the system (Figure 1.20-C). 
It has been proposed that PhoU is fundamental for the Pho system inhibition and 
deactivation. PhoU is structurally similar to eukaryotic proteins belonging to the Hsp70 
chaperone family (Oganesyan et al., 2005, Liu et al., 2005) and the activity associated to 
this protein is compatible with a chaperone functioning as an accessory protein. The most 
accepted hypothesis considers that PhoU acts along with PhoR to promote PhoB 
dephosphorylation once the inorganic phosphate concentration increases (Figure 1.20-C). 
The E. coli PhoB protein can be phosphorylated by other histidine kinases, such as 
CreC, or by low molecular weight phospho-donors such as acetyl phosphate (Yamamoto 
et al., 2005, Zundel et al., 1998). PhoB activation in the absence of PhoR has been 
observed with a lower activation level by histidine kinases ArcB, CreC, KdpD and QseC. 
This observation lead to the hypothesis that there is cross-regulation between different 
two-component systems that may play a role in the integration of multiple input signals 
(Hsieh et al., 2010). 
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1.  Design of Constructs, Cloning, Expression and 
Purification of the Pho proteins and their domains 
 
1.1. PhoR and PhoB domains design and cloning 
 
The PhoR and PhoB amino acid sequences were analysed and domain boundaries 
estimated using the program Phyre (V.0.2) (Kelley et al., 2009). The resulting domain 
organisations of PhoR and PhoB are shown in Figure 2.1 and Figure 2.2, respectively. 
 
 
 
B 
MEDVTEHRRREAELREATAVLSHEFRTPVAALRGVLEALEYDMPQDLAQNFVRQGLQETE
RLARLVEDLAVGFRPTRARTLPLAEAFARAERLLAAEVAARQVKLAFGQDHLVRADPDKL
LQVLLNLIENALKYGPAGQRIEVMTAQRGTWVEVSVLDRGEPIPDTESLFRAHTRGRDAT
GQGSGMGLYIVRSIVQGWGGQAWAERQGERNAFSFTLPGVGGLG 
Figure 2.1- PhoR domain boundaries. 
A- PhoR is composed of an N-terminal dimerisation and histidine phosphorylation domain (PhoRDHpD) and 
a C-terminal catalytic ATPase domain (PhoRCAD). B- PhoR amino acid sequence with PhoRDHpD 
highlighted in blue and PhoRCAD in yellow. PhoRDHpD comprises residues 1 to 78; PhoRCAD residues 79 to 
224. 
 
 
 
B 
MSHVVVIEDESTVRDVLRFHLERAGLRVSAYASTQAAEEAGALAGADALVLDWMLPGESG
IGFLRRLRTDNDLRRLPVLMLTARAAEAERVEGLETGADDYLTKPFSAAELVARVRALLR
RAQPETPQHLGNGPLTVDLAAAEAQLAGRTLNLTRREFDLLAFLTANAGRVYSRTELLDR
VWGADFLGGERTVDQHVTQLRAHLGDDPGKPSFLETVRGKGYRMRAWNADAARAEAPK 
Figure 2.2- PhoB domain boundaries. 
A- PhoB is composed of an N-terminal receiver domain (PhoBRD) and a C-terminal DNA-binding domain 
(PhoBDBD). B- PhoB amino acid sequence with PhoBRD highlighted in blue and PhoBDBD in yellow. PhoBRD 
comprises residues 1 to 121; PhoBDBD residues 130 to 230. 
 
 
A 
A 
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The phoR (DR2244; NCBI-GeneID of 1798996) and the phoB (DR2245; NCBI-
GeneID of 1797744) genes were amplified from D. radiodurans R1 strain genomic DNA 
using a high fidelity PCR enzyme mix (Fermentas) and complementary gene-specific 
primers (Table 2.1), with the polymerase chain reaction (PCR) (Saiki et al., 1988).  
The plasmids encoding the full length proteins, were used for the amplification of 
the domains, phoRDHpD from residue 1-79, phoRCAD from residue 79 to 224, phoBRD from 
residue 1-121 and phoBDBD from residue 130- 230; using gene-specific primers (Table 
2.1) and the protocol below. 
 
Table 2.1- Gene-specific primers used for amplification.  
Gene Primer Sequence (5' to 3') 
Forward  CACCCGCACGCTGCCGCTGGCC 
phoR 
Reverse  TCAGCCCAGCCCGCCCAC 
Forward  CACCATGAGCCATGTCGTTGTCATT 
phoB 
Reverse  TCACTTCGGGGCCTCG 
Forward  same as phoR forward 
phoRDHpD 
Reverse  TCAGCGGGCGCGGGTAGGCCG 
Forward  CACCCGCACGCTGCCGCTGGCC 
phoRCAD 
Reverse  same as phoR reverse 
Forward  same as phoB forward 
phoBRD 
Reverse  TCACCGGCGCAGCAGGGCGCG 
Forward  CACCCTCGGCAACGGCCCGCTG 
phoBDBD 
Reverse  TCAGCGTCGGCATTCCAGGCGCG 
 
PCR reactions consisted of an initial DNA denaturation step performed at 371 K for 
5 minutes, followed by 30 cycles (denaturation step: 1 minute at 368 K; annealing step: 1 
minute at 328 K; extension step: 1 minute at 345 K) and a final 10 minute extension step 
at 345 K. The amplicons, generated with a CACC extension, were purified from 1 % 
agarose gels using the QIAquick gel extraction kit (Qiagen). The fragments obtained were 
then cloned into the pET151/D-TOPO vector (Figure 2.3) using the TOPO cloning kit 
(Invitrogen). This vector adds a N-terminal hexa-histidine tag, a V5 epitope and a tobacco 
etch virus (TEV) protease cleavage site to the target recombinant protein. The vector also 
provides ampicillin resistance and contains several recognition sites for restriction 
enzymes that allow the confirmation of the target's insertion into the vector.  
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Figure 2.3- Topo vector pET151/D-.  
Schematic representation of the features of the pET151 directional Topo vector. Construct expression is 
regulated by a T7 promoter, which is activated by isopropyl-β-D-thiogalactopyranoside (IPTG). The 
recognition sites of several restriction enzymes as also shown in the vector. Figure produced with BVTech 
plasmid (v5) (Tech Inc., 2003). 
 
Recombinant clones were selected through ampicillin resistance, colony PCR 
analysis using T7 promoter primers, and double digestion with SacI and NcoI (Fermentas) 
restriction enzymes to confirm the presence of a correctly sized insert. The integrity of the 
cloned constructs was confirmed by DNA sequencing performed by Gene Core - EMBL 
(http://www.genecore.embl.de).  
 
1.2. Protein expression and cell lysis 
 
For expression, the constructs were transformed into chemically competent E. coli 
BL21 (DE3) cells (Invitrogen) using a heat-shock technique.  
Small 10 ml overnight cultures grown at 303 K in Luria-Bertani broth containing 
100 µg/ml ampicillin were used to inoculate 1 L cultures of the same mixture. In all cases, 
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cells were grown to an OD600 (optical density at λ = 600 nm) of 0.6. Expression of the 
recombinant protein was then induced by the addition of isopropyl-β-D-
thiogalactopyranoside (IPTG) to a final concentration of 0.3 mM. The culture for the full 
length PhoB (PhoBFL) protein was allowed to grow during one hour at 303 K after 
induction; whilst those of PhoRDHpD, PhoRCAD, PhoBRD and PhoBDBD were grown for 
three hours at 298 K. Overexpression of full-length PhoR (PhoRFL) was induced 
overnight at 291 K.  
In each case cells were harvested by centrifugation at 5000 g for 30 min at 277 K. 
Subsequently, the cells were frozen at 193 K, thawed and then resuspended in a lysis 
buffer. The lysis buffer consisted of 50 mM Tris-HCl buffer pH 7 containing 500 mM 
NaCl (Buffer A) for PhoRDHpD, PhoRCAD, PhoBRD and PhoBDBD; 50 mM Tris-HCl buffer 
pH 8 containing 500 mM NaCl (Buffer B) for the full length proteins. Prior to lysis 
protease inhibitors, DNAse and lysozyme were added to both Buffer A and Buffer B. 
Lysis was performed using three cycles of freeze (liquid nitrogen) and thaw (293 K water 
bath). For the PhoRDHpD domain lysis was in some cases performed via three cycles of 
sonication on ice followed by centrifugation at 20000 rpm for 20 minutes. To assess the 
success of overexpression samples retrieved before and after induction were analysed 
using SDS-PAGE gels. Pellets (insoluble fractions) were resuspended in sodium dodecyl 
sulphate SDS electrophoresis buffer for loading in the SDS-PAGE gel. 
 
1.3. Affinity chromatography purification protocols 
 
For the purification of all proteins except PhoBFL, a 1 ml HisTrap™ FF Column 
(GE-Healthcare) equilibrated with lysis buffer containing 20 mM imidazole was attached 
to an Äkta Prime system (GE-Healthcare). In the case of PhoBFL, the lysis buffer (Buffer 
B) with which the column was equilibrated, contained no added imidazole. 
The soluble fractions obtained from the centrifugation described in §1.2, were 
applied to the column and washed with 30 ml lysis buffer containing 20 mM imidazole 
followed by 25 ml of lysis buffer containing 50 mM imidazole. Target proteins were then 
eluted using a linear gradient of imidazole in lysis buffer, from 50 mM to 500 mM in six 
column volumes. For PhoBFL the first wash used imidazole free buffer, the second 20 mM 
imidazole. In this case the gradient applied was 20 mM to 500 mM imidazole rather than 
50 mM to 500 mM. 
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For histidine tag removed fractions containing the target proteins were identified by 
SDS-PAGE analysis and dialysed overnight at 277 K in the presence of TEV protease 
produce in house with 1:6 ratio in 20 mM Tris-HCl buffer pH 7 for the domains 
(PhoRDHpD, PhoRCAD, PhoBRD and PhoBDBD) or 20 mM Tris-HCl buffer pH 8 for the full-
length proteins. In both cases the buffer contained 150 mM NaCl, 1 mM DTT and 0.5 
mM EDTA. The resulting protein solutions were then loaded on 1 ml HisTrap™ FF 
Column (GE-Healthcare) and the flow through contained the His6-tag cleaved protein. 
Fractions containing untagged proteins were then identified by SDS-PAGE, pooled and 
dialysed into 20 mM Tris-HCl buffer pH 7, 150 mM NaCl for the domains (PhoRDHpD, 
PhoRCAD, PhoBRD and PhoBDBD), and 20 mM Tris-HCl buffer pH 8, 150 mM NaCl for 
the full-length proteins. 
All constructs were concentrated using 3 kDa or a 10 kDa molecular weight cut-off 
Amicon concentrator (Millipore) depending on molecular weight. Final concentrations 
were estimated from their absorption at λ of 280 nm, using the calculated extinction 
coefficient (Gill et al., 1989) for each construct. Sample purity was estimated by SDS-
PAGE. 
 
1.4. Size exclusion chromatography 
 
The full length proteins and the constructs (PhoRDHpD, PhoRCAD, PhoBRD and 
PhoBDBD) were analysed by gel filtration using a SuperdexTM 200 analytical column. 
SuperdexTM 200 column separated the proteins by molecular weight using the final 
buffers in §1.3. The column bed volume is 24 ml with each run being stopped at the 
elution of 30 ml of buffer after protein loading. Fractions of 1 ml were collected and 
analysed on a 12 % poliacrylamide gel allowing the determination of the protein elution 
volume. 
The PhoRFL and PhoBFL proteins needed further purification steps and were loaded 
into a Hiprep 16/60 Sephacryl S100 column, on which bigger amounts of protein can be 
properly purified. The buffers used are the final buffer mentioned in §1.3 with 125 ml of 
buffer being passed through the column in each case (column bed volume of 120 ml). 
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1.5. Proteins with extra purification steps 
 
For PhoBFL extra purification steps, or modifications to the protocol described in 
§1.3, were tested in attempt to improve protein purity in the hope that this would improve 
the prospects of crystallisation. One such modification was to increase, in Buffer A, the 
sodium chloride concentration from 500 mM to 1 M in order to reduce possible DNA 
contamination.  
Another approach used to reduce a possible DNA contamination was to further 
purify the protein using a 1 ml HiTrapTM Heparin column. Protein obtained after nickel 
column purification was dialysed into 10 mM Tris-HCl pH 8 and 10 mM NaCl. The 
protein was applied to the column and eluted through a sodium chloride gradient from  
10 mM to 2 M. 
The use of a MonoQ was also tested. Here the protein obtained after nickel column 
purification was dialysed into 10 mM Tris-HCl pH 8 and 10 mM NaCl, applied to the 
MonoQ column and eluted with a linear gradient of sodium chloride from 10 mM to 2 M. 
 
1.6. Dynamic light scattering analysis 
 
Dynamic light scattering (DLS) analyses based on size distribution by volume were 
performed using a Zetasizer Nano S DLS device (Malvern Instruments).  
Before DLS analysis all samples were centrifuged in a Eppendorf Centrifuge 5415 
R at 13200 rpm, 277 K for 5 minutes to reduce possible aggregation and the presence of 
dust that could interfere with the measurements. 
The buffers in which the constructs were contained were used for blank 
measurements. All measurements were carried out at 293 K as this would be the 
temperature of first crystallisation tests. In all cases the measurement was repeated three 
times to confirm consistency. 
 
1.7. In vitro autophosphorylation assay for D. radiodurans PhoR 
 
Phosphorylation assays were carried out by incubating 55.38 pmol of sample (Table 
2.2), with 1.5 µl of 0.1 M ATP (cold) and 1.5 µl of 100 µCi [γ-32P]ATP (which consists of 
15 µCi for the complete assay) in Buffer C (50 mM Hepes buffer pH 8, 50 mM KCl and 
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50 mM MgCl2). The samples were incubated for 4 minutes at 303 K and the reaction 
stopped by adding 5 µl of sodium dodecyl sulphate SDS electrophoresis buffer to 15 µl of 
the reaction mix. 
 
Table 2.2- Protein mixtures used in phosphorylation analysis. 
Sample A B C D 
Composition PhoRDHpD PhoRCAD 
PhoRDHpD 
plus PhoRCAD 
 
PhoRFL 
 
All samples were then loaded onto a 4–12 % NuPAGE Novex bis-Tris precast one-
dimensional electrophoresis gel (Invitrogen) with subsequent transfer onto a 
nitrocellulose membrane. The membrane was dried and exposed overnight on a 
phosphoimager screen (Typhoon 9410) for the identification of radioactive bands. 
For identification of the constructs on the membrane gel, 3 µg of each sample were 
also loaded onto a 4–12 % NuPAGE Novex bis-Tris precast one-dimensional 
electrophoresis gel (Invitrogen) and stained with Coomassie blue. 
A time-resolved phosphorylation assay was also carried out using PhoRFL construct 
with a hexa-histidine tag. The conditions described above were used except that the 
mixture was incubated at 303 K for 15 minutes and the reaction was stopped at different 
times (0, 1, 3, 5, 7, 9, 11, 13 and 15 minutes). The analysis of the results was carried out 
as described above. 
 
1.8. In vitro phosphotransfer of D. radiodurans PhoR-PhoB 
 
A phosphotransfer assay was used to check possible interaction between PhoRFL and 
PhoBFL. With that purpose PhoBRD or PhoBFL was added to the PhoRFL 
autophosphorylation in vitro mix in a 5:1 molar ratio and incubated at 303 K.  Reactions 
were stopped at different times (0, 1, 3, 5, 7, 9, 11, 13, 15, 17, 19 and 30 minutes) as 
previously described. The analysis of the samples was carried out using the protocol 
described in §1.7. 
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1.9. Determination of the D. radiodurans Pho box using bioinformatic 
methods 
 
For the prediction of the sequence of the D. radiodurans Pho box, an approach 
similar to that described by Su et al. (Su et al., 2007) was used, employing CUBIC 
(v.2.0.2) software (Olman et al., 2003). The Pho signalling system is poorly documented 
in D. radiodurans, therefore homologous proteins from the Streptomyces coelicolor Pho 
regulon were used (Sola-Landa et al., 2008). In Table 2.3 the correspondence between the 
genes known to be transcriptionally regulated by the S. coelicolor Pho system and their 
homologs in D. radiodurans is shown. 
 
Table 2.3 - S. coelicolor genes regulated by the pho system and the corresponding  
D. radiodurans homologues (Sola-Landa et al., 2008). 
S. coelicolor D. radiodurans Gene 
SCO4230 DR2245 phoB 
SCO4229 DR2244 phoR 
DR2243 
SCO42281 
DRA0161 
phoU 
SCO4142 DRA0157 pstS 
SCO6170 DRA0177 xanthine dehydrogenase 
SCO0034 DR1155 malate synthase 
SCO4261 DR0987 DNA-binding response regulator 
SCO1393 DR2471 acetyl-coA synthetase 
SCO2465 DR0916 rpoD 
DR2328 sensor histidine kinase 
DR0744 sensor histidine kinase 
DR1174 hypothetical protein 
DRA0205 sensor histidine kinase 
DR2419 sensor histidine kinase 
SCO42291 
DRA0050 Photoreceptor 
SCO1845 DR0925 Low-affinity inorganic phosphate transporter 
SCO4878 DR1224 glycosyl transferase-related protein 
1
- Numerous gene homologous are found in the D. radiodurans genome. 
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The nucleotide sequences consist of 300 bases in the region upstream of each gene 
were uploaded to CUBIC (v.2.0.2) (http://csbl.bmb.uga.edu/downloads/cubic/) in order to 
determine a consensus sequence present in this region. The consensus region length 
defined for the search was 10 base pairs (bps) which is similar to the S. coelicolor Pho 
box length. The motif identified obtained above a pre-selected cut-off (p < 0.001) had a 
score of 78.55 % (Olman et al., 2003). The sequences identified for each gene were 
analysed using WebLogo (v2.8.2) (Crooks et al., 2004) for a clear display of the 
consensus sequence. 
The Pho box DNA sequence has been shown to be repeated in the genomes of  
E. coli or S. coelicolor (Kimura et al., 1989, Sola-Landa et al., 2008). For that reason 
repetitions of the consensus sequence were searched for using different options and box 
arrangements as shown in Table 2.4. 
 
Table 2.4- Possible arrangements and possibilities tested in the search for the Pho box 
consensus region in the D. radiodurans genome. 
Options Box arrangements† 
- Without gap 
- Gap of 1, 2 and 3bp 
- Superposition of 1, 2 and 3 bps 
- AA1 
- BB1 
- AB 
- BA 
†
- Box definition in Chapter III 
1
- Not possible to test superposition with 3 bps since the sequence does not allow it. 
 
The sequences determined were used in the Regulatory Sequence Analysis Tools - 
DNA pattern (van Helden, 2004) in order to find the consensus sequence in the  
D. radiodurans genome. The genes found were analysed with the help of R software 
(www.R-project.org) with the purpose of organising the data retrieved and facilitating its 
analysis. 
 
1.10. D. radiodurans PhoBDBD DNA-binding shift assays in vitro 
 
The assessment of D. radiodurans PhoB DNA binding affinity was performed using 
different DNA sequences. The oligonucleotides presented in Table 2.5, were used for the 
binding assay after annealing. 
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Table 2.5- Primers used for D. radiodurans PhoB DNA binding assays. 
 Properties Sequence  
BA without gap 
(PhoB promoter)1 
5' GCGGCGCCGGGGGGCCGCGGCG 3' 
3' CGCCGCGGCCCCCCGGCGCCGC 5' CUBIC 
 
BA with a gap of 3bp 
between boxes 
5' GCGGCGCCGGGTCTGGGCCGCGGCG 3' 
3'CGCCGCGGCCCAGACCCGGCGCCGC 5' 
2 boxes repeated 
5' GTTCACCCGCCGTTCACCCGCC 3' 
3' CAAGTGGGCGGCAAGTGGGCGG 5' S. 
coelicolor 4 boxes repeated 5' GTTCACCCGCCGTTCACCCGCCGTTCACCCGCCGTTCACCCGCC 3' 
3' CAAGTGGGCGGCAAGTGGGCGGCAAGTGGGCGGCAAGTGGGCGG 5' 
1
- PhoB promoter region sequence found from CUBIC analysis in Table 5.1 of ChapterVI. 
 
The individual oligonucleotides were diluted in water to a final concentration of  
1 nmol/µl. Complementary oligonucleotides were then mixed in equal amounts, 
denatured at 368 K for 5 minutes then allowed to cool to room temperature. The final 
concentration of each double stranded DNA stock solution was 0.5 nmol/µl. The double 
stranded DNA was then radiolabelled using [γ-32P]ATP in the presence of the T4 
Polynucleotide Kinase (T4 PNK). This kinase promotes the transfer of the γ -phosphate of 
ATP to the 5'-termini of double stranded DNA. The reactions were carried out at 310 K 
for one hour, and the radiolabelled DNA purified using illustra MicroSpin™ G-25 
columns from GE Healthcare. The DNA was eluted with deionised water maintaining the 
same concentration assuming all DNA is recovered. 
DNA-binding analyses were performed using the PhoBDBD domain to avoid 
phosphorylation issues. The assay was performed using different concentrations presented 
in Table 2.6. 
The DNA-binding buffer 5x used in the assay consisted of 10 mM Tris-HCl pH 8, 
0.4 mM MgCl2, 10 mM KCl, 0.2 mM DTT and 13 % glycerol. Mixtures were incubated 
at 303 K for one hour and then analysed on a 8 % polyacrylamide Tris-HCl native gel and 
transferred to a nylon HybondTM-N+ Amersham membrane. The membrane was dried and 
exposed over-night on a phosphoimager screen (Typhoon 9410) for the identification of 
radioactive bands. 
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Table 2.6- Samples mixtures for the PhoBDBD DNA-binding assay. 
 Sample 
 1 2 3 4 5 6 7 8 
BSA 54 pmol - - - - - - - 
Cold DNA1 + + + + + + + + 
Hot DNA2 + - + + + + + + 
DNA-binding 
buffer 5x3 
+ + + + + + + + 
PhoBDBD - 54 pmol 14 pmol 34 pmol 54 pmol 74 pmol 94 pmol 114 pmol 
1
- 25 fmol of zebrafish DNA; 2- 25 fmol of radiolabelled DNA, 3- Diluted 5 times, (+) - present and  
(-) - absent. 
 
2. Crystallisation trials 
 
2.1. D. radiodurans PhoRFL  and PhoBFL crystallisation trials 
 
Crystallisation trials were set up for constructs both with and without the hexa-
histidine tag present. Initial trials were performed using the High Throughput 
Crystallisation facility of the EMBL Grenoble outstation (https://embl.fr/htxlab/). The 
experiment is set up in Greiner Crystal Quick plates in which sitting drops of 200 nl are 
deposited using a Cartesian PixSys 4200 (Genomic Solutions) robot. The drops, 
containing a 1:1 ratio of protein stock: crystallisation solution, were equilibrated against 
88 µl of crystallisation solution at both 293 K and 278 K. The commercial crystallisation 
solutions used are presented in Table 2.7. 
Crystallisation trials were also set up by hand using 24 well VDXm plates 
(Hampton Research). In these experiments 2 µl hanging or sitting drops, containing 1 µl 
of protein stock and 1 µl of crystallisation solution, were equilibrated against 500 µl of 
crystallisation solution. The list of solutions used in this process is presented in Table 2.8.  
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Table 2.7- Commercial screens used in HTX-EMBL platform crystallisation trials of 
PhoRFL and PhoBFL (with and without the His6-tag). 
Plate Crystallisation screen1 
1 Crystal Screen I & II 
2 Crystal Screen Lite & PEG/Ion 
3 MembFac & Natrix 
4 QuickScreen & Grid screens Ammonium Sulfate, Sodium Malonate - Sodium Formate 
5 Grid screens PEG 6K, PEG/LiCl, MPD - Screen Mme 
6 Index Screen 
1
- supplied by Hampton Research. 
 
Table 2.8- Commercial screens used in crystallisation trials set up manually for PhoRFL 
and PhoBFL (with and without the His6-tag). 
PhoRFL   PhoBFL 
- Crystal Screen I and II (Hampton 
Research) 
- Natrix (Hampton Research) 
- PACT premier I and II (Molecular 
Dimensions) 
- Wizard Screen I and II (Emerald 
BioSystems) 
  - Crystal Screen I and II (Hampton 
Research) 
- Sodium Malonate Grid Screen (Hampton 
Research) 
- PEG/Ion screen(Hampton Research) 
- Natrix (Hampton Research) 
- Structure Screen I (Molecular 
Dimensions) 
- PACT premier I and II (Molecular 
Dimensions) 
- Wizard Screen I and II (Emerald 
BioSystems) 
 
PhoRFL crystallisation trials were set up using protein concentrations of 4, 7, 8 and 
13 mg/ml; and optimisation experiments performed at 8 mg/ml. To try to improve the 
chances of PhoRFL crystallisation, substrates and Mg2+ cation were added to 
crystallisation mixture. The substrates added were ATP, its conversion product ADP and 
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the non-hydrolysable homologue substrate, AMP-PNP. Substrates and magnesium 
chloride were added to the protein stock solution to a final concentration of 1 mM. 
Optimisation of the most promising conditions (phase separation, spherulites and 
crystalline precipitant) carried out in 24 well VDXm plates. 2 µl hanging or sitting drop 
(1:1 ratio) were equilibrated against 500 µl of the crystallisation solution. The 
optimisation consisted, for each condition considered, in the systematic variation of 
several parameters. The first modifications included varying the concentration of the 
precipitants that yielded the most promising conditions. Based on the same conditions, a 
pH screen was also done using both the buffer of the original condition and different 
buffers that act at similar pH values. Crystallisation temperature was also screened (277, 
287, 293 and 303 K). Optimisations were performed to the following initial conditions: 
- 0.1 M Potassium chloride, 0.01 M Calcium chloride, 10 % (v/v) PEG 400 and 
HEPES sodium pH 7 ; 
- 0.01 M Magnesium chloride hexahydrate, 5 % (v/v) 2-propanol and 0.05 M Tris-
HCl pH 7.5; 
- 10 % (v/v) 2-propanol, 0.1 M Tris-HCl pH 8.5; 
- 5 % (v/v) MPD and Tris-HCl pH 8.4. 
 
Crystallisation trials of PhoBFL were performed at 10, 23, 30, 42 mg/ml. 
Optimisation was performed manually in 24-well VDX plates using hand made stock 
solutions for the reservoir solution mix. Drops of 2 µl with a 1:1 protein:reservoir solution 
ratio were equilibrated against 500 µl of reservoir solution. Here, trials were set up using 
different PEG precipitants at different percentage concentrations. The substitution of 
HEPES sodium buffer for Tris-HCl at the same pH values and at the same concentrations 
was also tested. 
During the process of attempted optimisation seeding techniques were also 
employed. For macroseeding, drops of 2 µl were made with a 1:1 ratio between protein 
and crystallisation condition and a single crystal transferred to the drop. For 
microseeding, two crystals were transferred to a 1.5 ml eppendorf tube containing 50 µl 
of the crystallisation solution. The tube was then vortexed for 2 minutes to break the 
crystals. The solution obtained was then used as an additive to the crystallisation drop. 
Drops of 2 µl were set up in which 1 µl corresponds to the protein volume, 0.8 µl to the 
crystallisation solution and 0.2 µl to the eppendorf solution containing the microseeds. 
For streak seeding, drops of 2 µl were set up with a 1:1 ratio between protein and 
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crystallisation solution. Crystals from an older drop were touched using a Hampton 
Research seeding tool which was then passed through the new drop. 
 
2.2. D. radiodurans PhoRDHpD, PhoRCAD, PhoBRD and PhoBDBD 
crystallisation trials  
 
Crystallisation trials were also set up for the different PhoR and PhoB domains 
obtained. These are summarised in Table 2.9. 
The concentrations used for the crystallisation trials for PhoBRD were 3.5 and  
6.6 mg/ml; for PhoBDBD 6 and 11.2 mg/ml; for PhoRDHpD 7.5 mg/ml; and for PhoRCAD 3 
and 6 mg/ml.  
 
Table 2.9- Commercial screens used for crystallisation trials of PhoR and PhoB domains. 
Protein Domains Screens 
PhoRDHpD 
- HTX-EMBL platform screens (Table 2.7)* 
- PEG/Ion Screen (Hampton Research) 
- Quik Screen (Hampton Research) 
- Crystal Screen I (Hampton Research) 
- Crystal Screen II (Hampton Research)  
PhoR 
PhoRCAD 
- HTX-EMBL platform screens (Table 2.7)* 
- Sodium Malonate Grid Screen (Hampton Research) 
- Quik Screen (Hampton Research) 
- Crystal Screen I (Hampton Research) 
- Crystal Screen II (Hampton Research)  
PhoBRD 
- HTX-EMBL platform screens (Table 2.7)*  
- Sodium Malonate Grid Screen (Hampton Research) 
- Crystal Screen I (Hampton Research) 
- Crystal Screen II (Hampton Research) 
PhoB 
PhoBDBD 
- HTX-EMBL platform screens (Table 2.7)* 
- Quik Screen (Hampton Research) 
- Crystal Screen I (Hampton Research) 
- Crystal Screen II (Hampton Research)  
- Ammonium sulphate grid screen (Hampton Research) 
* constructs with His6-tag. 
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Optimisation was performed for the most promising initial crystallisation conditions 
as described in §2.1. 
All PhoBDBD crystallisation optimisation was done using 6 mg/ml protein 
concentration. Further optimisation was done using macroseeding and microseeding 
techniques as previously described in §2.1. 
Optimisation of the crystallisation conditions of PhoRDHpD and PhoRCAD was done 
based on the analysis of the drops set up with commercial screens as described for PhoRFL 
and PhoBFL. 
 
3. Data collection and structure determination 
 
 All crystals obtained were tested for diffraction properties at various beamlines of 
the European Synchrotron Radiation Facility (ESRF). Tests of diffraction quality were 
carried out using either the DNA (Leslie et al., 2002) or EDNA software 
(http://www.edna-site.org/, Incardona et al., 2009) and, in the case that diffraction quality 
was sufficient, full data sets collected according to strategies calculated by these software 
packages. 
For full data sets, diffraction images were integrated with iMOSFLM (Leslie, 2006) 
and intensities scaled using SCALA (Evans, 2006). Space group determination was 
carried out POINTLESS (Evans, 2006) and solvent content analysed using MatthewsCoef 
(Matthews, 1968). Structure factors were derived from scaled intensity data using 
TRUNCATE (French et al., 1978). The programs cited here are from the CCP4 suite 
(Collaborative Computational Project, 1994).  
 
3.1. D. radiodurans PhoBFL 
 
One crystal obtained was tested on ESRF beamline ID23-2 after being cryo-
protected by adding 25 % (v/v) glycerol to the crystallisation solution. Data collection 
parameters are described in Table 2.10. Unfortunately a complete data set could not be 
collected from this crystal (see Results) due to the onset of radiation damage. 
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Table 2.10- X-ray diffraction data collections for PhoBFL crystal. 
Dataset PhoBFL 
Source ESRF ID23-2 
Detector MAR Mosaic 225 CCD 
Wavelength (Å) 0.8726 
Exposure time (s) 2 
Oscillation range (º) 0.5 
Number of images 20 
Crystal - obtained with 8 % (w/v) PEG 8000 and 10 mM HEPES sodium pH 7.4 
 
 
3.2. D. radiodurans PhoBDBD 
 
PhoBDBD crystals were cryo-protected using 25 % (v/v) glycerol, independent of the 
condition in which the crystals were obtained and tested as described in Table 2.11. 
 
Table 2.11- Diffraction quality tests for PhoBDBD crystals. 
Dataset PhoBDBD crystal 1 PhoBDBD crystal 2 
Source ESRF ID23-2 ESRF ID14-4 
Detector MAR Mosaic 225 CCD Q315r ADSC CCD 
Wavelength (Å) 0.8726 0.9395 
Exposure time (s) 1 0.5 
Oscillation range (º) 1 1 
Number of images 2 2 
Crystal 1- obtained with 4.3 M NaCl, 0.1 M HEPES sodium pH 7.5 
Crystal 2- obtained with 1.8 M Na/K Phosphate pH 5.6 
 
3.3. D. radiodurans PhoRDHpD 
 
PhoRDHpD crystal 1 was cryo-protected with 25 % (v/v) glycerol. Crystal 2 was not 
further cryo-protected as it was grown in the presence of 15 % (v/v) glycerol. The crystals 
were flash cooled in liquid nitrogen and diffraction data collected as described in Table 
2.12. 
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Table 2.12- X-ray diffraction data collections for PhoRDHpD crystals. 
Dataset PhoRDHpD crystal 1 PhoRDHpD crystal 2 
Source ESRF ID23-1 ESRF ID23-2 
Detector Q315r ADSC CCD MAR Mosaic 225 CCD 
Wavelength (Å) 1.0723 0.8726 
Exposure time (s) 0.2 2 
Oscillation range (º) 1 3 
Number of images 2 90 
Crystal 1- obtained with 12 % (w/v) PEG 3350, 0.2 M NaSO4 and 0.1 M HEPES sodium pH 7.2; 
Crystal 2- obtained with 25.5 % (w/v) PEG 4000, 0.085 M Tris-HCl pH 8.5, 0.17 M sodium acetate and 15 % (v/v) 
glycerol.   
 
3.3.1. Structure solution 
 
For structure determination attempts, Chainsaw (Stein, 2008) from the CCP4 suite 
(Collaborative Computational Project, 1994) was used to construct search models from 
the crystal structures of the homologs HK0853DHpD from T. maritima (pdb code: 2c2a) 
and ThkADHpD from  
T. maritima (pdb code: 3a0t). In particular, regions in which amino acid sequence was not 
conserved were deleted from the models (Figure 2.4).  
 
Figure 2.4- Search models used for PhoRDHpD molecular replacement protocols. 
HK0853DHpD dimer from T. maritima (A) and ThkADHpD dimer from T. maritima (B). 
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Molecular replacement calculations were performed using both the monomeric and 
dimeric search models with the programs Phaser (McCoy et al., 2007) and MolRep 
(Vagin et al., 2009) also from CCP4 suite (Collaborative Computational Project, 1994). 
 
3.4. D. radiodurans PhoRCAD 
 
Crystals of PhoRCAD were equilibrated into mother liquor comprising the 
crystallisation solution supplemented with 17 % (w/v) PEG 4000 then transferred to a 
cryo-protectant solution containing 20 % (v/v) glycerol. Both solutions were previously 
incubated at 287 K. Crystals were then flash cooled in liquid nitrogen and diffraction 
experiments carried out as described in Table 2.13. 
 
Table 2.13- X-ray diffraction data collections for PhoRCAD crystals. 
Dataset PhoRCAD 
crystal 1 
PhoRCAD crystal 
2 
PhoRCAD crystal 
3 
PhoRCAD crystal 
4 
 - ADP* ATP* - 
Source ESRF ID23-1 ESRF ID23-2 ESRF ID23-2 ESRF ID23-2 
Detector Q315r ADSC 
CCD 
MAR Mosaic 225 
CCD 
MAR Mosaic 225 
CCD 
MAR Mosaic 225 
CCD 
Wavelength (Å) 1.0723 0.8726 0.8726 0.8726 
Exposure time (s) 0.1 1 1 2 
Oscillation range (º) 0.8 1 1 2 
Number of images 2 2 2 70 
Crystal 1 - obtained with 0.1 M Tris-HCl pH 8.8, 14 % (w/v) PEG 4000 and 0.2 M MgCl2 at 287 K; 
Crystal 2, 3 and 4- obtained same condition but temperature maintained at 287 K; 
* - Co-crystallised with substrates. 
 
3.4.1. Structure solution 
 
The crystal structures of monomers of PhoRCAD homologues (note: the crystal 
structure of ThkA structure from T. maritima was not yet available) were superimposed in 
Coot version 0.5.2 (Emsley et al., 2004), loops deleted and the PhoRCAD amino acid 
sequence imposed using Chainsaw (Stein, 2008). The crystals structures superimposed 
were: 
- HK0853CAD from T. maritima (pdb code: 2c2a: 29 % sequence identity); 
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- NtrBCAD from E. coli (pdb code: 1r62: 27 % sequence identity); 
- PrrBCAD from M. tuberculosis (pdb code: 1ys3: 26 % sequence identity). 
 
Figure 2.5- Ensemble used for D. radiodurans PhoCAD molecular replacement protocols. 
Superimposition of the structure of HK0853CAD from T. maritima (pink), NtrBCAD from E. coli (green) and 
PrrBCAD from M. tuberculosis (blue) after deletion of non conserved regions and treatment with Chainsaw. 
 
Molecular replacement calculations were carried out using Phaser (McCoy et al., 
2007), in conjunction with the ensemble of homologue search models created above 
(Figure 2.5). The resulting solution was improved using ArpWarp (Perrakis et al., 2001) 
and Coot (v.0.5.2) (Emsley et al., 2004) to provide a starting model for structure 
refinement. Refinement of the model was carried out using Phenix.refine (Adams et al., 
2010) interspersed with manual rebuilding and the addition of water molecules using 
Coot. During the first three rounds of refinement non crystallographic symmetry (NCS) 
restraints were imposed. Each round of refinement consisted of an initial rigid body cycle 
followed several cycles of simulated annealing. In the last refinement cycles occupancies 
were refined as well as TLS (Translation/Libration/Screw) parameters. Validation of the 
model was done using Molprobity (Davis et al., 2007).  
 
3.4.2. Bio3D PhoRCAD structure comparison analysis 
 
 Structure comparison analyses were carried out in the program R (v2.9.2) (www.R-
project.org) using the bio3D (v1.0-7) package (Grant et al., 2006). 
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 Two main analyses were performed using this approach: first, the comparison of the 
PhoRCAD molecules found in the asymmetric units of D. radiodurans PhoRCAD crystals; 
second, the comparison of the structure of D. radiodurans PhoRCAD with all known 
homologues. To determine which homologue structures to use for comparison analysis a 
sequence search was done in the Protein Data Bank (www.pdb.org). The homologues 
proteins identified are presented in Table 2.14. 
 
Table 2.14- Crystal structures of D. radiodurans PhoRCAD homologues found in the 
Protein Data Bank. 
Protein PDB id Microorganism Seq. Identity (%) Residues 
HK_0853CAD 2c2a T. maritima 20 321-442 
ThkA CAD 3a0t T. maritima 27 604-755 
PhoQ CAD 1id0 E. coli 15 335-480 
PrrB CAD 1ys3 M. tuberculosis 18 299-446 
NtrB CAD 1r62 E. coli 19 194-349 
PhoQ CAD 3cgz S. typhimurium 15 331-487 
 
 In both intra crystal and intercrystal studies the rigid core of the different PhoRCAD 
subunits was determined in order to allow the superposition of the structures 
(core.find(pdbs) function). This analysis was followed by the Principle Component 
Analysis (PCA) and hierarchical cluster analysis (HCA). In the PCA, the contribution of 
each residue for the principal components was used to describe the system (pc.xray 
function). HCA was performed using the matrix of the scores of the given coordinates for 
component used for describing the system in the PCA (hclust function of pc.xray 
distance) (http://bio3d.pbworks.com/f/bio3d_vignette.pdf). 
 
4. Small angle X-ray scattering analysis (SAXS) 
 
Data were collected at the BioSAXS station (ID14-3) of the ESRF 
(http://www.esrf.fr/UsersAndScience/Experiments/MX/About_our_beamlines/ID14-3). 
Samples of 30 µl volume were exposed using X-rays with energy of 13.32 keV  
(λ = 0.931 Å) and the sample moved through the beam during exposure to minimise the 
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effect of radiation damage. The protein samples were in the final buffers described in 
§1.2. 
For each construct SAXS curves were measured at three different protein 
concentrations in order to assess and remove any concentration inter particle effects 
(Table 2.15). 2 mM dithiothreitol (DTT) was added to the protein buffer prior to 
measurements, in order to reduce the effect of radiation damage, acting as a free radical 
scavenger. 
 
Table 2.15- Concentrations of the constructs used for SAXS measurements. 
Protein PhoRFL PhoRDHpD PhoRCAD PhoBFL PhoBRD PhoBDBD 
11.8 10.8 12.3 11.8 11.4 5.4 
6.3 5.8 6.6 6.8 6.7 2.2 
Concentrations 
(mg/ml) 
3.7 2.4 2.8 2.2 2.2 - 
 
Between each experiment the cell containing the measured sample was cleaned 
(using a commercial detergent for quartz capillaries), rinsed (with distilled water) and 
dried using compressed air, in order to minimise cross contamination and dilution of the 
samples. 2D scattering images were collected using Vantec200 gas filled detector 
(Bruker) at a distance of 1.745 m from the sample. A data collection time of 5 minutes 
was used for all samples. This was split into ten 30 second frames to help assess and 
remove effects from radiation damage to the samples. 
Individual frames were processed automatically and independently using software 
(http://www.esrf.eu/UsersAndScience/Experiments/MX/About_our_beamlines/ID14-3/ 
Users/data_collection.html) developed at the ESRF. This yielded individual radially 
averaged curves of normalised intensity versus scattering angle (s=4πSinθ/λ). Frames 
were then combined, excluding any data points affected by aggregation induced by 
radiation damage to give an average scattering curve for each measurement. The 
scattering from the buffer alone was measured before and after each sample measurement 
and the average of these scattering curves used for background subtraction using the 
program PRIMUS (Konarev, 2003) from the ATSAS package (Konarev, 2006) which 
also allows determination of parameters such as radius of gyration (Rg) and forward 
scattering I(0) (determined by Guinier approximation) and Porod volume (excluded 
volume of the hydrated particle). GNOM (v4.5) (Svergun, 1992) was then used for the 
determination of the maximum particle size (Dmax) in order to prepare the data for 
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modelling, checking parameters such as OSCILL, POSITV and VALCEN for validation. 
Curve fitting was performed considering a monodisperse model. 
Protein envelopes were determined using DAMMIN (Svergun, 1999). Ten runs 
were performed in slow mode for each construct. The output coordinate files were then 
averaged using DAMAVER (Volkov, 2003) and a final run of DAMMIN performed. 
 For PhoRFL and PhoRDHpD a prolate shape and a P2 symmetry, based on the 
structures of homologous proteins structures was imposed during the envelope calculation 
protocol. 
The envelopes obtained were superposed to the crystal structures of homologues 
using SUPCOM (Kozin et al., 2001). The models were then further adjusted in Pymol 
version 0.99 (DeLano, 2002). 
For PhoRFL another envelope was calculated using SASREF (Petoukhov et al., 
2005). Here, the positions of T. maritima HK0853DHpD dimer and two D. radiodurans 
PhoRCAD were refered keeping the connection between the domains, in order to get a 
better fit to the experimental scattering data. 
CRYSOL (Svergun et al., 1995) was used to determine the fit between experimental 
data and theoretical scattering data from the crystal structures of homologous proteins. 
The fits of the several analyses were plotted with a new cross platform version of 
SASPLOT for Linux developed by the ATSAS team EMBL Hamburg. 
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In this chapter the properties of the D. radiodurans putative PhoR histidine kinase 
and PhoB response regulator will be shown. For all constructs obtained the 
characterisation will include purification profiles, purity and activity. PhoR 
autophosphorylation, PhoR and PhoB phosphotransfer and PhoB DNA binding capacity 
are also assessed. 
The only crystal structure described is that of PhoRCAD. This is compared with the 
crystal structures of known homologues using a statistical analysis approach. Due to the 
lack of crystallographic structural information, small angle X-ray scattering (SAXS) 
technique was also used to obtain some structural information. This is also described in 
this Chapter. 
 
1. Pho system proteins stability and biochemistry 
 
Since crystallographic structural studies depend on protein crystallisation, the 
individual domains of PhoR and PhoB (Figure 3.1) were also cloned in order to reduce 
protein flexibility and increase crystallisation probability.  
 
 
 
 
 
 
Figure 3.1- PhoR and PhoB domains. 
A- PhoR is composed of N-terminal DHpD (residues 1 to 78) and a C-terminal CAD (residues 79 to 224). 
B- PhoB is composed by N-terminal RD (residues 1 to 121) and a C-terminal DBD (residues 130 to 230).  
 
1.1. Purification of D. radiodurans PhoRFL, PhoRDHpD and PhoRCAD 
 
The overexpression of PhoRFL and its individual domains, PhoRDHpD and PhoRCAD, 
was performed recombinantly in E. coli BL21 cells using a pET151-D Topo cloning 
vector. The initial purification step for all constructs was affinity chromatography using a 
nickel column and elution via an imidazole gradient. The behaviour of PhoRFL, PhoRDHpD 
and PhoRCAD during this first step of purification is shown in §1.1 of Chapter VI. PhoRFL 
A 
B 
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purification yielded 24 mg per litre of culture, PhoRDHpD 28 mg per litre of culture and 
PhoRCAD 17 mg per litre of culture. 
Due to the existence of contaminants in all the PhoR constructs obtained, further 
purification steps were required. The addition of hexa-histidine tags to protein constructs 
is useful for initial protein purification; however the inclusion of those tags may alter 
protein behaviour. Keeping this in mind, many constructs allow the cleavage of these 
extensions. The vector pET151-D Topo, used for overexpression of the proteins includes 
a TEV protease cleavage site. By incubating the expressed proteins with TEV protease, 
the hexa-histidine tag is removed, leaving the following residues - GIDPFT - as an  
N-terminal extension in each construct. 
The existence or absence of the hexa-histidine tag may or may not be relevant for 
the crystallographic studies. When expressing small protein domains, the insertion of the 
tag leads to the inclusion of a big flexible region to the construct. In other cases this 
region allows formation of contacts that can promote protein crystallisation. All 
constructs used in the following studies were thus examined either with or without TEV 
protease treatment so that the effect of the existence of the tag could be monitored. The 
behaviour of PhoRFL, PhoRDHpD and PhoRCAD during the cleavage of the His6-tags is 
shown in §1.1 of Chapter VI. 
Following TEV protease cleavage, PhoRFL is the only protein that needed an extra 
purification step to remove the remaining contaminants. Size exclusion chromatography 
is the technique most commonly used as a last purification step and allows separation of 
proteins by their apparent size. This technique is, in addition used, for a buffer exchange 
and allows estimation of the proteins oligomeric state based on elution volume. The 
technique was also performed for PhoRDHpD and PhoRCAD, as a means to determine 
oligomeric homogeneity. For structural studies it is highly important to have the proteins 
in a single oligomeric state. 
Several columns are available for size exclusion chromatography allowing different 
ranges of protein separation. For an estimation of oligomeric state, a calibration curve for 
the column is required. This calibration is done by determining the elution volume of 
globular proteins with known molecular weights (§2.1 of Chapter VI) and establishing a 
linear regression in which the elution volume is related to protein molecular weight. The 
linear regression is optimised for globular proteins. Proteins with different shapes present 
a different elution behaviour which is not taken under consideration by such a calibration. 
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1.1.1. PhoRFL size exclusion chromatography 
 
For PhoRFL analytical chromatography was performed using a SuperdexTM 200 
column in order to determine the oligomeric state more accurately. Only one peak with a 
narrow shape is observed in the chromatogram; indicative of a single species in solution 
(Figure 3.2). The fact that the absorption measured at 260 nm (A260nm) is much lower than 
the absorption measured at 280 nm (A280nm) indicates a low nucleic acid contamination. In 
this chromatogram the A280nm/A260nm ratio is 2.17. This is much higher than the value of 
1.7, above which, according to Warburg and Christian, nucleic acid contamination can be 
neglected for PhoRFL produced (Warburg, 1942). 
Nevertheless, for improvements of sample purity and homogeneity, a Hiprep 16/60 
Sephacryl S100 size exclusion chromatography was also used (chromatogram in §2.2 of 
Chapter VI). 
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Figure 3.2- Size exclusion chromatogram of PhoRFL using a SuperdexTM 200 column.  
The black line shows A280nm and the grey line A260nm. PhoRFL is eluted at 14.7 ml. 
 
On the SuperdexTM 200 column PhoRFL elutes in a single peak at an elution volume 
of 14.7 ml, which corresponds to a species of a molecular weight of approximately  
51 kDa (calibration curve in §2.1 of Chapter VI). Since PhoRFL monomers have a 
molecular weight of 25425 Da (24794 Da of PhoRFL plus 649 Da for the GIDPFT  
N-terminal extension), this behaviour suggests that PhoRFL exists as a dimer in solution 
and is consistent with other studies done to homologous proteins (Marina et al., 2005). 
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1.1.2. PhoRDHpD size exclusion chromatography 
 
In size exclusion chromatography, PhoRDHpD elutes as a single peak with an elution 
volume of 15.3 ml suggesting that the molecular weight is approximately 38.4 kDa 
(Figure 3.3). This is consistent with a tetrameric oligomerisation state. However, 
structural homologues of PhoRDHpD are elongated dimers composed of alpha helical 
domains (Casino et al., 2009, Yamada et al., 2009, Marina et al., 2005, Bilwes et al., 
1999). The elution volume observed may thus also be consistent with a dimer of 
molecular weight 19 kDa that has an elution volume retarded due to the protein shape. 
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Figure 3.3- Size exclusion chromatogram of PhoRDHpD using a SuperdexTM 200 column.  
The black line shows A280nm and the grey line A260nm. PhoRDHpD is eluted at 15.3 ml. 
 
1.1.3. PhoRCAD size exclusion chromatography 
 
The elution volume of PhoRCAD is 17 ml consistent with a molecular weight of 
approximately 17 kDa (Figure 3.4) indicating that PhoRCAD is a monomer (15717 Da of 
PhoRCAD plus 649 Da for the GIDPFT N-terminal extension) in solution. In the 
chromatogram for PhoRCAD the A280nm/A260nm ratio is 1.6, suggesting a low nucleic acid 
contamination (Warburg, 1942).  
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Figure 3.4 - Size exclusion chromatogram of PhoRCAD using a SuperdexTM 200 column.  
The black line shows A280nm and the grey line A260nm. PhoRCAD is eluted 17 ml. 
 
Following the purification protocol PhoRFL, PhoRDHpD and PhoRCAD were 
concentrated for storage and for further studies. The proteins were concentrated to 
different final concentrations due to their different properties and stability in solution. For 
PhoRFL the final concentration was 17 mg/ml, for PhoRDHpD it was 7 mg/ml and for 
PhoRCAD it was 6 mg/ml. 
Each construct was purified to apparent homogeneity (Figure 3.5) and is therefore 
suitable for biochemical and structural studies. To reinforce the SDS-Page gel and the 
size exclusion chromatography analysis, dynamic light scattering (DLS) measurements 
were performed on the three protein samples. DLS results reinforce the conclusions from 
size exclusion chromatography and are shown in §1.1 of Chapter VI.  
 
 
Figure 3.5- SDS-Page gel analysis of PhoRFL, PhoRDHpD and PhoRCAD after 
concentration. 
PhoRDHpD is in lane 1, PhoRCAD in lane 2 and PhoRFL in lane 3. MW marker is on the left side of the gel. 
Chapter III 
 
Doctoral thesis of Sofia Caria 72 
1.2. Purification of D. radiodurans PhoBFL and the domains PhoBRD 
and PhoBDBD 
 
The overexpression and purification of PhoBFL, PhoBRD and PhoBDBD; was 
performed using a similar approach to that described for PhoR constructs (§1.2 of Chapter 
VI) and yielded 26 mg of PhoBFL, 6 mg of PhoBRD and 18 mg of PhoBDBD per litre of 
culture. Size exclusion chromatography was performed on all the constructs. 
 
1.2.1. PhoBFL size exclusion chromatography 
 
PhoBFL (Figure 3.6) elutes in two peaks, suggesting that the protein has two 
different oligomeric states in solution. This conclusion is supported by the fact that 
analysis, using SDS-Page gels, of samples retrieved in both peaks shows a single protein 
of a molecular weight of approximately 27 kDa (26081 Da of PhoBFL plus 649 Da of the 
N-terminal extension). The elution volumes of the peaks are 14.61 and 16.05 ml and 
correspond to molecular weights of 53.3 and 26.9 kDa respectively.  
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Figure 3.6- Size exclusion chromatogram of PhoBFL using SuperdexTM 200 column.  
The black line shows A280nm, and the grey line A260nm. PhoBFL is eluted in two peaks with elution volumes 
of 14.6 and 16.1 ml, respectively.  
 
The gel filtration chromatogram thus suggests that in solution PhoBFL exists both as 
a dimer (minor form) and a monomer (major form) in solution. PhoB homologs have been 
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mainly observed as monomers in solution, but is accepted that upon phosphorylation the 
protein dimerises thereby acquiring a good conformation for DNA-binding (King-Scott et 
al., 2007). 
For structural studies, namely SAXS, it is important to have not only a pure sample 
but also a homogeneous one (Koch et al., 2003). For this reason PhoBFL was further 
purified using a Hiprep 16/60 Sephacryl S100 column (chromatogram in Chapter VI 
§2.2). The purpose of this extra purification step was to isolate the main species in 
solution - the PhoBFL monomer - for further studies. 
 
1.2.2. PhoBRD size exclusion chromatography  
 
PhoBRD is eluted in a narrow single peak indicating the existence of a single species 
in solution (Figure 3.7). The A280nm/A260nm ratio is 1.3 suggesting nucleic acid 
contamination of about 1.25 % in the sample (Warburg, 1942). 
 
 
PhoBRD - SuperdexTM 200
0
500
1000
1500
2000
2500
0 2 4 6 8 10 12 14 16 18 20 22 24
Volume (mL)
m
A
U
260nm
280nm
 
Figure 3.7- Size exclusion chromatogram of PhoBRD using the SuperdexTM 200 column.  
The black line shows A280nm, and the grey line A260nm. The PhoBRD is eluted at 17.6 ml. 
 
PhoBRD elutes at 17.6 ml corresponding to a molecular weight of 12.9 kDa (Figure 
3.7). PhoBRD thus behaves as a monomer in solution since the molecular weight of the 
construct is 13924 Da (13275 Da from PhoBRD plus 649 Da from the N-terminal 
extension). 
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1.2.3. PhoBDBD size exclusion chromatography  
 
PhoBDBD is eluted in a narrow single peak indicating the existence of a single 
species in solution (Figure 3.8). However, the A280nm/A260nm ratio is 1.3 suggesting 
nucleic acid contamination of about 1.25 % in the sample (Warburg, 1942). 
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Figure 3.8 - Size exclusion chromatogram of PhoBDBD using the SuperdexTM 200 
column.  
The black line shows A280nm, and the grey line A260nm. PhoBDBD is eluted at 17.2 ml. 
 
The PhoBDBD elutes at 17.2 ml, indicating a molecular weight of 15.6 kDa. As 
PhoBDBD has a molecular weight of 12.6 kDa (11934 Da of protein plus 649 Da from the 
N-terminal extension), this indicates a monomer in solution (Figure 3.8). The difference 
between the estimated molecular weight and the real molecular weight may be due to the 
shape of the domain. 
 
After purification protocol either with (PhoBFL) or without (PhoBRD and PhoBDBD) 
an additional size exclusion chromatography step, all constructs were concentrated for 
further studies. Final concentrations were 22 mg/ml for PhoBFL, 12.4 mg/ml for PhoBRD 
and 7 mg/ml for PhoBDBD. Protein purity was verified by SDS-Page gel analysis (Figure 
3.9). It is clear that all construct were purified to apparent homogeneity (Figure 3.9) and 
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therefore suitable for biochemical and structural studies. To reinforce this conclusion 
DLS analysis was also performed for all PhoB constructs (§1.2 of Chapter VI). 
 
Figure 3.9- SDS-Page analysis of PhoBFL, PhoBRD and PhoBDBD after concentration.  
A- PhoBRD in lane 1 and PhoBFL in lane 2; B- PhoBDBD in lane 1. 
 
1.3. In vitro analysis of D. radiodurans PhoR autophosphorylation 
activity  
 
Histidine kinases are known to have an autophosphorylation activity (Himpens et 
al., 2000, Montagne et al., 2001, Yamada et al., 2006). One of the questions to be 
addressed is whether, for protein autophosphorylation, a physical linking of the histidine 
kinase domains is needed or if a simple proximity between the domains is enough to 
guarantee the phosphorylation. We therefore determined the autophosphorylation capacity 
of PhoRDHpD and PhoRCAD. For this analysis (§2.1.3 of Chapter II) [γ-32P]ATP was 
incubated with PhoRDHpD alone, with PhoRCAD alone, with the mixture of PhoRDHpD and 
PhoRCAD and, finally, with PhoRFL. The assay performed with isolated PhoRDHpD and 
PhoRCAD domains was carried out as negative control. The analysis of two domains 
mixed in equal amounts analysis was done to check if individual PhoRDHpD and PhoRCAD 
could interact effectively and mimic the behaviour of the full-length PhoR protein. 
PhoRFL was incubated with [γ-32P]ATP as a positive control (§1.7 of Chapter II). 
In the conditions used for this study (§1.7 of Chapter II) phosphorylation is 
observed only for PhoRFL (Figure 3.10 lane 4). This result implies that the conditions 
used are suitable for the PhoRFL autophosphorylation assay.  
The individual PhoRDHpD and PhoRCAD are not autophosphorylated is to be 
expected, since the autophosphorylation site is present in PhoDHpD (histidine 23) and the 
PhoRCAD is the domain responsible for ATP binding. It is however also interesting to 
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observe that D. radiodurans PhoR domains (unlike those from E. coli PhoR) are unable to 
interact (Figure 3.10 lane 3) if not physically linked (Carmany et al., 2003).  
 
Figure 3.10- In vitro phosphorylation assays of PhoRDHpD, PhoRCAD, a mixture of these 
two domains and the PhoRFL protein.  
The different constructs were incubated in the presence of [γ-32P]ATP and the divalent cation Mg2+ for 4 
minutes at 303 K. A-SDS-Page analysis, B-phosphoimager scan. The samples are PhoRDHpD (lane 1), 
PhoRCAD (lane 2), PhoRDHpD plus PhoRCAD (lane 3), and PhoRFL (lane 4) in both A and B. 
 
A protein sequence alignment (Figure 3.11) of D. radiodurans PhoRFL and its 
homologues from E. coli, M. tubercolosis and S. coelicolor; shows the insertion of extra 
10 residues in the linker between DHpD and CAD. This suggests that in D. radiodurans 
for autophosphorylation to occur the domains have to be close since interaction is 
abolished when the domains are further apart (Figure 3.11).  
 
To further characterise PhoRFL autophosphorylation in vitro, a temporal analysis 
was performed. Here, assays were performed using PhoRFL constructs with and without 
His6-tag and showed a higher activity for the former. An explanation for this could be that 
during the cleavage of the tag with TEV protease, the protein buffer is contaminated with 
ethylene diamine tetra acetic acid (EDTA) a known chelating agent. Residual amounts of 
this compound may prevent an effective binding of magnesium cations to the protein thus 
disrupting ATP binding which requires the presence of Mg2+ (Tanaka et al., 1998, Marina 
et al., 2001, Bilwes et al., 2001, Yamada et al., 2009). 
 
 
 
 
 
  
Results and Discussion 
 
Doctoral thesis of Sofia Caria 77 
 
           
 
 
 
Figure 3.11- Amino acid sequence alignment of D. radiodurans PhoR (DR_PhoR) with, E. coli PhoR (EC_PhoR), S. coelicolor PhoR 
(SC_PhoR) and M. tuberculosis SenX3 (MT_SenX3). 
The alignment was done using ClustalW2 (Larkin et al., 2007). The output obtained is a Cladogram (A), the sequence identity of the other proteins in relation with  
D. radiodurans PhoR (B) and a sequence alignment that was treated in ESPript2.2 (C). In the sequence alignment the DHpD is highlighted in blue and the CAD in pink. The 
unmarked region between the domains corresponds to the linker.  
Protein Seq. Identity (%) 
DR_PhoR --- 
MT_SenX3 29 
SC_PhoR 31 
EC_PhoR 28 
A B 
C 
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Figure 3.12- In vitro phosphorylation of PhoRFL as a function of time.  
His6-tagged PhoRFL was incubated in the presence of [γ-32P]ATP and the divalent cation Mg2+ at 303 K. 
Samples were taken and the reaction stopped at different times. A- Phosphoimager analysis of samples 
retrieved at different times: (-) no ATP added, (+) ATP is added. B- Graphical representation of PhoRFL 
phosphorylation detected via detection of radioactivity. 
 
 From Figure 3.12 it can be seen that phosphorylation reaches its maximum after 11 
minutes, after which time the radioactivity signal detected does not further increase. 
During the experiment there is no clear sign of protein dephosphorylation, since the 
protein reaches its maximum and stabilises at that value. 
 
1.4. In vitro study of D. radiodurans PhoR-PhoB phosphotransfer 
 
The PhoR-PhoB system, as any other two-component signalling system, depends on 
the interaction between the histidine kinase (PhoR) and the response regulator (PhoB) for 
phosphoryl group transfer. Only by the transfer of the phosphate group is a signal 
transmitted. To validate that the D. radiodurans PhoR and PhoB belong to the same 
signalling system, the phosphoryl group transfer between the two proteins was 
determined. 
The first attempt to perform this assay was carried out with histidine tagged PhoRFL 
and untagged PhoBFL. However, due to the molecular weight similarity between the two 
constructs (28 kDa for PhoRFL and 26.7 kDa for PhoBFL) no clear phosphotransfer could 
be detected (Figure 3.13-A). As a solution to this problem all further analysis of 
phosphotransfer used histidine tagged PhoRFL and untagged PhoBRD (Figure 3.13-B). 
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Figure 3.13- In vitro phosphotransfer from PhoRFL to either PhoBFL or PhoBRD.  
A- phosphoimager scan analysis of a mixture of PhoRFL and PhoBFL; following the addition of [γ32-P]ATP 
(lane 1), 1 minute (lane 2), 2 minutes (lane 3), 3 minutes (lane 4), 4 minutes (lane 5), 10 minutes (lane 6), 
15 minutes (lane 7) and 30 minutes (lane 8). B- phosphoimager scan analysis of PhoRFL and PhoBRD; 
negative control (no PhoR incubated at 303 K for 4 minutes- lane1), sample when [γ32-P]ATP was added to 
proteins mixture (lane 2), 1 minute (lane 3), 3 minutes (lane 4), 5 minutes (lane 5), 7 minutes (lane 6), 9 
minutes (lane 7), 11 minutes (lane 8), 13 minutes (lane 9), 15 minutes (lane 10), 17 minutes (lane 11), 19 
minutes (lane 12) and 30 minutes (lane 13). C- SDS-PAGE showing PhoRFL (lane 1), PhoBRD (lane 2), a 
mixture of PhoRFL and PhoBRD (lane 3), PhoBFL (lane 4), a mixture of PhoRFL and PhoBFL (lane 5).  
D- graphical representation of PhoRFL and PhoBRD phosphorylation as function of time. 
 
Using this system it is clear that, in the presence of PhoBRD, the PhoRFL protein 
loses the radioactivity signal (Figure 3.13-B and D). This indicates a decrease in PhoRFL 
phosphorylation over time. In parallel with this, an increment of radioactivity is observed 
for PhoBRD (Figure 3.13-B and D), indicating an increased phosphorylation. Through this 
analysis it is clear that phosphotransfer occurs between PhoRFL and PhoBRD. Although 
there is a decrease in the amount of phosphorylated PhoRFL, some protein is still 
D 
ho  
 
PhoBRD 
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phosphorylated after 30 minutes, and the PhoBRD gets progressively more phosphorylated 
although at different rates (gel B and graph D, Figure 3.13). 
PhoBRD is in excess in comparison with PhoRFL so this does not limit the 
phosphoryl transfer. The increase of phosphorylated response regulator was expected and 
already observed in similar systems, like the SenX3-RegX3 from M. tuberculosis 
(Himpens et al., 2000). It should be noted however the analysis of phosphotransfer 
efficiency carried out have may be affected by the absence of the DNA-binding domain 
of PhoB.  
 
1.5. Determination of the D. radiodurans consensus Pho box by 
bioinformatic methods 
 
The DNA sequence (Pho box) to which D. radiodurans PhoB binds after activation 
by PhoR is unknown. However, Pho boxes are annotated for systems in other bacterias 
such as S. coelicolor (PhoR-PhoP), E. coli (PhoR-PhoB) or M. tuberculosis (SenX-RegX) 
which are activated upon phosphate starvation (Himpens et al., 2000). 
In order to assess the most probable Pho box sequence for D. radiodurans a 
computational prediction was done using CUBIC (v2.0.2) (Olman et al., 2003), as 
described in §2.1.5 of Chapter II, and produced the DNA consensus sequence shown in 
Figure 3.14. 
The Pho box consensus sequence determined using CUBIC is not identical to the 
sequences previously characterised for S. coelicolor which consists of 
G(G/T)TCA(C/T)(C/T)(C/T)(A/G)(G/C)G (Sola-Landa et al., 2005), B. subtilis 
TTAACA (Qi et al., 1997) and E. coli (C/T)TGTCAT (Makino et al., 1986). As PhoB 
from other bacterias are known to bind as a dimer to a repeated DNA sequence (Blanco et 
al., 2002), an extensive search of the complete D. radiodurans genome was carried out 
looking for regions where the consensus DNA sequence occurred at least twice (note that 
the sequence was searched for in DNA strands both in orientation 5' to 3' and 3' to 5').  
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Figure 3.14- Consensus DNA sequence determined through CUBIC for PhoR-PhoB 
system of D. radiodurans.  
The consensus region (from base 5 to base 14) is as annotated on the image from 5' to 3' and it obtained a 
confidence score of 78.5 % in CUBIC software. The image was obtained using WebLogo server (Crooks et 
al., 2004). 
 
306 genes were identified in this way with some genes containing more than one 
Pho box sequence (Table 5.1, §3 of Chapter VI). A comparison of the genes used for the 
determination of the Pho box in CUBIC (§1.9 of Chapter II) and the genes obtained 
through analysis of D. radiodurans genome (§3 of Chapter VI), shows only 6 genes are 
common. These genes take into account genes that are in the same open reading frame 
(orf) as genes predicted to be regulated by the pho system. The genes that contain the 
possible Pho box on their upstream region are: DR2245 (PhoB), DR1174 (histidine 
kinase) and DRA0205 (histidine kinase). 
The genes DR2419 (histidine kinase), DR2244 (PhoR) and DR2243 (PhoU), are 
contained in the same orf of DR2418 (response regulator) in the first case, and of DR2245 
(PhoB) for the last ones. This finding suggests that the expression of the latest genes 
would be also regulated by the Pho system if the Pho box sequence determined is correct. 
According to the CUBIC prediction, and based on the analysis of the  
D. radiodurans genome, the most common sequence consists of two Pho boxes with 3 
bases pairs superposed (36 %) resulting in a 17 bp consensus region. The others cases of 
study appear with a similar frequency around 10 % (Figure 3.15). However, the cases 
with higher frequency consist of a smaller consensus sequence. This could indicate that 
they are not regulated by the Pho operon, but are just easier to find since there is a smaller 
sequence, imposing less restraints in the search. 
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During the analysis the consensus region in Figure 3.15 was searched for in the 5' to 
3' direction (Box A) and the 3' to 5' direction (Box B) as described in §3 of Chapter VI. 
The search included the possibility of having two boxes A, two boxes B, a box A 
followed by a box B and the opposite (§3 of Chapter VI). All cases were tested with the 
gaps mentioned above. The most commonly sequence found in the genome is box A 
followed by box B (Figure 3.16).  
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Figure 3.15- Graphical representation of the different predicted Pho boxes in  
D. radiodurans genome based on gaps between the consensus sequences.  
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Figure 3.16- Graphical representation of the different predicted Pho boxes in  
D. radiodurans genome on type of box found and in which order.  
 
It is important to keep in mind that these analyses are purely predictions made by 
computer software based on knowledge of the Pho operon on other bacteria, and from 
assumptions imposed. To confirm the CUBIC predicted Pho box, DNA binding assays 
have to be performed using PhoB. 
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1.6. PhoBDBD DNA-binding shift assays 
 
As previously mentioned in §1.4, the phosphorylation of PhoBFL in the presence of 
PhoRFL, could not be clearly followed due to the similar molecular weight of the two 
proteins. Since the optimisation of PhoBFL phosphorylation was not possible, and to 
assure that phosphorylation was not an issue; the DNA-binding assay was carried out 
using PhoBDBD. PhoBDBD is the domain known to bind to the specific DNA sequence 
once the protein gets phosphorylated.  
In order to validate the Pho box predicted by CUBIC software, the DNA sequence 
box without a gap (Figure 3.17-A), was used for the DNA-binding shift assays. Its exact 
sequence was the one found on the upstream region of the phoB gene (Table 6.1 in §3 
Chapter VI). Sequences with less than 20 bps were not used, since the smaller the DNA 
sequence leads to a higher probability of unspecific binding. For that reason the other 
tested sequence was the same but this time with a gap of 3 bps (Figure 3.17-B). 
Considering that CUBIC could have predicted an incorrect Pho box, DNA binding 
assays were also carried out using DNA with a sequence of the Pho box of the Gram + 
bacterium S. coelicolor. Being both Gram + positive bacterias and taking into 
consideration the lack of knowledge of the Pho system in D. radiodurans, this assay was 
performed with the aim of giving new information in the conserved sequence. The two 
boxes tested had no gaps between the conserved sequence, being in one case the full 
annotated Pho box of S. coelicolor (Figure 3.17-C) and on the other the same sequence 
repeated twice (Figure 3.17-D). 
A negative control was made by using BSA in the assay (Figure 3.17 lanes 1 in all 
gels). 
From the analysis of the gels few conclusions can be withdrawn, since only negative 
results were verified. In all cases no shift of the band is verified indicating an absence of 
binding. Several explanations can justify that fact. The most immediate one is that the  
D. radiodurans Pho box is considerably different from the one of S. coelicolor and that 
CUBIC failed to predict it. However other justifications can be considered that do not 
invalidate the predicted DNA sequence. One of those explanations is the binding 
conditions in which the assay was performed. Although the protocol was based in similar 
assays from other microorganisms for the same type of assay, D. radiodurans PhoBDBD 
may required a different condition, like different pH or different temperature of 
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incubation. The last explanation is that the protein was not active and for that reason did 
not allow binding to the DNA. 
 
 
Figure 3.17- PhoBDBD DNA-binding shift assay using DNA sequences based on Cubic 
prediction and using S. coelicolor known Pho box.  
DNA-binding shift assays were done marking the DNA with radiolabelled phosphorous. The DNA 
sequences tested in the assay were Cubic predicted box with no gap (A) and with a gap of 3 bp (B). It was 
also used the S. coelicolor known Pho box sequence with no gap (C) and the same but repeated twice (D). 
The samples in the gel correspond to the mixtures presented in Table 2.6 of Chapter II. On the gel: 1- BSA 
54 pmol, 2- no radiolabelled DNA and 54 pmol PhoBDBD, 3- 14 pmol PhoBDBD, 4- 34 pmol PhoBDBD, 5- 54 
pmol PhoBDBD, 6- 74 pmol PhoBDBD, 7- 94 pmol PhoBDBD and 8- 114 pmol PhoBDBD.  
 
From this assay we can not say that the CUBIC predicted box is either correct or 
incorrect.  
 
1.7. Discussion and conclusion 
 
All full length proteins and individual protein domains involved in the D. 
radiodurans PhoR-PhoB system have been produced, purified and stabilised. The 
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oligomeric state of all constructs has been identified using gel filtration experiments and 
DLS analysis and is compatible with those of homologous constructs, suggesting a similar 
behaviour. All constructs are stable and ready to use in all the further assays. 
D. radiodurans PhoRFL has been shown to autophosphorylate and to transfer the 
phosphoryl group to PhoBRD. This proves an interaction between PhoRFL and the PhoBRD. 
However, further biochemical analyses, such as assessing complex formation or 
comparing phosphotransfer from PhoR to other response regulators, are needed to 
definitively show that PhoR and PhoB are partners in the same signalling system.  
A consensus sequence for the D. radiodurans (Pho box) was predicted using 
CUBIC software. However, this prediction could not be confirmed by DNA-binding shift 
assays with PhoBDBD. In all experiments using a Pho box DNA sequence based either on 
the CUBIC prediction or on the sequence of the S. coelicolor Pho box, no DNA binding 
was observed. This may indicate either that the PhoBDBD construct is unable to bind to 
DNA by itself or that the conditions used in the DNA binding shift assays are not optimal. 
 
2. Crystallisation trials and data collection 
 
2.1. PhoRFL 
 
In the case of PhoRFL it was not possible to find a suitable crystallisation condition 
and due to the amount of attempts done it is clear that the protein is conformationally 
flexible, a situation which does not favours the protein crystallisation. 
 
2.2. PhoBFL 
 
As a result of the protocols described in §2.1 of Chapter II, crystals of PhoBFL 
without His6-tag were obtained from crystallisation drops consisting of 1:1 ratio of 
protein stock solution (23 mg/ml) equilibrated against 500 µl of reservoir solution. The 
reservoir solution consisted of either 8 % (w/v) PEG 8000, 10 mM HEPES sodium pH 7.6 
(Figure 3.18-A) or 8 % (w/v) PEG 8000, 10 mM HEPES sodium pH 7.4 (Figure 3.18-B). 
Crystals with the same shape and dimensions, were also obtained as well with lower 
molecular weight PEGs (PEG 2000, 4000 and 6000). For data collection the crystal 
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obtained were cryo-protected by adding 25 % glycerol to the reservoir solution and flash 
cooled in liquid nitrogen. 
                                                                                   
  
 
   
 
 
 
  
Figure 3.18- PhoBFL crystals and diffraction pattern.  
A- Image of PhoBFL crystal I (8 % PEG 8000, 10 mM HEPES-NaOH pH 7.6) taken on ID23-1. B- Image of 
PhoBFL crystal II (8 % PEG 8000, 10 mM HEPES-NaOH pH 7.4) taken on ID23-2. C- Diffraction pattern 
from crystal II collected on ID23-2.   
  
The larger of the two crystal obtained (crystal II, Figure 3.18-B) had dimensions of 
10 µm × 10 µm × 10 µm and diffraction data to dmin= 4.25 Å were collected from this 
crystal on ESRF beamline ID23-2 (Flot et al., 2010) at 100 K (Table 3.1).  
Unfortunately, radiation damage meant that only a partial data set could be 
collected. Nevertheless, using this data we were able to assign unit cell dimensions and 
Bravais lattice type using iMOSFLM (Leslie et al., 2002) and SCALA (Evans, 2006) 
from the CCP4 suite (Collaborative Computational Project, 1994). Examination of 
systematic absences indicates a tetragonal I41 space group (Table 3.1). 
A B 
C ID23-2 
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Table 3.1- Diffraction data processing statistics of native PhoBFL crystal in which values 
in parentheses correspond to the outer resolution shell. 
Dataset PhoBFL crystal B 
Source ESRF ID23-2 
Space group I41 
Unit cell parameters (Å) a= 124.14, b= 124.14, c= 188.14 
Wavelength (Å) 0.8726 
Redundancy 1.2 
Resolution  (Å) 53.25-4.25 (4.48-4.25) 
Completeness (%) 31.2 (33.2) 
Rmerge† 15.1(38.7) 
<I / σ (I)> 3.1 (1.5) 
† | |∑ ∑∑∑ −= iimerge I(h)/I(h)I(h)R  
According to the Matthews coefficient one should expect 6 or 7 molecules in the 
asymmetric unit giving 51 and 43 % solvent content respectively (Figure 3.19). 
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Figure 3.19- PhoBFL crystal II Matthews coefficient graphical representation. 
Graphical representation of the probability of the number of molecules in the asymmetric unit for the 
crystals of PhoBFL obtained. The percentage mentioned for each data corresponds to the solvent content for 
a given number of molecules in the asymmetric unit. 
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Although this crystallisation condition was promising, different batches of protein 
did not produce crystals either in the same conditions or related ones, and even with 
newly produced and purified it was never possible to reproduce crystals described here.  
Modifications to the protein purification protocol were also made in the hope that a 
cleaner sample, with a lower DNA contamination, might favour crystallisation. However, 
also this approach was not successful.  
Several seeding techniques described in §2.1 of Chapter II, were also used with the 
purpose of favouring crystallisation by provision of crystallisation nuclei (microseeding 
and streakseeding) or growth points (macroseeding). The former case was an attempt to 
understand if new protein batches were not able to form nuclei and for that reason to 
crystallise. If that was the only limitation of the newer batches, microseeding or 
streakseeding might overcome that problem and favour crystallisation. The macroseeding 
technique was an attempt to get bigger crystals that could resist radiation damage and 
allow a complete data set to be recorded. 
That the crystallisation of PhoBFL was impossible to reproduce is most probably due 
to an intrinsic flexibility at the protein. It may be that in the protein batch that produced 
crystals an unknown contaminant may have reduce the flexibility of this protein. 
Subsequent batches may not have contained this contaminant. 
 
2.3. PhoBRD 
 
The D. radiodurans PhoBRD domain showed a similar behaviour to PhoRFL, never 
yielding crystals and presenting a tendency to produce amorphous precipitate in the 
majority of crystallisation screens used. The presence or absence of the His6-tag in the 
domain appeared to have no effect for crystallisation purposes Different protein 
concentrations were tested in order to minimise the precipitation effect but the protein 
would either precipitate or, in cases of low protein concentration, give rise to a clear drop. 
The absence of crystals for this domain may be due to flexibility inside the domain, the 
charge distribution on the protein surface or the hydration required for protein stability 
(Akke et al., 1990). 
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2.4. PhoBDBD 
 
For this construct crystals were obtained in two conditions using a protein 
concentration of 6 mg/ml (Figure 3.20-A and C). Crystals from both conditions were 
cryo-protected in the crystallisation solution supplemented with 25 % (v/v) glycerol 
frozen in liquid nitrogen and tested for diffraction (Figure 3.20). The diffraction patterns 
from both crystals indicate that they are crystals of protein. However, in both cases 
diffraction limit and quality is poor (Figure 3.20-B and D), with the best crystal 
diffracting to dmin ≈ 8 Å. Crystal quality could not be improved even when modifications 
to the protein purification protocol were carried out. 
 
              
              
Figure 3.20- PhoBDBD crystals shape and diffraction quality. 
A- Crystal I obtained with 4.3 M NaCl, 0.1 M HEPES sodium pH 7.5; B- Diffraction pattern from crystal I  
collected on ESRF beamline ID23-2 (Flot et al., 2010); C- Crystal II obtained with 1.8 M Na/K Phosphate 
pH 5.6; D- Diffraction pattern from crystal II collected on ESRF beamline ID14-4 (McCarthy et al., 2009). 
 
 
 
 
 
 
7.65 Å 
9 Å 
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2.5. PhoRDHpD 
 
Crystallisation trials for PhoRDHpD without His6-tag yielded crystals between one 
day and a week after drop set up, in several different conditions. In all cases the crystal 
shape was similar and the diffraction patterns obtained were not satisfactory for indexing 
purposes (Figure 3.21). 
               
Figure 3.21- PhoBDHpD crystal shape and diffraction quality 
A- Crystal obtained with 12 % (w/v) PEG 3350, 0.2 M NaSO4 and 0.1 M HEPES sodium pH 7.2, cryo-
protected with 30 % (v/v) glycerol; B- Diffraction pattern from the crystal collected on ESRF beamline 
ID23-1 (Nurizzo et al., 2006). 
 
Optimisation attempts lead to crystals with an increased size but no improvement in 
X-ray diffraction resolution or quality. Streakseeding techniques were used to promote 
growth of crystals in a lower precipitant concentration. However, this resulted in showers 
of crystals that were too small for diffraction analysis. 
Small modifications on the protein purification and crystallisation protocols were 
made in order to try to improve the existent crystals or discover a new crystallisation 
condition that yielded crystals with improved quality. Among these changes was the 
change of the protein final buffer from 20 mM Tris-HCl pH 7 to 10 mM Tris-HCl pH 7.5. 
When crystallisation solution contained glycerol (Hampton cryo screen), multiple 
crystals with a different shape were obtained within 1 to 2 weeks, in a single condition: 
25.5 % (w/v) PEG 4000, 0.085 M Tris-HCl pH 8.5, 0.17 M sodium acetate and 15 % 
(v/v) glycerol. These conditions were reproduced at  295 K using personal stock solutions 
keeping and yielded crystals diffracting to dmin ≈ 2.7 Å from a specific region of the 
crystal (Figure 3.22-A and B). 
Crystals were directly flash cooled in liquid nitrogen since the crystallisation 
condition already contained 15 % (v/v) glycerol, and diffraction data measured on ESRF 
6.5 Å 
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beamline ID23-2 (Flot et al., 2010) at 100 K. The highest resolution diffraction data was 
obtained from a specific part of a multiple crystal with dimensions 20 µm × 40 µm × 5 
µm (Figure 3.22). In order to obtain a full data set without significant contamination from 
other lattices it was vital to use the small X-ray beam (7 x 5 µm2) available on the 
microfocus beamline ID23-2.  
 
Figure 3.22- PhoRDHpD crystal mounted on ID23-2 and its diffraction pattern.  
Image of PhoRDHpD crystals obtained with 25.5 % (w/v) PEG 4000, 0.085 M Tris-HCl pH 8.5, 0.17 M 
sodium acetate and 15 % (v/v) glycerol (A) and a corresponding diffraction image (B).  
 
The crystals are monoclinic with a P21 space group (Table 3.2). Calculation of the 
Matthews Coefficient (Matthews, 1968) suggested the existence of four molecules in the 
asymmetric unit and 49 % of solvent content. This result may indicate the presence of 
four independent molecules in the asymmetric unit or the presence of two dimers, since 
this domain is the dimerisation domain of PhoR, or the presence of a tetramer as indicated 
by the gel filtration analysis shown in §1.1.1.  
Attempts at structure determination using Molecular Replacement were carried out 
using Phaser (McCoy et al., 2007) and MolRep (Vagin et al.) from CCP4 suite 
(Collaborative Computational Project, 1994) and a search model constructed as described in 
§3.3.1 of Chapter II. The search in both programs was carried out either using a monomer 
model and searching for two or four molecules in the asymmetric unit, or using a dimer 
model and searching for one or two dimers. 
A 
B 
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Table 3.2- Diffraction data processing statistics of a native PhoRDHpD crystal. Values in 
parentheses correspond to the highest resolution shell. 
Dataset PhoRDHpD 
Source ESRF ID23-2 
Detector MAR Mosaic 225 CCD 
Space group P21 
Unit cell parameters (Å) a= 32.7, b= 87.1, c= 63.0, β= 102.5 
Resolution  (Å) 50.3 – 2.69 (2.84-2.69) 
Wavelength (Å) 0.8726 
Nr. unique intensities 9651 (1399) 
Redundancy 4.3 (4.3) 
Completeness (%) 100 (100) 
Rmerge (%)† 7.9 (34.6) 
Rpim (%)‡ 4.3 (18.8) 
<I / σ (I)> 11.9 (4.1) 
† | |∑ ∑∑∑ −= iimerge I(h)/I(h)I(h)R ,‡ | |∑ ∑∑∑ −
−
= iipim I(h)/I(h)I(h)1N
1R  
 
Phaser (McCoy et al., 2007) failed to find a solution according to the selective 
parameters of the program. With both search models the translation function Z-score were 
below 7 for all potential solutions. Molrep gave a contrast of 2.19 which indicated a 
possible solution however, when refining and building the model, electron density would 
disappear from the model were no flexibility is expected (middle of the α-helice) which 
prevented model building and suggested that the solution obtained was incorrect. 
 
2.6. PhoRCAD crystallisation and data collection 
 
Initial crystallisation screening at 295 K in the hanging-drop vapour diffusion 
method using PhoRCAD at 6 mg/ml yielded crystals within 1 to 2 days in two conditions: 
0.2 M MgCl2, 30 % (w/v) PEG 4000 and 0.1 M Tris-HCl pH 8.5 (Crystal Screen I); 0.1 M 
NaH2PO4, 0.1 M KH2PO4, 2 M NaCl and 0.1 M MES pH 6.5 (Crystal Screen II). 
Further optimisation of the first condition yielded large single crystals. The best 
diffraction-quality crystals were grown from a solution 0.1 M Tris-HCl pH 8.8, 14 % 
(w/v) PEG 4000 and 0.2 M MgCl2. Streakseeding and incubation at 287 K were essential 
Results and Discussion 
Doctoral thesis of Sofia Caria 93 
factors for obtaining single well shaped crystals. By this process the clusters of very thin 
plate-shaped crystals obtained directly from the Crystal Screen I at 293 K were replaced 
by bigger crystal cluster (Figure 3.23-A) grown at 287 K that were optimised to produce  
the single crystals used for data collection (Figure 3.23-B). 
A single crystal was transferred to a stabilisation solution (0.1 M Tris-HCl pH 8.8, 
17 % (w/v) PEG 4000 and 0.2 M MgCl2) then cryoprotected by adding 20 % (v/v) 
glycerol to the stabilisation solution at 295 K. Crystal diffraction quality proved to be 
very sensitive to temperature variations. 
 
 
Figure 3.23- PhoRCAD crystals and diffraction pattern. 
A- PhoRCAD crystals obtained with 0.1 M Tris-HCl pH 8.8, 14 % (w/v) PEG 4000 and 0.2 M MgCl2 at  
287 K. B- Crystal obtained in the same condition after streak seeding. C- A diffraction pattern from the 
crystal shown in B collected on ESRF beamlinse ID23-1. 
 
The highest resolution x-ray diffraction data were obtained from a crystal with 
dimensions 100 µm × 50 µm × 10 µm flash cooled in liquid nitrogen and measured on 
ID23-1 beamline of the ESRF (Nurizzo et al., 2006) (Figure 3.23-B). Diffraction data 
(Table 3.3) were collected  at dmin = 2.2 Å at 100 K using a strategy calculated by EDNA 
(http://www.edna-site.org/, Incardona et al., 2009).  
 The crystals are orthorhombic, space group P21212. Calculation of the Matthews 
Coefficient suggested the existence of one molecule in the asymmetric unit and a solvent 
content of 38.9 %. Structure solution was performed using Molecular Replacement with 
A 
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Phaser (McCoy et al., 2007) (Table 3.3) and the search model described in §3.4.1 of 
Chapter II. Model refinement was carried out as described in §3.4.1 of Chapter II. 
 
Table 3.3- Diffraction data processing, molecular replacement and structure refinement 
statistics for native PhoRCAD. Values in parentheses correspond to the highest resolution 
shell. 
Data Collection 
Dataset PhoRCAD (Figure 3.18-B) 
Source ESRF ID23-1 
Detector Q315r ADSC CCD 
Space group P21212 
Unit cell parameters (Å) a= 44.6,  b= 69.5, c= 41.14 
Resolution  (Å) 41 - 2.20 (2.32- 2.20) 
Wavelength (Å) 1.0723 
Nr. unique intensities 6905 
Redundancy 3.6 (3.5) 
Completeness (%) 99.8 (98.9) 
Rmerge (%)† 5.8 (33.3) 
Rpim (%)‡ 3.6 (20.3) 
<I / σ (I)> 13 (3.6) 
Phaser 
Translation function Z-score 7.9 
Log Likelihood Gain 41 
Phenix.refine 
Model built A: Asp 2 to  Ser 82 and Gly 114 to Gly 146 
R (Initial/ Final) 0.3365 / 0.2973 
RfreeϮ (Initial/ Final) 0.3358 / 0.3130 
rmsd from ideal geometry:  
Bond lengths (Å) 0.007 
Bond angles (º) 1.217 
Ramachandran plot:  
Favored (%) 95.24 
Allowed (%) 3.57 
Disallowed (%) 1.19 
† | |∑ ∑∑∑ −= iI(h)/I(h)iI(h)mergeR ,  ‡ | |∑ ∑∑∑ −
−
= iipim I(h)/I(h)I(h)1N
1R ,  
Ϯ Calculated using 5% of the reflections, ∑∑
==
−=
n
1i
data
n
1i
elmoddata )i(F)i(F)i(FR  
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To improve the electron density map, Arp/Warp (Perrakis et al., 2001) automated 
model building starting from an existing model was used. The Arp/Warp output gave an 
improved defined density map (Figure 3.24), but the model that was obtained was more 
incomplete and incorrect that the original model. For this reason further model building 
and refinement was based on the model retrieved from the molecular replacement 
protocol and the Arp/Warp electron density map. Nevertheless, at the of the refinement 
procedure no electron density could be seen for Ser82 to Gly114 which forms the 
PhoRCAD ATP-lid. 
 
     
Figure 3.24- PhoRCAD electron density after molecular replacement and improvement 
using ArpWarp.  
PhoRCAD electron density obtained with Phaser (A) and the improved map obtained from ArpWarp (B). In 
both cases the final refined model is superimposed on the electron density (transparent yellow model). 
 
Since PhoRCAD consists of only 143 residues, the lack of 1/3 of the protein in the 
refined model was substantial. To try to improve electron density in the ATP-lid region, 
PhoRCAD was co-crystallised with various substrates (ATP, ADP, AMPPNP and 
AMPPCP) in the presence of Mg2+. Unfortunately, crystallisation in the previous 
condition was abolished when AMPPCP or AMPPNP were used as an additive. With 
ATP (Figure 3.25-A) and ADP (Figure 3.25-C) as additive, the resulting crystals were 
much smaller and the diffraction limit much reduced (Figure 3.25-B and D). Full data sets 
were thus not collected from the crystals. 
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Figure 3.25- PhoRCAD crystals obtained from co-crystallisation with substrates (ATP and 
ADP) and the corresponding diffraction patterns.  
A- PhoRCAD crystal obtained from co-crystallisation with 1 mM ATP, cryo-protected with 17 % (w/v) PEG 
4000 and 25 % glycerol added to the crystallisation solution. B- Diffraction pattern of crystal A collected on 
ESRF beamline ID23-2. C- PhoRCAD crystal obtained from co-crystallisation with 1 mM ADP, cryo-
protected with 17 % (w/v) PEG 4000 and 25 % glycerol added to the crystallisation solution. D- Diffraction 
pattern of crystal B collected on ESRF beamline ID23-2. 
 
Since co-crystallisation of the PhoRCAD with substrates yielded poorly diffracting 
crystals, more native crystals were produced for substrate soaking experiments. During 
this protocol more caution was taken with the crystallisation temperature (287 K) since 
changes in this had proven to be determinant for crystal diffraction quality. All solutions 
were thus previously incubated at 287 K for a minimum of two hours prior to the drops 
setup. Transfer to stabilisation and cryo-protection solution was carried out at 287 K  
rather than at 295 K as was the case for the crystals described above. 
Some of the new crystals obtained were soaked in substrates yielding a different 
unit cell than the PhoRCAD crystals previously obtained (Figure 3.26). 
Diffraction data from these crystals (Table 3.4) were collected, based on EDNA 
strategy (http://www.edna-site.org/, Incardona et al., 2009), on ESRF beamline ID23-2 
(Flot et al., 2010) and processed as previously described.  
6.5 Å 
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This new crystal form is also orthorhombic, but has cell dimensions of a= 46.9 Å, 
b= 81.9 Å and c= 205.2 Å, and a P212121 space group (Table 3.4). The alteration of the 
space group is likely be due to a phase transition when there is a temperature shift from 
crystallisation temperature (287 K) to the temperature of the crystallisation room where 
the crystals are frozen (293 K). Calculation of the Matthews Coefficient suggests the 
existence of six molecules in the asymmetric unit with a solvent content of 40.9 %. 
Structure solution was performed with Molecular Replacement using Phaser (Table 3.4).  
In this case the search model was the refined model from the crystal structure of the 
P21212 form of PhoRCAD. 
 
               
Figure 3.26- PhoRCAD crystal mounted on ID23-1 and its diffraction pattern.  
Image of PhoRCAD crystal obtained for temperature controlled conditions (A) and the respective diffraction 
pattern (B). 
 
Once again ArpWarp automated model building starting from existing model was 
used to improve the electron density map and the model resulting from the molecular 
replacement protocol. In this case manual building was also done in Coot (v0.5.2) 
(Emsley et al., 2004), model refinement was performed in Phenix.refine (Adams et al.). 
In the refined structure (Table 3.4) molecules A and B are complete, molecules C 
and D have gaps of around 12 residues in the ATP-lid region, and molecules E and F have 
gaps of 25 residues in the same region. 
A 
B 
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Table 3.4- Diffraction data processing, molecular replacement and structure refinement 
statistics from native PhoRCAD crystals obtained under temperature controlled conditions. 
Values in parentheses correspond to the highest resolution shell. 
 Data Collection 
Dataset PhoRCAD (Figure 3.26) 
Source ESRF ID23-2 
Detector MAR Mosaic 225 CCD 
Space group P212121 
Unit cell parameters (Å) A= 46.9,  b= 81.9, c= 205.2 
Resolution  (Å) 41 - 2.25 (2.37 – 2.25) 
Wavelength (Å) 0.8726 
Nr. unique intensities 38659 
Redundancy 5.6 (5.6) 
Completeness (%) 99.9 (99.9) 
Rmerge (%)† 12.3 (35.9) 
Rpim (%)‡ 5.7 (16.4) 
<I / σ (I)> 11.1 (5) 
Phaser 
Translation function Z-score 6.5, 33.6, 19.6, 26.0, 27.4, 22.3 
Log Likelihood Gain 53, 383, 678, 1038, 1382, 2219 
Phenix.refine 
Model built Chain A: Ile1-Gly149; Chain B: Pro3- Val147; Chain C: Phe4-Thr101 
and Gly112- Val147; Chain D: Ile1-Thr101 and Gly114- Gly148 ; 
 Chain E: Phe4-Pro91 and Leu115- Gly 149; Chain F: Thr5-Arg86  
and Met113-Gly149; 102 H2O;  9 Cl- and 3 glycerol. 
R (Initial/ Final) 0.3376 / 0.2171 
RfreeϮ (Initial/ Final) 0.3756 / 0.2776 
rmsd from ideal geometry:  
Bond lengths (Å) 0.013 
Bond angles (º) 1.244 
Ramachandran plot:  
Favored (%) 97.27 
Allowed (%) 2.6 
Disallowed (%) 0.13 
† | |∑ ∑∑∑ −= iI(h)/I(h)iI(h)mergeR ,  ‡ | |∑ ∑∑∑ −
−
= iipim I(h)/I(h)I(h)1N
1R ,  
Ϯ Calculated using 5% of the reflections, ∑∑
==
−=
n
1i
data
n
1i
elmoddata )i(F)i(F)i(FR  
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2.2. Discussion and conclusions 
 
No crystals of PhoRFL could be obtained despite a thorough screening of 
crystallisation solutions, temperature and protein concentration. Co-crystallisation 
attempts using the substrates (ATP, ADP, AMP-PNP and AMP-PCP) in the presence of 
Mg2+ also failed to produce crystals. Based on these observations it becomes clear that the 
flexibility present in the protein does not favour crystallisation. 
Crystals were obtained for PhoBFL. However, these were very small, diffracted only 
to 4.25 Å resolution and a full diffraction data set could not be collected. These crystals 
were not reproducible with other protein batches, suggesting that a contaminant in the 
original protein sample favoured the crystallisation. The contaminant possibly "locked" 
the protein into a less flexible conformation, thus promoting its crystallisation. 
In the resulting absence of crystallographic information on the full length proteins, 
crystallisation screening was carried out for the individual domains of the two proteins. 
 PhoBRD failed to yield a crystallisation condition which may indicate flexibility 
inside the domain, which was not accounted for in the construct design. In the case of 
PhoBDBD two crystallisation conditions were found, but even after optimisation the 
crystals yield presented a high mosaicity and the diffraction resolution would go beyond  
8 Å, preventing the domain structure determination.  
The most successful cases of crystallisation were obtained with the PhoR domains. 
PhoRDHpD demonstrated a high crystallisation tendency, yielding crystals in several 
crystallisation conditions. However, in the majority of the cases the diffraction pattern 
obtained was unsuitable for indexing purposes. One crystallisation condition yielded a 
multiple crystal from which, at one specific region, it was possible to collect a full X-ray 
diffraction data set using the microfocus beam on the ESRF ID23-2 beamline (Flot et al., 
2010). The crystal diffracted to 2.7 Å and analysis of the diffraction data pointed to a P21 
space group. Several attempts were made to determine the structure using Molecular 
Replacement. These were all unsuccessful. From known homologous structures it was 
expected that the PhoRDHpD would adopt a four helix bundle motif formed by a PhoRDHpD 
dimer. However, the known structures of DHpD are from full length histidine kinases. 
This may mean that the CAD imposes restraints to DHpD conformation, that are absent 
when the domain is crystallised in isolation and the search models available for Molecular 
Replacement were unsuitable 
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PhoRCAD crystallised in two conditions, one of which yielded crystals from which 
the structure could be determined. Crystals obtained at 287 K and cryo-protected at 295 K 
were orthorhombic, space group P21212 and contained one molecule in the asymmetric 
unit. When the cryo-protection step was carried out at 287 K a second orthorhombic 
crystal form, containing six molecules in the asymmetric unit, is obtained (P212121 space 
group).  
The structure of the P21212 crystal form was the first to be determined by Molecular 
Replacement. However, after refinement it was seen that the ATP-lid region is mobile and 
the electron density in the crystal did not allow 1/3 of the PhoRCAD to be built. However, 
of the six molecules in the asymmetric unit of the P212121 crystal form, two are complete. 
This latter crystal form thus allows the elucidation of the structure of the entire PhoRCAD 
domain. 
 
3. Analysis of crystal structure of PhoRCAD from  
D. radiodurans  
 
3.1. Analysis of the D. radiodurans PhoRCAD structures in the two 
crystals forms 
Depending on temperature control, two different crystal forms of PhoRCAD were 
obtained, containing one (P21212) or six (P212121) molecules per asymmetric unit.  
In the P21212 crystal form the single monomer in the asymmetric unit (Figure 3.23-
B) PhoRCAD has a flexible ATP-lid region and model for the structure in this region could 
not be built. In the P212121 crystal form, with six molecules in the asymmetric unit 
(Figure 3.26-A), the ATP-lids of two molecules (A and B) are stabilised via crystal 
packing (Figure 3.27). In the other molecules in the asymmetric unit (C to F) the ATP-lid 
is solvent exposed and the resulting flexibility gives rise to poor electronic density that 
does not allow full model building in this region.  
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Figure 3.27- The asymmetric unit of the P212121 crystal form of PhoRCAD from  
D. radiodurans.  
PhoRCAD molecules are coloured by chain: pink (A), blue (B), cyan (C), purple (D), green (E) and red (F). 
ATP-lid is in all cases highlighted in black. 
 
The different crystal forms were obtained due to different temperatures during the 
cryo-protection procedures. When cryo-protection is carried out at 287 K, the crystal does 
not have any temperature change since that is the temperature at which the crystals are 
obtained. In this case six molecules are present in the asymmetric unit. However, if the 
cryo-protection is performed at 295 K the crystals are exposed to a temperature change 
(from 287 to 295 K). The molecules in the asymmetric unit change packing, and a new 
asymmetric unit containing one monomer (Figure 3.28). 
 Chapter III 
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Figure 3.28- D. radiodurans PhoRCAD crystal packings depending on the two different space groups.  
Crystallographic structures of PhoR
CAD
 when crystallised in a P21212 with 1 molecule (yellow) in the asymmetric unit in shaded colours (crystal in figure 3.23-A) and P212121 
with 6 molecules in the asymmetric unit in which different chains are represented in pink (A), blue (B), cyan (C), purple (D), green (E) and red (F) (crystal in figure 3.26-A). 
For the comparison of the two packings it was superposed the only molecule of P21212 crystal with molecule A of P212121 crystal. Representation with both crystals unit cells 
(A) and a zoom of the crystallographic packing (B). 
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3.2. Analysis of the D. radiodurans PhoRCAD structure using bio3d 
(v1.0-7) package 
 
The overall structure of D. radiodurans PhoRCAD consists as already had been seen 
for other CADs of homologs histidine kinases, of an α/β sandwich with five β-strands in 
one layer and three α-helices in the other. 
A statistical analysis of the six PhoRCAD molecules in the asymmetric unit of the 
P212121 crystal form of PhoRCAD was performed with R (v2.9.2) (www.R-project.org) 
using the bio3d (v1.0-7) package (Grant et al., 2006).  
Bio3d allows the determination of the rigid core common to different structures, 
enabling molecules superposition as well as a comparison of conserved structural 
components. The determination of the proteins core structure is accomplished through the 
exclusion of the residues with the largest Cartesian coordinates distance in Angstroms of 
equivalent positions (Gerstein et al., 1995). The bio3d core function refines an original 
structural superposition obtained through sequence alignment. The refinement of the 
superposition is an interactive process, in which during each cycle the position presenting 
the largest difference in Angstroms is excluded. The superposition of the 6 molecules in 
the asymmetric unit thus obtained is shown in Figure 3.29. 
N
C
ATP-lid
 
Figure 3.29- Superposition of the six molecules contained in asymmetric unit of the 
P212121 crystal form of D. radiodurans PhoRCAD.  
Chain A shown in blue, chain B in pink, chain C in cyan, chain D in yellow, chain E in green and chain F in 
red. 
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The rigid core comprises residues Thr5 to Arg86 and Val118 to Val147, and 
comprises the entire protein except the first four N-terminal residues and the residues that 
compose the ATP-lid (Ser82 to Gly114). 
Using the bio3d package two multivariate statistics analyses were performed: a 
Principle Component Analysis (PCA) and a hierarchical cluster analysis (HCA). PCA is a 
statistical method that represents multidimensional data in smaller variable number by 
relating the data into components. In this specific case the relationship between the matrix 
of the Cartesian coordinates of the different monomers based on their equivalent residues 
was examined. This allows the identification of patterns in the data and the highlight of 
similarities. Here, PCA was used to find the principal components that describe the data 
in the eigenvalue spectrum Figure 3.30-A. This eigenvalue spectrum is derived from the 
variance of the Cartesian coordinates of the PhoRCAD molecules. 
The numbers of principal components needed to describe of system depends on the 
representativity of each principal component in the system, taking into account that, if the 
first two components describe 70 - 90 % of the total variance then the remaining 
components might be irrelevant (Garib, 2006, Grant et al., 2006). From Figure 3.30-A, 
can be seen that the first principal component (PC1) describes 52.3 % of the total 
variance; the second principal component (PC2) describes 26.4 % and the third principal 
component (PC3) 12.9 %. Taking into consideration the first two principal components, 
78.7 % of the total variance is accounted for, and these will be used in further analysis. 
Figure 3.30-B describes how the coordinates of the structures are distributed in 
space as a function of PC1 and PC2. Chains A and B in the asymmetric unit are very 
close in the Principal Component (PC) space and form group I of the PhoRCAD molecules 
analysed. Chains C and D, although further apart from each other, when compared to 
group I, are distributed in the same region of PC space and form group II. Chains E and F 
make up group III. Through PCA one can thus see, that the six molecules present in the 
the asymmetric unit of the P212121 crystal form can be organised into three different 
groups.  
The three groups can be related to the ATP-lid gap size in the structures of the 
different molecules in the asymmetric unit (Figure 3.31). In the case of chains A and B, 
there is no gap (Figure 3.31-I). In chain C a gap is found between Thr101 and Gly112 
while in chain D the gap occurs between Thr101 and Gly114. 
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Figure 3.30- Principal component analysis of the six molecules in the asymmetric unit of 
the P212121 crystal form of D. radiodurans PhoRCAD.  
A- Eigenvalue spectrum resulting from the diagonalisation of the atomic displacement covariance matrix of 
the Cα atoms coordinates for the different PhoRCAD molecules found in the asymmetric unit of the P212121 
crystal form; B- Biplot of PhoRCAD molecules in terms of the two principal components that characterise the 
system. Letters indicate the different molecules within the asymmetric unit. 
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Figure 3.31- PCA grouping of the six molecules found in the asymmetric unit of P212121  crystal form of D. radiodurans PhoRCAD. 
Group I, Chain A in blue and chain B in pink; group II, chain C in cyan and chain D in yellow; group III, chain E in green and chain F in red. Missing regions in the crystal 
structure are shown as dashed lines. 
I III II 
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The grouping of those two chains clearly reflects the different conformations they 
adopt (compared with group I chains) in the region surrounding the gap in the ATP-lid 
(Figure 3.31-II). Chains E and F have much larger gaps in the ATP-lid region when 
compared with chains in the previous groups. In Chain E the gap is between Pro91 and 
Leu115, in Chain F it is between Arg86 and Met113. Thus, molecules from group I 
correspond to full length PhoRCAD structures, group II contains molecules with an average 
gap of 12 residues in the ATP-lid region, and group III comprises molecules with bigger 
gaps, approximately 25 residues, in the ATP-lid region. 
A graphical representation of the average, over all molecules, the contribution of each 
residue to the principal components, PC1 and PC2, is shown in Figure 3.32. Here, it is 
clear that PC1 (Figure 3.32-A) and PC2 (Figure 3.32-B) describe the system well, as in 
each case only a few residues present a Cartesian coordinate displacement different from 
the overall behaviour of the system. The dominant feature described by PC1 is a 
displacement of residues at the N-terminus, indicating differences in the different 
structures. This result is not surprising since the first six residues (GIDPFT) of the 
construct crystallised correspond to the tag that was not removed by TEV protease 
treatment (§1.1.3). This region is unstructured and presents different conformations in the 
different molecules. The dominant feature described by PC2 is a small displacement of 
Leu 84 which is contained in the ATP-lid region. The ATP-lid is known to have some 
flexibility and this is further reflected in the results of the PCA analysis. 
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Figure 3.32- Contribution of each residue (averaged over the six molecules in the 
asymmetric unit) to the principal components of the D. radiodurans PhoRCAD in the 
P212121 crystal form.  
A- Residues contribution for PC1, B- Residues contribution for PC2. 
A B 
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The HCA (Crawley, 2007) presenting similarities between samples based on the 
distance between them was also carried out. The output retrieved from this analysis is 
represented by a tree like structure, called a dendrogram. The top of the tree represents the 
group containing all the data (root), the bottom each molecule. The HCA was performed 
using the matrix of scores of the PC1 and PC2 coordinates; obtained for the six PhoRCAD 
molecules present in the asymmetric unit. In Figure 3.33, one can see that following HCA 
the molecules cluster in a way that is in agreement with the groups defined using PCA. 
 
 
Figure 3.33- HCA of the six molecules contained in the crystal asymmetric unit of the 
P212121 crystal form of the D. radiodurans PhoRCAD.  
 
HCA groups the initial data into two principal clusters. Cluster φ contains chains 
E and F in the l asymmetric unit, and is comparable with group III from the PCA study. 
As previously mentioned, for these two molecules a larger region (≈ 25 residues) of the 
ATP-lid which is flexible and, thus, not defined in the electron density.  
Cluster κ contains the other 4 molecules found in the asymmetric unit. Inside 
Cluster κ it is clear that molecules A and B form a sub-cluster which is compatible with 
group I from the PCA study. This confirms the similarity between the two molecules 
(Figure 3.31-I). Although present in cluster κ, chains C and D are more similar to each 
other than to the AB sub-cluster. As previously mentioned, molecules C and D have a 
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flexible region in the structure leading to undefined electron density for 12 residues in the 
ATP-lid region. HCA thus confirm the PCA results. 
 
3.3. Comparison of D. radiodurans PhoRCAD structure with known 
homolog structures with R program using bio3d (v1.0-7) package 
 
From the previous analysis of the six molecules in the asymmetric unit of the 
P212121 crystal form of PhoRCAD, molecules A and B are the most relevant for 
comparison with homologous structures as they present a complete ATP-lid regions. 
Molecule A was used in the following analysis. 
The structure of D. radiodurans PhoRCAD was compared with the structure of 
homologous proteins, using a similar statistical approach to the one used in §3.2. Protein 
core regions were determined, allowing the superposition of the different proteins (Figure 
3.34). As can be seen, although the overall fold of domain is conserved, the orientations 
of the α- helices and the β-strands within the core are slightly different (Figure 3.35). 
 
Figure 3.34- Superposition of the D. radiodurans PhoRCAD with the homologous protein 
structures based on core determination using bio3d.  
D. radiodurans PhoRCAD (dark red), T. maritima HK0853CAD (blue), T. maritima ThkACAD  (green), E. coli 
PhoQCAD (yellow), M. tuberculosis PrrBCAD (red), E. coli NtrBCAD (pink), S. typhimurium PhoQCAD (cyan). 
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As for the molecules in the P212121 crystal form of D. radiodurans PhoRCAD, PCA 
was performed with the purpose of retrieving extra information concerning structural 
comparisons.  
 
 
 
Figure 3.35- Principal component analysis done to the D. radiodurans PhoRCAD with 
known homolog protein structures.  
Eigenvalue spectrum (A) resulting from the diagonalisation of the atomic displacement correlation matrix 
of the Cα atoms coordinates for the different CAD proteins. Biplot (B) of the CAD proteins in terms of the 
two principal components that characterise the system.  
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Only two principal components are needed to describe the system, since 81.6 % of 
the system is represented by them (Figure 3.35-A). PC1 describes 55 % and PC2 26.5 %. 
A biplot showing the distributions of PC1 and PC2 is represented in Figure 3.35-B and 
suggests three groups of CAD crystal structures. Group I consists of DR PhoRCAD, TM 
ThkACAD and ST PhoQCAD; group II comprises EC PhoQCAD and MT PrrBCAD; group III is 
made up of TM HK0853CAD and EC NtrBCAD. Groups I and II (Figure 3.37-I and II) have 
a very conserved fold between the different proteins, with the main difference between 
the two groups being ATP-lid conformation. In group III the main feature in common the 
absence of the residues that form the ATP-lid. 
When analysing the contributions of each residue to the principal components 
(Figure 3.36). 
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Figure 3.36- Contribution of each residue for the principal components determined by the 
PCA of the D. radiodurans PhoRCAD and its homologs.  
Each protein residue contribution for the first principal component (PC1) (A) and for the second principal 
component (PC2) (B). 
 
No large displacements are highlighted (Figure 3.36). However, Figure 3.36-A does 
indicate some mobility from residue 80 to the C-terminus of the proteins. One explanation 
for this is the observed variation in the ATP-lid region, which can adopt different 
conformations. 
A B 
  
Chapter III 
 
 
 
 
Doctoral thesis of Sofia Caria 112 
ABC
 
Figure 3.37- PCA grouping of different CAD crystal structures based on core determination.  
Group I consists of D. radiodurans PhoR
CAD
 (crimson), T. maritima ThkA
CAD 
(green) and S. typhimurium PhoQ
CAD
 (cyan). Group II comprises E. coli PhoQ
CAD
 (yellow) and 
M. tuberculosis PrrB
CAD
 (red). Group III composed of T. maritima HK0853
CAD
 (blue) and E. coli NtrB
CAD
 (magenta). Missing parts in dashed line.
I II III 
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HCA was also performed on the data and the results are represented in Figure 3.38. 
The data can be divided into two clusters. Cluster φ comprises the crystal structure of  
T. maritima HK0853CAD and E. coli NtrBCAD; on PCA group III (Figure 3.36) which have 
less ordered ATP-lid regions than the other CAD homologues compared in this study. 
Cluster κ is composed of the remaining structures compared and consists of two sub-
clusters. The first sub-cluster contains E. coli PhoQCAD and M. tuberculosis PrrBCAD; and 
corresponds to Group II from the PCA (Figure 3.36-II). The second sub-cluster comprises 
S. typhimurium PhoQCAD, D. radiodurans PhoRCAD and T. maritima ThkACAD in which 
the two latter structures are closer to each other than they are to the structure of  
S. typhimurium PhoQCAD. 
 
Figure 3.38- Cluster analysis of D. radiodurans PhoRCAD crystal structure homologues.  
  
This result indicates that the structure of molecule A found in the asymmetric unit 
of P212121 crystal form of D. radiodurans PhoRCAD is most similar to that of T. maritima 
ThkACAD. The ThkACAD structure might therefore have been a better search model for the 
PhoRCAD crystal structure molecular replacement search. However, at the time this 
structure was no yet available. 
The structure solution of the P212121 crystal form of the D. radiodurans PhoRCAD 
was solved using a refined structure of the single molecule in the P21212 crystal form, 
which was solved by molecular replacement search consisting of an ensemble of the 
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structures of T. maritima HK0853CAD, M. tuberculosis PrrBCAD and E. coli NtrBCAD 
(§3.4.1 of Chapter II). That the statistical analyses outlined above shows that the 
molecule A structure of the P212121 crystal form from D. radiodurans PhoRCAD, is 
different from these search models, indicates a lack of model bias in the structure 
determination and refinement process. If model bias was present there would be a 
tendency for the structure of molecule A structure of the P212121 crystal form of  
D. radiodurans PhoRCAD no cluster with the search models used for the initial molecular 
replacement. 
  
3.4. D. radiodurans PhoRCAD and T. maritima ThkACAD ATP-lids 
 
 In the P212121 crystal form of PhoRCAD the ATP-lid regions of molecules A and B 
in the asymmetric unit are stabilised by crystal packing and crystal contacts between the 
two molecules (§3.1). Since the structure most closely related to these is that of  
T. maritima ThkA which has substrate bound in the active centre, a superposition could 
in principle, be use to locate where substrate would bind in molecules A and B of 
PhoRCAD. 
 Figure 3.39-A shows this superposition which, when looked at in detail (Figure 
3.39-B), shows that in molecules A and B of P212121 crystal form of D. radiodurans 
PhoRCAD, the conformation of the ATP-lid region prevents substrate binding. This 
suggests that, for this crystal form, the soaking of the crystals with the substrates would 
have been unsuccessful due to inability of the substrates to access the active centre 
molecules, as they are partially occupied by the ATP-lid region responsible for crystal 
contacts. 
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Figure 3.39- Superposition of the crystal structure of the molecule A of the P212121 
crystal form of D. radiodurans PhoRCAD with the crystal structure of T. maritima 
ThkACAD - Mg2+ - ADP complex. 
D. radiodurans PhoRCAD (purple) was superposed to the T. maritima ThkACAD structure (yellow) that 
contains Mg2+ and ADP in the active site (A). Zoom showing that the conformation of the ATP-lid in the 
PhoRCAD crystal structure prevents substrate binding (B). 
  
 The fact that co-crystallisation with some substrates yielded different crystals forms 
with lower diffraction capacity and quality may indicate that the presence of the substrate 
resulted in a different conformation of the ATP-lid that did not favour the protein 
crystallisation. 
 
 Discussion and conclusions 
 
Depending on temperature control, D. radiodurans PhoRCAD crystallised, from the 
same crystallisation solution, in two different space groups, P21212 (crystal form A) and 
P212121 (crystal form B). An analysis of crystal packing shows that a temperature 
increase at the cryo-protection step led to a looser packing with a consequence disorder of 
the ATP-lid, that is thus not seen in crystal A. 
The overall structure of D. radiodurans PhoRCAD consists of an α/β sandwich 
composed of five β-strands in one layer and three α-helices in the other. The ATP-lid 
region is flexible and can adopt different conformations. The six molecules present in the 
A 
B 
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asymmetric unit of crystal form B, were divided in three groups using PCA and HCA. 
Those groups reflect the flexibility of the ATP-lid which is dependent on crystal packing. 
The most complete PhoRCAD molecule was used for comparison with the crystal 
structures of known homologues. PCA and HCA showed that the most closely related 
structure is that of T. maritima ThkACAD. Structure comparisons showed that in PhoRCAD 
the conformation of the ATP-lid prevents substrate binding. Co-crystallisation of 
PhoRCAD with substrates either prevented crystallisation or yielded different crystal forms 
with lower diffraction capacity and quality. This suggests that substrate binding results in 
a different conformation of the ATP-lid that does not favour crystal packing. 
 
4. Small angle X-ray scattering analysis 
 
Small angle X-ray scattering (SAXS) was used a complementary technique to 
retrieve more structural information on the D. radiodurans Pho system since difficulties 
in crystallising many of the constructs studied in this thesis, resulting on a lack of high 
resolution crystallographic information. 
SAXS allows the study of proteins in solution and provides information about their 
structure in conditions similar to their physiological ones. The information retrieved by 
this technique is the low resolution three dimensional shape of a protein. 
For a correct determination of particle shape in solution, highly monodisperse 
samples are required. For reliable estimation of molecular weight both sample 
concentration and X-ray flux must be known accurately. The molecular weight can then 
be estimated from the scattering intensity I(0) since the two values are proportional. After 
scattering data are collected, ab-initio and rigid body modelling analysis are carried out 
based on the assumption that a single species is present in solution. 
For each construct different concentrations were measured to try to account for any 
interparticle effects that may influence determination of the radius of gyration (Rg) and 
I(0). For the determination of molecular weight (MW), scattering data are, at the 
beginning of an experiment, measured from a solution of bovine serum albumin (BSA) 
with known concentration. This is then used to extrapolate the MW of the different 
samples in solution is then extrapolated. 
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4.1. SAXS analysis of PhoRFL, PhoRDHpD and PhoRCAD 
 
 In all cases, scattering curves measured indicated the existence of various 
oligomeric states in solution. This suggests that the samples are not monodisperse and the 
effect was most evident in PhoRDHpD, although gel filtration and DLS analysis did not 
confirm that aggregation. This may be due to the fact that the construct is small and 
maybe able to oligomerise into different conformations yielding a non monodisperse 
sample. Thus, in order to reduce interparticle effects, data measured at different 
concentrations were compared and some data points close to the beamstop (large particle 
sizes) rejected to minimise the effect of non specific aggregation present in the data.  
 For all samples, Rg was determined using the Guinier approximation, the Porod 
volume and Dmax calculated using GNOM (Table 3.5).  
 
Table 3.5- Global structural parameters calculated from SAXS scattering curves for 
PhoRFL, PhoRDHpD and PhoRCAD. Values calculated from the crystal structures of  
T. maritima homologues proteins and D. radiodurans PhoRCAD with CRYSOL (Svergun 
et al., 1995) are shown in grey. 
 Rg (Å) Porod Volume (Å) Dmax (Å) 
PhoRFL 29.5 90644 180 
HK0856 28.4 87430 94 
PhoRDHpD 27.4 33820 210 
HK0856DHpD (dimer) 22.7 13700 83 
HK0856DHpD (tetramer) 32.5 65730 116 
PhoRCAD 19.2 25891 120 
PhoRCAD 14.6 21850 47 
   
 A comparison of the Rg's (Table 3.5) obtained from the experimental scattering data 
with those calculated using CRYSOL, from the crystal structures of homologues proteins 
shows these to be in the same range. However, large differences in both Porod volume 
and Dmax are apparent. The latter observation may be due to non specific aggregation 
effects. The PhoRDHpD Dmax initially obtained using GNOM was clearly underestimated 
as no structurally valid ab-initio reconstruction envelope could be produced due to the 
constraints in the search volume (Dmax). After increasing Dmax manually, the ab-initio 
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modelling envelope for this construct resulted in an envelope that fits the experimental 
data. 
 The Dmax values in Table 3.5 were then used in the determination of molecular 
envelopes for the constructs studied. In all cases envelopes were obtained using 
DAMMIN (Svergun, 1999) which builds a sphere of diameter Dmax and fills it with beads. 
The position of the beads is changed in a trial an error manner in order to produce an 
envelope that best characterises the scattering data. To avoid model bias several different 
runs were carried out and averaged to produce a final model.  
 
4.1.1. PhoRFL 
 
 Once a final envelope had been calculated it was superposed to the relevant 
homologue crystal structure using SUPCOM. Pymol was used to visualise the fit between 
the two. CRYSOL was also used to calculate theoretical scattering curves from crystal 
structure data. These curves were then compared to those obtained experimentally.  
 The superposition of the DAMMIN envelope derived for PhoRFL and the crystal 
structure of the homologous T. maritima HK0853 is shown in Figure 3.40 along with the 
fit of the experimental and CRYSOL calculated scattering curves. As can be seen, both 
the envelope superposition and the fit of the experimental and calculated curves (χ ≈ 5) is 
suboptimal and suggests that the conformation of PhoRFL in solution is slightly different 
to that observed to the T. maritima HK0853 crystal structure.  
 To assess if the poor fit could be due to domains movements, that would imply a 
different conformation, SASREF (Petoukhov et al., 2005) was used to try to improve fit. 
In SASREF the individual PhoR domains were defined by the crystal structures of the  
T. maritima HK0853DHpD dimer and the D. radiodurans PhoRCAD monomers (Figure 
3.41).  Several SASREF runs were performed in order to check for consistency. In 
different SASREF runs the orientation of PhoRCAD is slightly different but due to the 
globular overall shape of the domain, the SASREF PhoRFL envelope shape does not 
change (Figure 3.41). 
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Figure 3.40- PhoRFL experimental small angle scattering data compared with theoretical 
scattering curves from the PhoRFL DAMMIN envelope and from homologous T. 
maritima HK0853 crystallographic structure.  
A- The experimental PhoRFL SAXS curve shown in blue dots (with error bars in grey) is plotted against the 
theoretical scattering curves of the PhoRFL DAMMIN envelope (red), the PhoRFL SASREF envelope (cyan)  
and the curve derived from the crystal structure of the T. maritima HK0853 (green). B and C- PhoRFL 
DAMMIN envelope superposed using SUPCOM onto the crystal structure of T. maritima HK0853 (other 
orientation in are shown in §4 of Chapter VI). 
 
It is clear from Figure 3.41 that, in solution, the arrangement between the two 
domains is different than in the homologue structure, with PhoRCAD being in a different 
orientation. However, the SASREF model still fits the experimental data poorly (χ ≈ 5). 
This may indicate, based on all the information available that besides the different 
orientation of the domains the PhoRDHpD is shorter than the one from the homologue 
crystal structure. 
 
 
A 
B 
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Figure 3.41- PhoRFL SASREF envelope with DAMMIN envelope and homologous  
T. maritima HK0853 crystal structure. 
A - PhoRFL SASREF envelope (light yellow) superposed with PhoRFL DAMMIN envelope (light blue) and 
with T. maritima HK0853 crystallographic structure (green) using SUPCOM and Pymol. B- Different 
orientation. 
 
4.1.2. PhoRDHpD 
 
 Figure 3.42 shows both the fit of the experimentally determined DAMMIN 
envelope of the PhoRDHpD to the crystal structure of a HK0853DHpD dimer from  
T. maritima, and the fit of the experimental and CRYSOL derived scattering curves. The 
fit for both is rather poor (χ ≈ 2.6) which may suggest that PhoRDHpD and T. maritima 
HK0853DHpD have different folds. This may be though to be unlikely since the fold of the 
DHpD is well characterised for class I histidine kinases. The differences observed could 
be justified by discrepancies due to artefacts in the data resulting from protein 
aggregation. 
 However, existing DHpD crystal structures are under restrictions imposed by 
CADs, since their crystal structure have only been determined as part of full-length 
PhoR-type proteins. Perhaps, the structures of isolated DHpDs and DHpDs associated 
with CADs in crystal structures are different. This might also explain why the crystal 
structure of isolated PhoRDHpD (§2.5) could not be solved using existing structures of 
PhoR DHpD homologous as search models. 
 Nevertheless, both gel filtration and DLS experiments indicated that, in solution, 
PhoRDHpD is a tetramer (§1.1 of Chapter VI). When two dimers are fitted manually on the 
DAMMIN envelope, the fit is improved with a χ ≈ 1.2 (Figure 3.43). 
A B 
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Figure 3.42- PhoRDHpD experimental small angle scattering data compared with 
theoretical scattering curves from the PhoRDHpD DAMMIN envelope and from 
homologous T. maritima HK0853 crystallographic structure.  
A- PhoRDHpD experimental SAXS data (A) in blue dots (with error bars in grey) plotted against the 
theoretical scattering curves of the PhoRDHpD DAMMIN envelope (red) and the T. maritima HK0853DHpD 
crystal structure of dimer (green) and of tetramer (cyan). B- PhoRDHpD DAMMIN envelope superposed with 
crystal structure of T. maritima HK0853DHpD (other orientations in §4 of Chapter VI). 
                               
Figure 3.43- Orthogonal views of PhoRDHpD DAMMIN envelope superimposed  
T. maritima HK0853DHpD tetramer (two dimers).  
Monomers in different colours. 
A 
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4.1.3. PhoRCAD 
 
 Through the analysis of the experimental solution scattering data of the  
D. radiodurans PhoRCAD a DAMMIN bead model was retrieved and superposed to the 
crystal structure previously characterise in §3.1 (molecule A) (Figure 3.44-B). When 
comparing the experimental data with the theoretical curve of the PhoRCAD crystal a χ 
value of 1.3 is obtained. 
 However, the envelope obtained is rather larger than expected. This suggests the 
existence of several oligomeric states in solution and that the dominant species in solution 
corresponds to a PhoRCAD monomer form since a dimer would not fit the envelope (in 
grey Figure 3.44-A). 
 
Figure 3.44- PhoRCAD experimental small angle scattering data compared with 
theoretical scattering curves from the PhoRCAD DAMMIN envelope and respective 
crystallographic structure.  
A- PhoRCAD experimental SAXS data in blue dots (with error bars in grey) plotted against the theoretical 
scattering curves of the PhoRCAD DAMMIN envelope (red) and the D. radiodurans PhoRCAD crystal 
structure (green). B- PhoRCAD DAMMIN envelope superposed on the crystal structure of D. radiodurans 
PhoRCAD (other orientations in §4 of Chapter VI). 
A 
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4.2. SAXS analysis of PhoBFL. PhoBRD and PhoBDBD 
 
 As for the PhoR constructs, the SAXS data measured from PhoB constructs also 
indicated aggregation and some data close to the beamstop was removed. Global 
parameters derived from the scattering curves are shown in Table 3.6 and compared with 
values calculated from the crystal structure of M. tuberculosis RegX3 (King-Scott et al., 
2007). 
 
Table 3.6- Global structural parameters calculated from SAXS scattering curves for 
PhoBFL, PhoBRD and PhoBDBD. Values calculated from the crystal structure of  
M. tuberculosis homologous domains are also shown in grey. 
 Rg (Å) 
Porod 
Volume (Å) Dmax (Å) 
PhoBFL 25.3 46360 210 
RegX3 28.4 87430 94 
PhoBRD 17.9 17900 124 
RegX3RD 22.7 13700 82.5 
PhoBDBD 16.2 17800 116 
RegX3DBD 14.6 21850 47.4 
 
 A comparison of the Rgs obtained from the experimental scattering data and 
theoretical values determined from the closest homologous crystal structure shows that 
they are in the same range. However, for PhoBFL and PhoBRD the experimentally 
determined Rg values are smaller than those expected from the homologous crystal 
structure, which may indicate a more packed structure for PhoBFL protein and for its RD. 
As for the PhoBFL constructs in all cases, Dmax from experimental is larger than 
determined from the relevant crystal structure, suggesting either the aggregation of the 
constructs in solution or real differences between the structure of the constructs in 
solution and known crystal structures (Table 3.6). 
 
 
 
 
Chapter III 
 
Doctoral thesis of Sofia Caria 124 
4.2.1. PhoBFL 
 
 Comparisons of the theoretical scattering curve of M. tuberculosis RegX3 retrieved 
from CRYSOL and the experimental scattering data (Figure 3.45) resulted in a chi value 
of 3.6. The high value can be explained by small structural modifications between the two 
proteins or by errors in the experimental data/DAMMIN model due to aggregation in 
solution. A superposition of the PhoBFL DAMMIN envelope and the M. tuberculosis 
RegX3 crystal structure, shown in Figure 3.45 (or more extensively in §4 of Chapter VI) 
indicates that the solution structure of PhoBFL is close to that of the crystal structure. The 
envelope does contain extra features but these are probably a representation of the 
different oligomeric states present in solution although the monomeric form of PhoBFL is 
the most representative. 
 
Figure 3.45- PhoBFL experimental small angle scattering data compared with theoretical 
scattering curves from the PhoBFL DAMMIN envelope and homologous RegX3 from  
M. tuberculosis crystallographic structure.  
A- PhoBFL SAXS data in blue dots (with error bars in grey) plotted against the theoretical scattering curves 
of the PhoBFL DAMMIN envelope (red) and the M. tuberculosis RegX3 crystal structure (green). B and  
C- PhoBFL DAMMIN envelope superposed on crystal structure of M. tuberculosis RegX3 (other 
orientations in §4 of Chapter VI).   
B 
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4.2.2. PhoBRD 
 
The SAXS analysis of PhoBRD allows similar conclusions to those drawn for 
PhoBFL. The DAMMIN envelope (Figure 3.46) fits well with the crystal structure of the 
RD of M. tuberculosis RegX3 but a comparison of the theoretical and experimental 
scattering curves resulted in a 3.4 chi value.  
From the DAMMIN envelope it is clear that the PhoBRD consists of a globular 
domain and an extended region that may justify the inability to find a crystallisation 
conditions for this domain. In order to improve the crystallisation probability a more 
globular construct of the domain could be designed, removing the unstructured extension. 
 
Figure 3.46- PhoBRD experimental small angle scattering data compared with theoretical 
scattering curves from the PhoBRD DAMMIN envelope and homologous RegX3RD from 
M. tuberculosis crystallographic structure. 
A- PhoBRD experimental SAXS in blue dots (with error bars in grey) plotted against the theoretical 
scattering curves of the PhoBRD DAMMIN envelope (red) and the M. tuberculosis RegX3RD crystal 
structure (green). B- PhoBRD DAMMIN envelope on the crystal structure M. tuberculosis RegX3RD (other 
orientations in §4 of Chapter VI). 
 
B 
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4.2.3. PhoBDBD 
 
For PhoBDBD deviations (χ ≈ 2) between experimental and theoretical curve is 
derived from the M. tuberculosis RegX3DBD crystal structure (Figure 3.47-B and C). 
Those deviations can be justified by the hypothesis already exposed for the other proteins 
and domains.  
The superposition of the PhoBDBD DAMMIN envelope with the homologous crystal 
structure indicates a conserved overall fold if one considers the top of the envelope as 
features resulting from the existence of several oligomeric forms in solution. 
 
   
Figure 3.47- PhoBDBD experimental small angle scattering data compared with 
theoretical scattering curves from the PhoBDBD DAMMIN envelope and homologous 
RegX3DBD from M. tuberculosis crystallographic structure. 
A- PhoBDBD experimental SAXS in blue dots (with error bars in grey) plotted against the theoretical 
scattering curves of the PhoBDBD DAMMIN envelope (red) and the M. tuberculosis RegX3DBD crystal 
structure (green). B and C- PhoBDBD DAMMIN envelope superposed on the crystal structure of  
M. tuberculosis RegX3DBD (other orientations in §4 of Chapter VI). 
 
B 
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4.3. Discussion and conclusions 
 
Small angle X-ray Scattering was used as a complementary technique to extract 
structural information that could not be retrieved through X-ray crystallography for many 
of the construct studied here. In all experiments the results contain inherent errors that are 
probably due to different oligomeric states of the proteins in solution. However, the 
SAXS envelope of PhoRFL is consistent with crystal structure of T. maritima HK0853, if 
we take into account domain movements and the fact that PhoRFL has a smaller DHpD. 
In PhoRDHpD the presence of higher oligomeric states leads to an overestimation 
of Dmax and the DAMMIN envelope retrieved contains features that are absent in the 
structure of the DHpD dimer seen in the T. maritima HK0853DHpD crystal structure. 
Indeed, it seems that the DAMMIN envelope fits better to a tetramer of PhoRDHpD in 
solution, which supports the gel filtration and DLS results. However, the structure of the 
PhoRDHpD may actually be different than seen in the HK0853 crystal structure, thus 
explaining the failure to solve the structure of PhoRDHpD using molecular replacement. 
The PhoRCAD DAMMIN envelope fitted the crystallographic structure previously 
described. 
PhoBFL, PhoBRD and PhoBDBD present SAXS envelopes which are compatible 
with the M. tuberculosis RegX3 crystal structure, which indicates that the overall 
structure is conserved. In the case of PhoBRD an unstructured region in the protein is 
observed. This may be preventing crystallisation of the domain. A new construct should 
be design removing this region for new crystallisation trials 
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Signal transduction systems activated upon phosphate starvation have been studied 
in several bacteria such as E. coli, S. coelicolor and M. tuberculosis. This thesis presents 
the first biochemical and structural characterisation of two proteins (PhoR and PhoB) 
involved in the Pho system, for phosphate sensing in D. radiodurans.  
1. D. radiodurans PhoR-PhoB signalling mechanism  
 
The autophosphorylation, in vitro, of the full length PhoR (PhoRFL) was confirmed. 
However, the studies carried out in this thesis also show that, unlike in E. coli PhoR 
(Carmany et al., 2003), autophosphorylation does not occur in a mixture of the two PhoR 
domains, PhoRDHpD and PhoRCAD. This suggests that, in D. radiodurans, the two domains 
are unable to interact effectively with each other unless they are physically linked.  
Although autophosphorylation of the PhoRFL was observed, further studies, similar 
to those described for the HK0853 histidine kinase from T. maritima and PhoR from 
Staphylococcus aureos  (Casino et al., 2009) will be required to determine if the reaction 
occurs in a cis or in a trans fashion. 
Experiments carried out during this thesis also confirmed, in vitro, phosphotransfer 
between D. radiodurans PhoR and PhoB. This implies an interaction between the two 
proteins. However, PhoR-PhoB complex formation was not observed either in native gel 
or pull down assay experiments (unpublished results). Nevertheless, the efficiency of the 
phosphotransfer observed indicates that D. radiodurans PhoR and PhoB are partner 
proteins. Previous studies have shown that response regulators can be phosphorylated by 
different histidine kinases and their true partner can be assessed through phosphotransfer 
efficiency. To assess whether, in D. radiodurans, the PhoR histidine kinase is preferential 
partner of the PhoB response regulator, the same protocol should be carried out with other 
annotated histidine kinases from D. radiodurans and the phosphotransfer capacity 
compared in each case. 
Upon activation of PhoB by the PhoR histidine kinase, it is known from studies in 
other microrganisms that PhoB protein binds to a specific a specific region of DNA 
named Pho box. The D. radiodurans Pho box sequence is unknown. During this thesis 
work a prediction of the D. radiodurans Pho box sequence was performed using the 
CUBIC software and based on what is known concerning the Pho box sequence of S. 
coelicolor and its Pho regulon. However, in DNA-shift assays, no binding of PhoB was 
observed either to DNA containing the predicted D. radiodurans Pho box sequence or to 
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DNA with a sequence corresponding to that of the S. coelicolor Pho box. The predictions 
concerning the D. radiodurans Pho box DNA sequence could thus not be confirmed. A 
better approach might be to determine the D. radiodurans PhoB DNA sequence target 
experimentally. In such an experiment, one could incubate PhoB with the complete D. 
radiodurans genome, promote unbound DNA degradation with DNAse and extract the 
bound DNA for the sequencing analyses. 
 
2. Crystallisation of D. radiodurans PhoR and PhoB  
 
The extensive crystallisation trials setup for both full length proteins (PhoRFL and 
PhoBFL) involved in the D. radiodurans Pho system failed to produce diffraction quality 
crystal. This indicates that intrinsic protein flexibility prevents crystallisation. 
As a result of the failure to crystallise the two full length proteins, the overall 
approach of the project was modified in order to produce some structural information. 
The final approach was to clone and purify each of the domains of the two full length 
proteins and to try to crystallise these. Those analyses would be complemented by SAXS 
analysis of the two full length proteins and their respective domains in solution. 
PhoBRD failed to yield a crystallisation condition indicating a probable intrinsic 
flexibility, that was not accounted for in the construct design. PhoBDBD crystallised in two 
different conditions, but crystals presented both a high mosaicity and low diffraction, 
preventing the solution of the crystal structure of this domain. 
The most successful cases of crystallisation were obtained with the PhoR domains. 
PhoRDHpD crystallised in several conditions, although only one crystal form was 
suitable for single crystal diffraction data collection. However, structure determination 
was not possible by molecular replacement regardless as to which of the homologous 
crystal structures available was used as a search model. This may be because the known 
homologous structures were of all taken from the crystal structures of full length histidine 
kinases and in these the fold of the DHpD might be restrained by interactions with the 
CAD. A better approach to structure solution might therefore be to prepare a 
selenomethionyl derivative of PhoRDHpD. Anomalous scattering from the selenium 
atom(s) could then be used in a SAD or MAD experiment for phase determination and 
consequent structure solution. This approach appears to be reasonable since PhoRDHpD 
contains one methionine (Met43) in 79 amino acid residues. 
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Crystals obtained of PhoRCAD enabled structure determination using molecular 
replacement and an ensemble of known homologous structures as search models. While 
the crystals of PhoRCAD were grown at 287 K, differences in the temperature of the cryo-
buffer led to different crystals forms. When increasing the temperatura from 287 to  
295 K, the crystal space group changed from P212121 to P21212, and the number of 
molecules in the asymmetric unit changed from 6 to 1. 
  
3. D. radiodurans PhoRCAD structure 
 
The overall structure of D. radiodurans PhoRCAD consists in an α/β sandwich 
composed by five stranded β-sheet in one layer and three α-helices in the other with a 
considerable flexible region that goes from residue 78 to 110, known as ATP-lid. The 
flexibility of the ATP-lid region was observed in the single molecule contained in the 
asymmetric unit of the P21212 crystal form and confirmed when analysing the 6 
molecules contained in the asymmetric unit of the P212121 crystal form. In the latter, the 
same region appeared more or less disordered depending on the molecule, but the 
complete models were built for molecules A and B since crystal packing allowed the 
locking of the flexible region in these. From a comparison of the arrangement of the 
molecules in the two space groups it is clear that the increase of temperature leads to an 
expansion and consequent disorder of the ATP-lid in all molecules. 
D. radiodurans PhoRCAD shows a conserved fold when compared with the structures of 
homologous proteins. Through statistical analysis, ThkACAD from  
T. maritima (Yamada et al., 2006) was identified as being the most similar in terms of 
fold although it also shares a higher sequence identity. Comparing the crystal structure of 
ThkACAD of T. maritima containing ADP in the active centre with the D. radiodurans 
PhoRCAD obtained here, one can see that, in the latter, the ATP-lid region partially 
occluded the binding site. This may explain the failure in soak different substrates into the 
crystals of PhoRCAD obtained. This hypothesis is supported by the knowledge that  
co-crystallisation of the PhoRCAD with substrates either prevented the crystallisation or 
yielded different crystals forms with lower diffraction capacity and quality.  
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4. D. radiodurans PhoR and PhoB SAXS studies 
 
Due to the lack of crystallographic structure information, Small Angle X-ray 
Scattering (SAXS) was used as complementary technique yield structural information on 
the full length proteins and their domains. 
Although all SAXS experiments were affected by the existence of different 
oligomeric states of the protein in solution, the model retrieved indicate, in all cases, that 
the proteins adopt similar fold to known homologous structures. The fact that the overall 
PhoRDHpD envelope indicates that the protein associates as a tetramer, supporting the gel 
filtration and DLS data. However, one should also keep in mind that the structure of 
isolated PhoRDHpD can be different from the structures of DHpDs seen in full length 
crystal structures of PhoR homologs such as HK0853DHpD or ThkADHpD T. maritima 
(Yamada et al., 2009, Casino et al., 2009, Marina et al., 2005). This last hypothesis is 
supported by the fact that the molecular replacement using the models previously 
mentioned failed. 
Although adopting a similar fold, SAXS experiments do suggest differences 
between the structures of D. radiodurans PhoR and the homologous T. maritima HK0853 
(Marina et al., 2005). In particular, the DHpD of D. radiodurans PhoR seems to be 
smaller than in HK0853 and the orientation of the CAD of each monomer in different 
when related with the DHpD with, in D. radiodurans PhoR the two domains appearing to 
be in the same plane. 
 In future work, the SAXS technique could be used to assess changes in 
conformation upon ATP binding and autophosphorylation of PhoR. In this case a  
time-resolved SAXS beamline would be needed such as ID02 of ESRF and comparisons 
could be made with what is known for the ThkA and HK0853 histidine kinases from  
T. maritima (Yamada et al., 2009, Casino et al., 2009, Marina et al., 2005). 
 Once the sequence of the D. radiodurans Pho box is determined and binding to 
the PhoB is optimised one can also use SAXS, in combination with SANS (Small Angle 
Neutron Scattering), to assess the PhoB-DNA complex shape and compare to the known 
crystal structure of the E. coli PhoBDBD-DNA complex. 
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1. Pho system proteins purification 
 
1.1. Affinity chromatography, histidine tag cleavage and dynamic light 
scattering for PhoRFL, PhoRDHpD and PhoRCAD 
 
Figure 6.1-A shows that the overexpression of PhoRFL with the SDS-PAGE analysis 
of the soluble fraction showing a band at 28 kDa (molecular weight of the protein plus the 
hexa-histidine tag). To remove contaminants the protein was loaded on to the nickel 
column with 20 mM imidazole in order to prevent nonspecific binding to the column and 
further washed with 50 mM imidazole. PhoRFL was eluted at 250 mM imidazole. The 
behaviour of the PhoRFL affinity chromatography is shown in Figure 6.1-B. 
 
  
 
Figure 6.1- Overexpression and affinity column purification of PhoRFL. 
A- SDS-Page gel, in which non induced (lane 1), induced with IPTG (lane 2), insoluble fraction (lane 3), 
soluble fraction (lane 4), and gradient peak (lanes 5) samples were analysed. B- The affinity column 
purification chromatogram in which the blue trace corresponds to UV280nm measurement. The green line 
shows the concentration of imidazole. The fractions collected are shown in red. 
 
PhoRDHpD overexpression was successful (Figure 6.2-A) with a molecular weight as 
expected for the domain with the hexa-histidine tag insertion (14 kDa). PhoRDHpD is very 
soluble (lane 3 from gel in Figure 6.2-A). The soluble fraction was further purified by 
affinity chromatography following the protocol described for PhoRFL. The elution of 
PhoRDHpD occurs along with some contaminants at 260 mM (Figure 6.2-B). 
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Figure 6.2- Overexpression and affinity purification of PhoRDHpD.  
A- SDS-Page gel, in which non induced (lane 1), induced with IPTG (lane 2), soluble fraction (lane 3), 
insoluble fraction (lane 4), and gradient peak (lanes 5) samples were analysed. B- The affinity column 
purification chromatogram in which the blue tracer corresponds to UV280nm measurement. The green line 
shows the concentration of imidazole. The fractions collected are shown in red. 
 
 
 
Figure 6.3- Overexpression and affinity column purification of PhoRCAD.  
A- SDS-Page gel, in which non induced (lane 1), induced with IPTG (lane 2), soluble fraction (lane 3), and 
gradient peak (lanes 4) samples were analysed. B- The affinity column purification chromatogram in which 
the blue trace corresponds to UV280nm measurement. The green line shows the concentration of imidazole . 
The red numbers to fractions collected. 
 
500mM 
Imidazole 
50mM 
Imidazole 20mM 
Imidazole 
kDa 
43 
31 
 
20 
 
14.4 
  1  2  3                  4 
20mM 
Imidazole 
500mM 
Imidazole kDa 
43 
31 
 
20 
 
14.4 
1  2   3  4                    5 
50mM 
Imidazole 
A 
B 
A 
B 
Supplementary Material 
Doctoral thesis of Sofia Caria 151 
For PhoRCAD overexpression was also successful (Figure 6.3-A) and produced a 
construct of the molecular weight expected for the domain with the hexa-histidine tag 
insertion (19 kDa). The soluble fraction was further purified by affinity chromatography 
using the described protocol. The elution of PhoRCAD is accomplished at 220 mM 
imidazole along with some contaminant proteins (Figure 6.3-B). 
Hexa-histidine tag cleavage was successful for PhoRFL, PhoRDHpD and PhoRCAD. 
The proteins without tag are eluted in the flow through from the His-trap FF column with 
no imidazole in the buffer (lanes 2 of Figure 6.4-A, B and C). 
From the gels presented it is also visible that following this purification step, the 
PhoRDHpD and PhoRCAD are mainly pure (Figure 6.4-B and C) which in the case of 
PhoRFL contaminants are present (Figure 6.4-A). 
 
                          
Figure 6.4- SDS-Page gels of PhoRFL (A), PhoRDHpD (B) and PhoRCAD (C) after over-
night TEV protease digestion. 
For each gel presented, sample loaded on the column (lane 1) and flow through (lanes 2). Elution with 
imidazole gradient (corresponding to protein with tag or contaminants- lanes 3).  
 
DLS size distribution analyses were performed for all cases. Single peak is visible 
for PhoRFL (at least three measurements were done for each sample). This single peak 
suggests the existence of a unique species with a diameter of 8.42 nm in solution (Figure 
6.5). Using the DLS software the protein molecular weight estimation can also be 
obtained. If PhoRFL is globular the estimated molecular weight is 97.2 kDa, if elongated 
the molecular weight is estimated to be 48.1 kDa. From studies of PhoR homologues 
(Marina et al., 2005, Yamada et al., 2009) is expected to be an elongated protein. A 
molecular weight of 48.1 kDa therefore corresponds to that of a PhoR dimer. 
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Figure 6.5- DLS size distribution analysis by volume for PhoRFL.  
The single monodisperse and its peak suggest that PhoRFL is a dimer in solution. 
 
The DLS size distribution analysis for PhoRDHpD shows that, in the sample volume, 
98.8 % correspond to a particle of 5.67 nm of diameter (Figure 6.6-A). The second 
species found in much smaller amounts has a diameter of 51.2 nm that could indicate 
either some aggregation of the protein, some scratches on the cuvette or some dusts that 
could not be removed. Depending on the shape adapted by PhoRDHpD multimers the DLS 
results are consistent with either a globular tetramer or an elongated dimer in solution. 
Keeping in mind the results discussed in Chapter III, it is likely to be a tetramer. 
DLS analysis of PhoRCAD (Figure 6.6-B) indicates the presence of a two particle 
with an averaged in diameter of 4.93 nm since the peak is asymmetric. The estimation of 
molecular weight for a globular particle of 4.93 nm is 27.8 kDa while for protein 
resembling a branched polysaccharide the estimation is 14.3 kDa. So the protein can be 
either a monomer or a dimer but taking together with our expectations for PhoRCAD a 
monomer of 16 kDa is more probable. 
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Figure 6.6- DLS size distribution analysis by volume to PhoRDHpD and PhoRCAD domains. 
Analysis for PhoRDHp at 7 mg/ml (A) and for PhoRCA at 6 mg/ml (B). In both cases measurements were 
done at 293 K. The tables shows the statistics for the volume measurements and the graphs represents the 
particle size distribution in the sample volume. 
 
1.2. Affinity chromatography, histidine tag cleavage and dynamic light 
scattering for PhoBFL, PhoBRD and PhoBDBD 
 
Figure 6.7-A shows the overexpression of PhoBFL. After induction with IPTG (lane 
2) a intense corresponding to a protein of molecular weight of 29 kDa (24 kDa PhoBFL 
plus 4 kDa from the N-terminal tag). The behaviour of the PhoBFL during the affinity 
chromatography is shown in Figure 6.7-B. PhoBFL is eluted at 240 mM imidazole after a 
column wash of 20 mM imidazole to remove possible protein contaminants (Figure 6.7-B 
lanes 3). 
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Figure 6.7- Overexpression and affinity column purification of PhoBFL. 
A- SDS-PAGE gel, in which induced with IPTG (lane 1), non induced (lane 2) and gradient peak (lanes 3). 
B- The affinity column purification chromatogram in which the blue trace corresponds to UV280nm 
measurement. The green line shows the concentration of imidazole. The fractions collected are shown in 
red. 
 
 
 
 
Figure 6.8- Overexpression and affinity column purification of PhoBRD.  
A- The SDS-Page gel, in which non induced (lane 1), induced with IPTG (lane 2), soluble fraction (lane 3) 
and gradient peak (lanes 4) samples were analysed. B- The affinity column purification chromatogram in 
which the blue trace corresponds to UV280nm measurement. The green line shows the concentration of 
imidazole. The fractions collected are shown in red. 
 
The successful overexpression of PhoBRD is shown in Figure 6.8-A. After induction, 
a band corresponding to the molecular weights expected for the PhoBRD construct  
(17 kDa; PhoBRD 13 kDa, tag 4 kDa) is apparent on a SDS-PAGE gel. During affinity 
column purification pure PhoBRD elutes a 220 mM imidazole (Figure 6.8-B).  
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Figure 6.9- Overexpression and affinity column purification of PhoBDBD.  
A- The SDS-Page gel, in which non induced (lane 1), induced with IPTG (lane 2), soluble fraction (lane 3) 
and gradient peak (lanes 4) samples were analysed. B- The affinity column purification chromatogram in 
which the blue trace corresponds to UV280nm measurement. The green line shows the concentration of 
imidazole. The fractions collected are shown in red. 
 
The PhoBDBD overexpression was also successful. After induction a band 
corresponding to a construct of the correct molecular weight (16 kDa; PhoBDBD 12 kDa, 
tag 4 kDa) appears in the SDS-PAGE (Figure 6.9-A). During affinity column purification 
(Figure 6.9-B) PhoBDBD elutes at 200 mM imidazole. 
All PhoB constructs were treated with TEV protease to cleave the hexa-histidine 
tag. As for the PhoR constructs §1.1, the tag less constructs are eluted in the flow through 
of the His-trap FF column. It is apparent (Figure 6.10) that the cleavage protocol resulted 
in pure untagged constructs in all samples. 
 
Figure 6.10- SDS-Page gels of the PhoBFL (A) and domains PhoBRD (B) and PhoBDBD (C) 
after over-night TEV digestion of the hexa-histidine tag.  
The 12 % SDS-Page in which following samples were analysed: loaded on the column (lane 1), flow 
through (lanes 2) eluted with imidazole gradient (lanes 3). 
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DLS analyses were also performed on the PhoB constructs obtained. In these 
experiments PhoBFL was shown to be monodisperse, with an estimated particle of  
5.92 nm in diameter. Molecular weights estimated are 53.1 kDa for a globular protein, 
26.7 kDa for an elongated protein. Given that PhoB is expected to be elongated (King-
Scott et al., 2007), it suggests that the PhoBFL is a monomer in solution, confirming the 
gel filtration results (§1.2.1 of Chapter III).  
 
 
Figure 6.11- DLS size distribution analysis by volume for PhoBFL. 
The single peak suggests that PhoBFL sample is monodisperse and that is a monomer in solution. 
 
DLS size distribution analysis for PhoBRD (Figure 6.12-A), also indicates the 
sample to be monodisperse. Molecular weight estimates are 27.5 kDa for a globular 
protein and 14.1 kDa for an elongated protein. As PhoBRD is elongated (Chapter III §4) 
this suggests that the species present in solution is a monomer.  
For PhoBDBD a similar behaviour is observed (Figure 6.12-B). A narrow single peak 
indicates that the sample is monodisperse with a particle diameter 4.64 nm. Estimated 
molecular weights are 24.1 kDa for a globular protein, 12.4 kDa for a protein that 
resembles a branched polysaccharide.  
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Figure 6.12- DLS size distribution analysis by volume for PhoBRD (A) and PhoBDBD (B) 
domains. 
In both cases, the single peak suggests that both samples are monodisperse. 
 
2. Size exclusion chromatography 
 
2.1. Calibration curve for SuperdexTM 200 
 
For calibration of the SuperdexTM 200 column, proteins of different molecular 
weights were used in order to calibrate elution volume and molecular weight. The elution 
volumes for each protein were determined experimentally and treated against the bed and 
void volume of the column: 
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The Kav values are then plotted against the logarithm of the proteins molecular 
weights (Figure 6.13). 
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Figure 6.13- Calibration curve of SuperdexTM 200 size exclusion column.  
The proteins used in the calibration eluted at 9 mL (thyroglobulin), 12 mL (catalase), 15.15 mL 
(ovalbumine), 15.7 mL (chymotrypsinogen) and 17.7 mL (ribonuclease). The bed volume of the column is 
24 mL, the void volume 8.3 mL. Linear regression of the data was determined and its equation is presented. 
 
The linear regression fit of the data was determined with a correlation coefficient 
(R2) of 0.98 which indicates that the calibration of the column is good. The equation is 
used during this thesis for the estimation of molecular weight of the proteins analysed 
using this column (§1.1 and §1.2 of Chapter III). 
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2.2. PhoRFL and PhoBFL size exclusion chromatography using a Hiprep 
16/60 S100 column 
 
A Hiprep 16/60 S100 column was used to remove the contaminants still present in 
the PhoRFL sample after hexa-histidine tag cleavage (§1.1). This column is ideal for the 
PhoRFL sample because it has a bigger volume (120 mL). The column is suitable for 
proteins in a molecular weight range of 1 to 100 kDa; allowing the separation of a 
possible monomer (25 kDa) from the dimer (50 kDa). This column is not an analytical 
column and is less accurate than such columns for protein size estimation. For this, 
oligomerisation state determination was carried out using a SuperdexTM 200 column (§1 
of Chapter III). 
The large majority of PhoRFL eluted from the Hiprep 16/60 S100 column at 51.8 mL 
which is in agreement with the volume expected for a dimer (Figure 6.14). The pooled 
fractions from this peak were analysed on a SDS-PAGE gel and the resulting sample is 
pure and free of contaminants (Figure 3.5 §1.1 of Chapter III). A minor peak eluting at  
37 mL on the chromatogram corresponds to aggregation of the protein that was also 
registered in the SAXS analysis (§3 of Chapter III).  
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Figure 6.14- Size exclusion chromatogram for PhoRFL on a Hiprep 16/60 Sephacryl S100 
column. 
On the chromatogram A280nm is shown in black and A260nm in grey. 
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PhoBFL protein was also further purified using Hiprep 16/60 S100 column. This was 
not done due to contaminant problems, but because during the analytic chromatography 
step (Figure 3.6 §1.2 of Chapter III) a smaller amount of protein eluted as a dimer. Here, 
the idea was to isolate the monomer form of PhoBFL for use in structural studies. 
On this column, PhoBFL eluted as a single peak at 78.4 mL (Figure 6.15) indicating 
that the large majority of PhoBFL in a monomeric form. However, there is a clear shoulder 
in the elution peak indicating (as seen in analytical chromatography) the presence of some 
PhoBFL dimers. 
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Figure 6.15- Size exclusion chromatogram for PhoBFL using a Hiprep 16/60 Sephacryl 
S100 column. 
On the chromatogram the A280nm is shown in black and A260nm in grey. 
 
3. CUBIC analysis 
 
The CUBIC analysis carried out as described in §1.9 of Chapter 2. As discussed in 
§1.5 of Chapter 3, the analysis was based on an extensive study of the D. radiodurans 
genome in which some conditions were imposed. The D. radiodurans genome was 
searched for the occurrences of the DNA sequences shown in Figure 6.16. The complete 
results of the search are shown in Table 6.1. 
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A                                                                    B 
 
Figure 6.16- Consensus DNA sequences determined using CUBIC for PhoR-PhoB 
system of D. radiodurans.  
A- Consensus sequence directly obtained from CUBIC and B- mirror image of consensus sequence A. 
 The complete results from that analysis are summarised on the following Tables. 
 
Table 6.1- Summary of D. radiodurans genes containing the predicted Pho box 
consensus sequence in the promoter region, using CUBIC.  
In the table: ID-Rolling total of the number of genes that contains the hypothetical Pho box at least twice; 
Strand- which DNA strand is the box found (F- 5' to 3' and R- 3' to 5'); Gene ID- gene identification; Gene- 
gene annotation; Start- distance from the gene start and the beginning of the box; End- distance from the 
gene start and the end of the box; and Sequence- exact potential Pho box sequence found for the gene. In 
grey genes that are in the same reading frame as genes used for the CUBIC search. The table is composed 
by sub-table: A- No Gap between Pho box sequences, B- Gap of one bp, C- gap of two bps, D- gap of three 
bps, E- one bp superposed, F- two bps superposed and G- three bps superposed. 
 
A- No Gap 
ID Strand Pattern Gene ID Gene Start End Sequence 
1 R DR_0162 hypothetical protein 137 156 GCGGCGTCGGGCGGCACGGG 
2 F DR_1536 serine protease 61 80 GCGGGGGCGGGCGGCGCTGC 
3 R 
AA 
 
DR_1887 hypothetical protein 208 227 GCGGCAGCGGGCGGTGTGGG 
4 R DR_1639 hypothetical protein 36 55 CGGCGCGGCGGGCCACGGCG 
5 F DR_1802 hypothetical protein 278 297 CGCTGGGGCTGGGGGCGGCG 
6 F DR_1970 
transcription elongation 
factor 
127 146 GGCCGGGGCTGGCGAGGGCT 
7 R DR_1971 hypothetical protein 278 297 GGCCGGGGCTGGCGAGGGCT 
8 R,F DR_1615 hypothetical protein 123 142 GGTCACGGCG,GGGCGCGGCG 
9 F,R 
BB 
 
DR_1299 hypothetical protein 114 133 CGCTGGGGCT,GGGGAGGGCG 
10 R AB DR_0581 hypothetical protein 95 114 TCGGCGCGGCGGCGGGGGCG 
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11 F DR_1034 
branched-chain amino acid 
ABC transporter, ATP-
binding protein 
255 274 TCGGCAGCGGCGCGGCGGCG 
12 R DR_1346 peptidase, putative 244 263 TCGGTGCCGCCGGCATGGCG 
13 R DR_1721 hypothetical protein 91 110 GCGGCGCTGCGGCTGCGGCT 
14 F DR_1733 hypothetical protein 147 166 GCGGCGCGGCGGCTGCGGCG 
15 F DR_1863 pilin biogenesis protein 67 86 TCGGCGGCGGCGGCGGGGCG 
16 R DR_1970 
transcription elongation 
factor 
4 23 TCGGTGCCGGCGCCGTGGCT 
17 R DR_2016 hypothetical protein 9 28 TCGGCGGCGGCGCTGCGGCG 
18 F obgE GTPase ObgE 53 72 GGTCAGGGCGTCGGCATGGG 
19 R rpmA 50S ribosomal protein L27 217 236 CGGTGCGGCGGCGGTACTGC 
20 F DR_0423 hypothetical protein 80 99 GGTGACGGCGGCGGTGCGGG 
21 R DR_0581 hypothetical protein 94 113 CGGCGCGGCGGCGGGGGCGG 
22 F DR_0855 hypothetical protein 90 109 CGTGGTGGCGGCGGCGTTGC 
23 F DR_1018 hypothetical protein 35 54 GGCGACGGCGGCGGCGCTGG 
24 F DR_1341 hypothetical protein 118 137 CGCGGTGGCGGCGGCGGTGG 
25 R DR_1479 hypothetical protein 18 37 GGTGGTGGCTTCGGTGTTGG 
26 R DR_1757 hypothetical protein 64 83 CGCTGCGGCGTCGGCAGCGG 
27 F DR_2245 
phosphate regulon 
transcriptional regulatory 
protein PhoB 
58 77 GGGCGTGGCTGCGGCGTCGG 
28 F DR_2271 hypothetical protein 26 45 CGGGGGGGCGGCGGCATCGC 
29 F DR_2323 transposase, putative 163 182 GGCGACGGCGGCGGCGCTGC 
30 F rpoZ 
DNA-directed RNA 
polymerase subunit omega 
19 38 CGCCACGGCGGCGGGGTCGC 
31 R DR_2606 
primosomal protein n', 
putative 
169 188 GGCGAGGGCGGCGGCAGCGG 
32 R,F DR_1006 
dGTP 
triphosphohydrolase-
related protein 
102 121 CGCGGTGGCGTCGGCGTGGC 
33 F,R 
BA 
DR_A0048 
mannose-6-phosphate 
isomerase, putative 
226 245 CGGGACGGCG,GCGGTATCGC 
 
B- Gap of one bp 
ID Strand Pattern Gene ID Gene Start End Sequence 
34 R DR_0581 hypothetical protein 94 114 TCGGCGCGGCGGCGGGGGCGG 
35 F 
AnA 
DR_0735 
TetR family 
transcriptional regulator 
223 243 TCGGGAGCGGGTCGGTGGGGG 
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36 F DR_1034 
branched-chain amino acid 
ABC transporter, ATP-
binding protein 
255 275 TCGGCAGCGGCGCGGCGGCGG 
37 F DR_1549 hypothetical protein 93 113 GCGGCGTCGCGGCGGTGCTGG 
38 R DR_2016 hypothetical protein 5 25 GCGGCGGCGCTGCGGCGCGGG 
39 F DR_2197 ABC transporter permease 106 126 GCGGTGCGGGTGCGGGGTGGG 
40 F DR_A0230 hypothetical protein 85 105 GCGGCGTGGGCGCGGCGGTGG 
41 R,F DR_1561 
UDP-N-acetylglucosamine 
2-epimerase 
93 112 GCGGTGCGGG,TCGGCGCGGC 
42 R,F DR_2607 
molybdenum cofactor 
biosynthesis protein D/E 
81 101 GCGGTATGGC,TCGGCGCTGC 
43 R,F DR_2609 brkB protein, putative 27 47 TCGGCGCTGC,GCGGTATGGC 
44 F DR_0191 
glycogen debranching 
enzyme-related protein 
122 142 GGTGGCGGCGCGGTCACGGCT 
45 R DR_1465 hypothetical protein 167 187 CGCGGGGGCTCGGCTGTGGCG 
46 R,F 
BnB 
DR_1977 hypothetical protein 38 58 CGCTGGGGCG,GGTGGCGGCG 
47 R rpsR 30S ribosomal protein S18 64 84 GCGGCAGGGGTGGCTGCGGCG 
48 F DR_0838 hypothetical protein 253 273 GCGGCGGCGGAGGTGGGGGCG 
49 R DR_0890 
D-tyrosyl-tRNA(Tyr) 
deacylase 
117 137 GCGGCACTGGCGGTGGCGGCG 
50 R DR_0903 hypothetical protein 133 153 GCGGCGCTGCCGGCGGTGGCG 
51 R DR_1639 hypothetical protein 36 56 TCGGCGCGGCGGGCCACGGCG 
52 F DR_1661 
stage V sporulation protein 
S-related protein 
13 33 GCGGGGGCGCGGGCTGGGGCT 
53 R proA 
gamma-glutamyl 
phosphate reductase 
260 280 GCGGCGGCGGCGGGCGCGGCG 
54 R DR_2133 hypothetical protein 2 22 TCGGGGTCGGTGGTCAGGGCG 
55 F DR_2310 hypothetical protein 233 253 GCGGCGGCGCAGGTCGCGGCG 
56 F DR_2457 hypothetical protein 191 211 GCGGTGGCGCTGGTCGCGGCG 
57 R DR_A0204 response regulator 178 198 GCGGCGTTGCGGGTCACGGCG 
58 F DR_A0221 
glucan synthase 1-related 
protein 
159 179 GCGGTATCGGACGCGACGGCG 
59 R DR_A0345 hypothetical protein 3 23 TCGGCGTTGCGGGCGGCGGCT 
60 R,F DR_2351 hypothetical protein 198 218 GCGGCGCGGG,GGTGAGGGCG 
61 F,R DR_0263 hypothetical protein 109 129 TCGGCGTCGG,CGTGGTGGCG 
62 F,R DR_0777 3-dehydroquinate synthase 267 287 GCGGCGTGGG,GGGCAGGGCG 
63 F,R 
AnB 
DR_1837 hypothetical protein 252 272 TCGGCACTGC,CGGGACGGCG 
64 F BnA apaG ApaG 55 75 CGGCGCGGCGCTCGGCACCGC 
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65 R DR_0348 
cytochrome c-type 
biogenesis protein, heme 
exporter protein C 
223 243 CGGCGCGGCGGGCGGGGTGGC 
66 F DR_0349 
ATP-dependent protease 
LA 
49 69 CGGCGCGGCGGGCGGGGTGGC 
67 R DR_0729 
CbbY/CbbZ/GpH/YieH 
family hydrolase 
244 264 GGGCGCGGCGCGCGGCATCGG 
68 F DR_1050 hypothetical protein 277 297 CGTGACGGCGTTCGGGGGCGG 
69 F DR_1536 serine protease 60 80 GGCGGGGGCGGGCGGCGCTGC 
70 F DR_2163 hypothetical protein 23 43 CGCTGGGGCGCGCGGTGCCGG 
71 F DR_2313 hypothetical protein 163 183 CGGGGTGGCGAGCGGCGCGGC 
72 R,F DR_0949 hypothetical protein 108 128 GGTGATGGCG,GCGGCATTGC 
73 R,F DR_1410 
carboxynorspermidine 
decarboxylase 
66 86 GGGCGCGGCG,GCGGGGGGGC 
 
C- Gap of two bps 
ID Strand Pattern Gene ID Gene Start End Sequence 
74 F apaG ApaG 54 75 GCGGCGCGGCGCTCGGCACCGC 
75 R DR_0348 
cytochrome c-type 
biogenesis protein, heme 
exporter protein C 
223 244 GCGGCGCGGCGGGCGGGGTGGC 
76 F DR_0349 
ATP-dependent protease 
LA 
48 69 GCGGCGCGGCGGGCGGGGTGGC 
77 F lysS lysyl-tRNA synthetase 38 59 TCGGTGTTGCGGGCGGCGTTGG 
78 R DR_0731 response regulator 174 195 TCGGCGCCGGGCGCGGGGCCGC 
79 F DR_0732 
imidazole glycerol 
phosphate synthase 
subunit HisF 
278 299 TCGGCGCCGGGCGCGGGGCCGC 
80 R DR_1694 hypothetical protein 257 278 GCGGGGCCGCGCGCGGTGCGGC 
81 F aat 
leucyl/phenylalanyl-
tRNA--protein transferase 
6 27 TCGGTGGCGGGCGCGGGGGTGG 
82 F DR_1936 hypothetical protein 105 126 GCGGCGCTGCGGGCGGCGCTGG 
83 F DR_2031 hypothetical protein 98 119 TCGGCGGCGCTCTCGGCGGGGC 
84 F DR_2503 prolyl endopeptidase 175 196 GCGGTGGCGGGGTCGGCGCTGG 
85 R DR_A0191 hypothetical protein 182 203 GCGGTGGCGGACGCGGCATGGC 
86 R,F DR_2096 
endopeptidase IV-related 
protein 
60 81 TCGGCATTGG,GCGGCGTTGG 
87 R,F 
AnnA 
fimA adhesin B 34 55 TCGGCACGGG,GCGGCGTGGG 
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88 F DR_0838 hypothetical protein 252 273 GGCGGCGGCGGAGGTGGGGGCG 
89 R DR_0858 hypothetical protein 245 266 GGTTGGGGCTGGGGTTGGGGCT 
90 F DR_1550 ftsE protein 197 218 GGCCACGGCGGCGGTGAGGGCG 
91 F DR_1661 
stage V sporulation protein 
S-related protein 
12 33 GGCGGGGGCGCGGGCTGGGGCT 
92 R proA 
gamma-glutamyl 
phosphate reductase 
260 281 CGCGGCGGCGGCGGGCGCGGCG 
93 R DR_1991 hypothetical protein 57 78 GGCCGCGGCGGGGGTGACGGCG 
94 F DR_2310 hypothetical protein 232 253 GGCGGCGGCGCAGGTCGCGGCG 
95 F DR_2313 hypothetical protein 163 184 CGGGGTGGCGAGCGGCGCGGCG 
96 F DR_2351 hypothetical protein 103 124 CGGGGCGGCGCAGGGCGTGGCG 
97 F DR_2457 hypothetical protein 190 211 GGCGGTGGCGCTGGTCGCGGCG 
98 R DR_A0173 hypothetical protein 25 46 GGCGGGGGCTTCGGCCAGGGCG 
99 R DR_A0280 
ABC transporter, ATP-
binding protein 
39 60 GGCGGCGGCGATGGCCACGGCG 
100 R,F 
BnnB 
DR_1280 hypothetical protein 259 280 GGCCAGGGCT,GGCTGGGGCT 
101 F DR_1322 hypothetical protein 93 114 GCGGTGGTGGACGGCGACGGCG 
102 F DR_1440 
cation-transporting 
ATPase 
146 167 GCGGGGCGGCAAGGTTGCGGCG 
103 F DR_1449 hypothetical protein 219 240 TCGGCGCGGGGACGGCGGGGCT 
104 R,F DR_0082 hypothetical protein 234 255 GCGGGGCCGG,GGCTGGGGCT 
105 R,F DR_0572 
sporulation protein 
SpoIID-related protein 
118 139 TCGGTGTGGGCGGCACGGCG 
106 F,R 
AnnB 
DR_2095 
c-type cytochrome, 
putative 
63 84 GCGGCACCGC,CGGGGCGGCG 
107 R DR_1490 hypothetical protein 74 95 CGGCGCGGCGGCGCGGGGCGGG 
108 R nusA 
transcription elongation 
factor NusA 
249 270 CGGCGCGGCTCAGCGGTGCCGG 
109 F DR_1801 hypothetical protein 81 102 GGCCAGGGCGCGGCGGCAGCGG 
110 R DR_2016 hypothetical protein 5 26 GGCGGCGGCGCTGCGGCGCGGG 
111 F DR_2036 
trehalose synthase, 
putative 
171 192 GGGGGCGGCGCAGCGGCGGGGC 
112 R DR_2095 
c-type cytochrome, 
putative 
63 84 CGGGGCGGCGAAGCGGTGCCGC 
113 R DR_2155 
amino acid ABC 
transporter, permease 
protein 
183 204 CGTCACGGCTCAGCGGCAGCGC 
114 R,F 
BnnA 
DR_A0277 malate synthase 120 141 GGCGGGGGCT,GCGGCGTCGG 
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115 F,R trpD 
anthranilate 
phosphoribosyltransferase 
172 193 CGTCATGGCG,GCGGTGGCGC 
 
D- Gap of three bps 
ID Strand Pattern Gene ID Gene Start End Sequence 
116 F DR_B0028 
sensor histidine 
kinase/response regulator 
33 55 TCGGCAGTGCCGGGCGGCGCGGC 
117 F DR_B0081 
DNA-binding response 
regulator 
165 187 GCGGGGGCGGGCAGCGGCAGCGG 
118 R DR_0261 MutT/nudix family protein 181 203 GCGGCGCTGCTGCTCGGCGCGGC 
119 F DR_0423 hypothetical protein 119 141 GCGGCGGTGGAGGGCGGCGCGGG 
120 F DR_1036 
branched-chain amino acid 
ABC transporter, 
permease protein 
61 83 GCGGCGGTGCTCGGCGGCATCGG 
121 F DR_1449 hypothetical protein 206 228 GCGGGGCTGCTGCTCGGCGCGGG 
122 R DR_1490 hypothetical protein 74 96 GCGGCGCGGCGGCGCGGGGCGGG 
123 F DR_1536 Serine protease 58 80 TCGGCGGGGGCGGGCGGCGCTGC 
124 F DR_1565 hypothetical protein 160 182 GCGGTGGGGGAACTCGGTGGGGG 
125 R DR_1654 hypothetical protein 168 190 GCGGCGGTGGGCAGCGGCGCCGG 
126 F DR_2163 hypothetical protein 34 56 GCGGTGCCGGTGGTCGGGGTCGC 
127 R,F DR_1406 hypothetical protein 272 296 GCGGCGTGGG,GCGGCACGGG 
128 R,F DR_1474 hypothetical protein 168 190 GCGGGGGGGG,GCGGTGCGGG 
129 F,R era GTP-binding protein Era 188 210 GCGGGGTCGG,GCGGCGCTGG 
130 F,R DR_0830 ion transporter, putative 14 36 GCGGCGCCGGa,TCGGGGTCGC 
131 F,R DR_1408 hypothetical protein 84 106 GCGGTGGCGG,TCGGCGCGGG 
132 F,R 
AnnnA 
DR_2261 aldo/keto reductase 85 107 TCGGGAGCGC,TCGGCACGGC 
133 F DR_0245 hemK protein 249 271 GGCGAGGGCGCCGCGCGGCGGCT 
134 R DR_0484 hypothetical protein 253 275 CGGCGCGGCTTAACGGTGGGGCG 
135 R DR_0724 hypothetical protein 258 280 GGGCGCGGCGCCGGGCGGGGGCT 
136 F DR_1050 hypothetical protein 277 299 CGTGACGGCGTTCGGGGGCGGCT 
137 R DR_1350 aminotransferase, class V 105 127 GGGGGTGGCTGTCGGTCAGGGCG 
138 R DR_1932 transposase, putative 68 90 GGCTACGGCGGCCCGGCGGGGCT 
139 F 
BnnnB 
DR_2036 
trehalose synthase, 
putative 
171 193 GGGGGCGGCGCAGCGGCGGGGCG 
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140 F DR_2199 
ATP-dependent DNA 
helicase RecG-related 
protein 
65 87 GGTGGTGGCGCTGCGCGGCGGCG 
141 R,F DR_1084 
methylmalonyl-CoA 
mutase 
125 147 GGCGGCGGCG,GGCCGGGGCT 
142 R DR_0281 
branched-chain amino acid 
ABC transporter, 
permease protein 
34 56 GCGGCAGCGCCTTGGCGGCGGCG 
143 F DR_1209 
bacterioferritin 
comigratory protein 
239 261 GCGGTGCTGGACACGCTGCGGCG 
144 F DR_1271 hypothetical protein 73 95 GCGGGGCTGCGGGGGCTATGGCT 
145 F DR_1293 hypothetical protein 118 140 GCGGCGCGGCCCTGGGCACGGCG 
146 F DR_1320 hypothetical protein 197 219 GCGGGGCCGGTGGCGTGGCGGCT 
147 R DR_1694 hypothetical protein 256 278 GCGGGGCCGCGCGCGGTGCGGCT 
148 F DR_2031 hypothetical protein 98 120 TCGGCGGCGCTCTCGGCGGGGCT 
149 F DR_2481 hypothetical protein 120 142 TCGGCGGCGGCATGGGCGCGGCG 
150 R DR_A0191 hypothetical protein 181 203 GCGGTGGCGGACGCGGCATGGCG 
151 F DR_A0230 hypothetical protein 85 107 GCGGCGTGGGCGCGGCGGTGGCG 
152 R,F DR_2573 hypothetical protein 83 105 GCGGCGCCGG,GGGTGCGGCT 
153 F,R 
AnnnB 
DR_A0204 response regulator 165 187 GCGGCATCGG,GGTCACGGCG 
154 R DR_0099 
single-stranded DNA-
binding protein 
165 187 GGCGATGGCGGTTTCGGGGTTGC 
155 R DR_0624 hypothetical protein 78 100 CGGCGCGGCGAAATCGGTGCCGG 
156 F DR_0670 hypothetical protein 269 291 GGGCGTGGCGGGCGCGGGGGTGC 
157 F DR_0676 acetyltransferase, putative 28 50 CGTGGTGGCGGGTGCGGGGTTGG 
158 F DR_1040 hypothetical protein 140 162 GGTCACGGCGCGGGCGGCGCGGC 
159 R DR_1104 hypothetical protein 259 281 GGGGGTGGCGGGGGCGGGGTGGG 
160 F DR_1362 
streptomycin biosynthesis 
protein StrI-related protein 
214 236 CGCGACGGCGATGGCGGTGTCGG 
161 R DR_1379 
TetR family 
transcriptional regulator 
93 115 CGTCGCGGCGGGCGCGGGACTGC 
162 R DR_1428 
acetyl-CoA 
acetyltransferase 
96 118 GGTCAGGGCGTCGTCGGGGCCGG 
163 F hisG 
ATP 
phosphoribosyltransferase 
catalytic subunit 
127 149 CGCGGCGGCGACGGCGGCGCGGG 
164 F DR_1561 
UDP-N-acetylglucosamine 
2-epimerase 
190 212 GGTGGTGGCGGTCGCGGCGCTGG 
165 R 
BnnnA 
DR_2498 GGDEF family protein 74 96 GGGGGCGGCGTTGGCGGGGTTGG 
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166 F DR_2503 prolyl endopeptidase 174 196 CGCGGTGGCGGGGTCGGCGCTGG 
167 F DR_2600 hypothetical protein 204 226 GGTCACGGCGCGGGCGGCGGGGC 
168 R DR_A0153 hypothetical protein 25 47 GGTGGCGGCGAGTTCGGCAGCGC 
169 R DR_A0191 hypothetical protein 182 204 GGCGGTGGCGGACGCGGCATGGC 
170 R,F DR_0998 mrp protein 146 155 GGTGGGGGCT,GCGGTGGGGG 
171 F,R DR_2573 hypothetical protein 70 92 GGTCGGGGCG,GCGGCGCCGG 
172 F,R DR_1174 
sensory box sensor 
histidine kinase 
221 243 GGGCGTGGCG,GCGGCGTCGC 
173 F,R DR_1937 serine protease 10 32 GGCGGTGGCG,GCGGCATCGG 
 
E- One bp superposed 
ID Strand Pattern Gene ID Gene Start End Sequence 
174 F DR_B0072 
salicylate monooxygenase-
related protein 
32 50 GCGGGGTCGGCGGTGGCGG 
175 R DR_0552 hypothetical protein 32 50 TCGGCGTGGGCGGCAGCGG 
176 F DR_0555 
glutamate-1-semialdehyde 
aminotransferase 
64 82 TCGGCAGCGGCGGGGCTGC 
177 F DR_0787 hypothetical protein 113 131 GCGGCGCTGGCGGGGCCGG 
178 R DR_0890 
D-tyrosyl-tRNA(Tyr) 
deacylase 
119 137 GCGGCACTGGCGGTGGCGG 
179 R DR_1253 hypothetical protein 203 221 TCGGGGCGGGCGGCGTGGC 
180 F asnC 
asparaginyl-tRNA 
synthetase 
198 216 GCGGCGGGGGCGGCGTGGG 
181 F DR_1341 hypothetical protein 119 137 GCGGTGGCGGCGGCGGTGG 
182 R DR_1358 outer membrane protein 253 271 TCGGCGCGGGCGGCGGCGC 
183 F DR_1863 pilin biogenesis protein 67 85 TCGGCGGCGGCGGCGGGGC 
184 F DR_1979 hypothetical protein 212 230 GCGGTAGGGGCGGTGCGGC 
185 F DR_2068 
alkaline shock protein-
related protein 
126 144 GCGGGGCTGGCGGCGCTGC 
186 R DR_2417m hypothetical protein 225 243 GCGGCAGCGGCGGGGCCGG 
187 F DR_2418 
DNA-binding response 
regulator 
84 102 GCGGCAGCGGCGGGGCCGG 
188 R DR_2498 GGDEF family protein 74 92 GCGGCGTTGGCGGGGTTGG 
189 F,R DR_0704 hypothetical protein 60 78 GCGGCGCGGG,TCGGGGCCGC 
190 F,R 
A-nA 
DR_1366 
glutamine 
amidotransferase subunit 
PdxT 
57 75 GCGGCGTGGC,GCGGGGGTGG 
191 R DR_0197 hypothetical protein 213 231 CGTTGCGGCGGCTGGGGCT 
192 F 
B-nB 
DR_0441 hypothetical protein 239 257 GGCGGCGGCGGGCAGGGCT 
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193 R DR_0581 hypothetical protein 95 113 CGGCGCGGCGGCGGGGGCG 
194 F DR_1561 
UDP-N-acetylglucosamine 
2-epimerase 
190 208 GGTGGTGGCGGTCGCGGCG 
195 F DR_1733 hypothetical protein 148 166 CGGCGCGGCGGCTGCGGCG 
196 R proA 
gamma-glutamyl 
phosphate reductase 
260 278 GGCGGCGGCGGGCGCGGCG 
197 R DR_1918 
aminoglycoside 
acetyltransferase (6') type I 
257 275 CGTCAGGGCGGGCGGGGCG 
198 R DR_A0028 hypothetical protein 127 145 CGCCGGGGCGGTGGCGGCT 
199 R,F DR_A0128 hypothetical protein 69 87 GGCGGCGGCT,CGGGGGGGCG 
200 R DR_0067 hypothetical protein 149 167 GCGGGGCCGGGGTGTGGCG 
201 R DR_0325 malate dehydrogenase 59 77 TCGGCGTTGGGCTGGGGCG 
202 R DR_0335 
ATP-dependent RNA 
helicase, putative 
132 150 GCGGCGCGGGGCCGGGGCG 
203 F pyrE 
orotate 
phosphoribosyltransferase 
228 246 TCGGCGGGGCGGCGCGGCG 
204 R DR_0449 hypothetical protein 44 62 TCGGCGGGGCGGCGCGGCG 
205 R DR_0724 hypothetical protein 258 276 GCGGCGCCGGGCGGGGGCT 
206 F DR_1142 hypothetical protein 9 27 GCGGCACTGCGGCGCGGCG 
207 F DR_1529 hypothetical protein 3 21 TCGGCGTGGCGCTGCGGCG 
208 F DR_1801 hypothetical protein 72 90 TCGGCGCGGGGCCAGGGCG 
209 F DR_2581 
LytR/CspA/Psr family 
protein 
72 90 TCGGCGCTGCGCTGCGGCG 
210 F DR_A0266 hypothetical protein 6 24 GCGGTGCTGGGGCAGGGCG 
211 R,F 
A-nB 
DR_1350 aminotransferase, class V 120 138 GCGGGGGTGG,CGCGGTGGCG 
212 F DR_0058 
serine/threonine protein 
kinase, putative 
203 221 GGTCACGGCGCGGCGGCGC 
213 F DR_0169 dihydroneopterin aldolase 196 214 CGCTGCGGCGCGGCGCTGG 
214 F DR_0411 short chain dehydrogenase 190 208 GGTGGTGGCGCGGGAGGGC 
215 R DR_0454 
bacitracin resistance 
protein 
39 57 GGCGACGGCGCGGCGCGGG 
216 R DR_1024 metal-dependent hydrolase 198 216 GGGGATGGCTCGGTGCTGG 
217 R DR_1490 hypothetical protein 74 92 CGCGGCGGCGCGGGGCGGG 
218 F DR_1574 hypothetical protein 103 121 GGGCGCGGCGCGGGGCTGG 
219 R DR_1872 hypothetical protein 19 37 GGGCGCGGCGCGGCGCCGG 
220 F DR_2090 hypothetical protein 86 104 GGCCGGGGCGCGGTGCTGG 
221 F 
B-nA 
DR_A0128 hypothetical protein 78 96 CGGGGGGGCGCGGTACTGC 
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222 R DR_A0210 
peptide ABC transporter, 
periplasmic peptide-
binding protein 
28 46 GGCGGCGGCGCGGCAGCGG 
223 F,R DR_A0013 
ferredoxin-nitrite 
reductase 
184 202 CGTGACGGCG,GCGGCAGTGC 
 
F- Two bps superposed 
ID Strand Pattern Gene ID Gene Start End Sequence 
224 R DR_0151 NifS-related protein 156 173 TCGGCGTGGCGGTGTCGC 
225 F DR_0350 hypothetical protein 214 231 GCGGGGTGGCGGGGCTGC 
226 F DR_0413 hypothetical protein 266 283 GCGGCGCGGCGGCGCGGC 
227 F DR_0431 hypothetical protein 265 282 GCGGCACGGCGGCAGGGG 
228 R DR_0432 
DNA-binding response 
regulator 
257 274 GCGGCACGGCGGCAGGGG 
229 F pyrE 
Orotate 
phosphoribosyltransferase 
228 245 TCGGCGGGGCGGCGCGGC 
230 R DR_0449 hypothetical protein 45 62 TCGGCGGGGCGGCGCGGC 
231 F DR_0453 
guanyl-specific 
ribonuclease SA 
31 48 TCGGCGGCGCGGCGCTGC 
232 R DR_0581 hypothetical protein 97 114 TCGGCGCGGCGGCGGGGG 
233 R DR_0757 citrate synthase 79 96 TCGGGGCGGCGGGGCTGC 
234 R DR_0783 MutT/nudix family protein 179 196 GCGGCAGGGCGGCGCTGC 
235 F DR_1142 hypothetical protein 9 26 GCGGCACTGCGGCGCGGC 
236 F DR_1331 hypothetical protein 12 29 GCGGCGCTGCGGGGCCGG 
237 R DR_1462 hypothetical protein 269 286 GCGGCGCCGCGGCGCCGG 
238 R DR_1490 hypothetical protein 74 91 GCGGCGGCGCGGGGCGGG 
239 F DR_1549 hypothetical protein 93 110 GCGGCGTCGCGGCGGTGC 
240 F DR_1623 hypothetical protein 64 81 GCGGCGCGGCGGGGCTGG 
241 F DR_1631 hypothetical protein 156 173 GCGGCGCGGCGGCAGCGG 
242 R DR_1989 hypothetical protein 144 161 GCGGCAGGGCGGCGGTGG 
243 R DR_2016 hypothetical protein 5 22 GCGGCGCTGCGGCGCGGG 
244 F DR_2312 carbohydrate kinase 44 61 GCGGGGTCGCGGTGCGGG 
245 F DR_A0163 hypothetical protein 30 47 TCGGCGTGGCGGTGCGGC 
246 R DR_A0210 
peptide ABC transporter, 
periplasmic peptide-
binding protein 
28 45 GCGGCGGCGCGGCAGCGG 
247 F 
A-nnA 
DR_A0353 
methyl-accepting 
chemotaxis-related protein 
142 159 GCGGGGTCGCGGCGCCGC 
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248 F DR_0015 hypothetical protein 85 102 CGCTGCGGCGTGGCGGCG 
249 F DR_0058 
serine/threonine protein 
kinase, putative 
203 220 GGTCACGGCGCGGCGGCG 
250 R DR_0249 oxidoreductase, putative 21 38 CGTCGGGGCGCTGCGGCG 
251 F pyrE 
orotate 
phosphoribosyltransferase 
229 246 CGGCGGGGCGGCGCGGCG 
252 R DR_0449 hypothetical protein 44 61 CGGCGGGGCGGCGCGGCG 
253 R DR_0523 hypothetical protein 225 242 CGCGAGGGCGGCGGGGCG 
254 R DR_0748 RNA methyltransferase 69 86 GGGCGGGGCGCTGCGGCT 
255 F DR_1108 hypothetical protein 30 47 GGTGATGGCGCTGCGGCT 
256 F DR_1220 
ferrous iron transport 
protein A 
173 190 GGTGGCGGCGGCAGGGCT 
257 R DR_1412 hypothetical protein 223 240 CGTCACGGCGCTGGGGCT 
258 F DR_1529 hypothetical protein 4 21 CGGCGTGGCGCTGCGGCG 
259 F DR_1699 hypothetical protein 134 151 CGGCGCGGCGGCGCGGCT 
260 F DR_1863 pilin biogenesis protein 69 86 GGCGGCGGCGGCGGGGCG 
261 R DR_2016 hypothetical protein 9 26 GGCGGCGGCGCTGCGGCG 
262 R DR_2055 
oligoendopeptidase F, 
putative 
180 197 CGCGGCGGCGTTGCGGCT 
263 R DR_2439 hypothetical protein 47 64 GGTCACGGCGGTGCGGCG 
264 F DR_A0225 sulfite oxidase, putative 16 33 GGCCGGGGCGCCACGGCG 
265 R DR_A0274 
flavin monoamine 
oxidase-related protein 
252 269 CGCTGTGGCGGCGCGGCG 
266 R,F DR_0357 hypothetical protein 157 174 CGCCGGGGCT,CGTGGGGGCG 
267 R,F DR_2310 hypothetical protein 218 235 CGTTGTGGCG,CGCGGCGGCG 
268 R,F DR_2456 hypothetical protein 209 226 CGGGGCGGCG,CGTGGTGGCT 
269 R,F DR_A0205 sensor histidine kinase 38 55 CGCGGCGGCG,CGCTGGGGCG 
270 F,R DR_A0225 sulfite oxidase, putative 16 33 GGCCGGGGCG,CGCCGTGGCG 
271 F,R 
B-nnB 
DR_2193 hypothetical protein 80 97 GGTGGCGGCG,CGCTACGGCG 
272 F DR_B0072 
salicylate monooxygenase-
related protein 
32 49 GCGGGGTCGGCGGTGGCG 
273 R DR_0008 hypothetical protein 274 291 TCGGGGGCGGGCACGGCG 
274 F DR_0441 hypothetical protein 240 257 GCGGCGGCGGGCAGGGCT 
275 F DR_0489 hypothetical protein 71 88 GCGGTGCGGGTGGCGGCG 
276 R DR_0698 
v-type ATP synthase, C 
subunit 
143 160 TCGGCGTCGGGCACGGCT 
277 F 
A-nnB 
DR_0846 
bacterioferritin 
comigratory protein 
20 37 GCGGCGTCGGTGGTGGCG 
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278 R DR_0890 
D-tyrosyl-tRNA(Tyr) 
deacylase 
120 137 GCGGCACTGGCGGTGGCG 
279 R DR_0957 
sugar ABC transporter, 
ATP-binding protein 
8 25 GCGGCGCGGGCCACGGCG 
280 F DR_1101 hypothetical protein 191 208 GCGGGGTCGGGCAGGGCG 
281 F DR_1343 
glyceraldehyde 3-
phosphate dehydrogenase 
92 109 GCGGGGTCGGTGAGGGCG 
282 R DR_1358 outer membrane protein 254 271 TCGGCGCGGGCGGCGGCG 
283 R proA 
gamma-glutamyl 
phosphate reductase 
260 277 GCGGCGGCGGGCGCGGCG 
284 R DR_1991 hypothetical protein 57 74 GCGGCGGGGGTGACGGCG 
285 F DR_2021 hypothetical protein 167 184 TCGGGGGTGGCGATGGCG 
286 R DR_2402 hypothetical protein 20 37 GCGGTGTGGGGCGTGGCG 
287 F DR_2406 comA protein 157 174 GCGGGACTGGGCGCGGCG 
288 R DR_2602 acetate kinase 170 187 TCGGTGTCGGGCGTGGCG 
289 F DR_2607 
molybdenum cofactor 
biosynthesis protein D/E 
110 127 GCGGTGCGGGTCACGGCT 
290 R DR_2609 brkB protein, putative 1 18 GCGGTGCGGGTCACGGCT 
291 R DR_A0008 hypothetical protein 197 214 TCGGCGCCGGCCAGGGCG 
292 R DR_A0195 
short chain 
dehydrogenase/reductase 
family oxidoreductase 
269 286 GCGGGGTGGGGCGCGGCG 
 
G- Three bps superposed 
ID Strand Pattern Gene ID Gene Start End Sequence 
293 F DR_0035 
adenylosuccinate 
synthetase 
138 154 GCGGCGCGGGCGTGGCT 
294 R DR_0088 
short chain 
dehydrogenase/reductase 
family oxidoreductase 
132 148 TCGGCGGGGCGGCGGCG 
295 F DR_0398 hypothetical protein 100 116 GCGGCATGGGCATGGCG 
296 F DR_0555 
glutamate-1-semialdehyde 
aminotransferase 
64 80 TCGGCAGCGGCGGGGCT 
297 F DR_0564 
amino acid ABC 
transporter, periplasmic 
amino acid-binding 
protein 
38 54 TCGGCGGCGCGACGGCG 
298 F 
A-nnnB 
DR_0629 
cell division protein FtsQ-
related protein 
67 83 TCGGCGGGGCGACGGCG 
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299 R DR_0778 
3-dehydroquinate 
dehydratase 
257 273 GCGGCAGGGCTGGGGCT 
300 R DR_0779 hypothetical protein 87 103 GCGGCAGGGCTGGGGCT 
301 R DR_0806 
Sec-independent protein 
translocase protein TatC, 
putative 
74 90 GCGGCACCGGCGCGGCG 
302 F DR_0878 
Adenine 
phosphoribosyltransferase 
271 287 GCGGCGCGGGCACGGCG 
303 F DR_1034 
branched-chain amino acid 
ABC transporter, ATP-
binding protein 
255 271 TCGGCAGCGGCGCGGCG 
304 R DR_1168 MutT/nudix family protein 202 218 TCGGCGTGGCTGGGGCT 
305 F DR_1215 
acetyl-CoA carboxylase 
carboxyl transferase, beta 
subunit 
266 282 GCGGCGCGGCGGCGGCT 
306 F rpsT 30S ribosomal protein S20 16 32 GCGGCGGGGCCGGGGCT 
307 F DR_1429 hypothetical protein 239 255 GCGGCATGGGCGCGGCG 
308 F DR_1430 
metallo-beta-lactamase-
related protein 
1 17 GCGGCATGGGCGCGGCG 
309 F DR_1449 hypothetical protein 219 235 TCGGCGCGGGGACGGCG 
310 R DR_1469 hypothetical protein 254 270 TCGGCATCGGCGCGGCG 
311 R DR_1607 hypothetical protein 110 126 TCGGCGGCGGCACGGCT 
312 R DR_1772 hypothetical protein 279 295 TCGGCACCGCCGGGGCG 
313 F DR_1773 hypothetical protein 248 264 TCGGCACCGCCGGGGCG 
314 F DR_1863 pilin biogenesis protein 70 86 GCGGCGGCGGCGGGGCG 
315 F DR_1900 hypothetical protein 112 128 GCGGCACGGGCGCGGCG 
316 R DR_1944 hypothetical protein 68 84 GCGGTGTGGGTGGGGCT 
317 R DR_2016 hypothetical protein 9 25 GCGGCGGCGCTGCGGCG 
318 F DR_2481 hypothetical protein 126 142 GCGGCATGGGCGCGGCG 
319 F DR_A0230 hypothetical protein 85 101 GCGGCGTGGGCGCGGCG 
320 R,F DR_0774 
general secretion pathway 
protein D, putative 
5 21 GCGGTGCTGG,CGCTACGGCG 
321 R,F DR_2557 hypothetical protein 100 116 GCGGCAGTGG,CGCGAGGGCG 
322 F,R DR_1085 hypothetical protein 65 81 GCGGCGTCGC,GGCGGTGGCG 
323 F,R DR_1363 hypothetical protein 41 57 GCGGTGCCGC,GGTCAGGGCG 
324 F DR_B0006 hypothetical protein 10 26 GGTGGCGGCGGCGCTGG 
325 F DR_B0012 cobyric acid synthase 32 48 GGGCACGGCGGCGCTGC 
326 F DR_0049 hypothetical protein 168 184 GGCTGCGGCGGGACCGC 
327 R 
B-nnnA 
DR_0151 NifS-related protein 156 172 CGGCGTGGCGGTGTCGC 
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328 F DR_0204 hypothetical protein 133 149 CGGCGCGGCGGCGTGGG 
329 F DR_0218 hypothetical protein 259 275 GGGGGGGGCGGTAGGGG 
330 R DR_0238 hypothetical protein 58 74 CGCTGTGGCGGTGGTGG 
331 F DR_0350 hypothetical protein 215 231 CGGGGTGGCGGGGCTGC 
332 R DR_0406 
ABC transporter, ATP-
binding protein 
33 49 CGTGGCGGCGGCGGTGG 
333 R DR_0412 
pyridine nucleotide-
disulphide oxidoreductase, 
class II 
123 139 GGGCGTGGCGGTGCGGC 
334 F DR_0413 hypothetical protein 267 283 CGGCGCGGCGGCGCGGC 
335 F DR_0423 hypothetical protein 80 96 GGTGACGGCGGCGGTGC 
336 F DR_0431 hypothetical protein 266 282 CGGCACGGCGGCAGGGG 
337 R DR_0432 
DNA-binding response 
regulator 
257 273 CGGCACGGCGGCAGGGG 
338 F pyrE 
orotate 
phosphoribosyltransferase 
229 245 CGGCGGGGCGGCGCGGC 
339 R DR_0449 hypothetical protein 45 61 CGGCGGGGCGGCGCGGC 
340 R DR_0518 hypothetical protein 133 149 GGCGGGGGCGGTGTTGC 
341 R DR_0523 hypothetical protein 226 242 CGCGAGGGCGGCGGGGC 
342 R DR_0581 hypothetical protein 94 110 CGCGGCGGCGGGGGCGG 
343 F purU 
Formyltetrahydrofolate 
deformylase 
79 95 GGGCGCGGCGGCGGTGC 
344 R DR_0739 hypothetical protein 22 38 GGCGGCGGCGGTGCCGG 
345 F DR_0749 hypothetical protein 107 123 GGTCACGGCGGTGGGGG 
346 R DR_0757 citrate synthase 79 95 CGGGGCGGCGGGGCTGC 
347 R DR_0783 MutT/nudix family protein 179 195 CGGCAGGGCGGCGCTGC 
348 R DR_0800 hypothetical protein 181 197 CGCGAGGGCGGCACGGG 
349 R DR_0814 
proline dehydrogenase, 
putative 
219 235 GGCGATGGCGGGGCCGG 
350 F DR_0838 hypothetical protein 264 280 GGTGGGGGCGGGGCTGC 
351 F DR_0855 hypothetical protein 93 109 GGTGGCGGCGGCGTTGC 
352 R DR_0908 hypothetical protein 129 145 CGTCGCGGCGGGGGCGG 
353 R DR_0933 alpha-amlyase 155 171 GGTGAGGGCGGCAGCGC 
354 F DR_0940 hypothetical protein 112 128 CGTGGCGGCGGGGGTGG 
355 F DR_0967 hypothetical protein 51 67 GGCGGCGGCGGTGTCGG 
356 F DR_1018 hypothetical protein 35 51 GGCGACGGCGGCGGCGC 
357 R DR_1104 hypothetical protein 259 275 GGCGGGGGCGGGGTGGG 
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358 R DR_1115 
S-layer-like array-related 
protein 
122 138 CGTGGCGGCGGTGTCGG 
359 R DR_1147 
Chorismate 
mutase/prephenate 
dehydratase 
271 287 CGCGGGGGCGGCGCGGG 
360 F DR_1148 hypothetical protein 138 154 CGCGGGGGCGGCGCGGG 
361 R DR_1190 hypothetical protein 154 170 CGTCACGGCGGTGTCGC 
362 F DR_1220 
ferrous iron transport 
protein A 
173 189 GGTGGCGGCGGCAGGGC 
363 F asnC 
asparaginyl-tRNA 
synthetase 
200 216 GGCGGGGGCGGCGTGGG 
364 F DR_1281 hypothetical protein 137 153 GGCTGTGGCGGCAGCGC 
365 F DR_1321 signal peptidase I 33 49 GGTGATGGCGGGGCTGG 
366 F DR_1341 hypothetical protein 118 134 CGCGGTGGCGGCGGCGG 
367 F DR_1362 
streptomycin biosynthesis 
protein StrI-related protein 
220 236 GGCGATGGCGGTGTCGG 
368 R DR_1363 hypothetical protein 41 57 GGTCAGGGCGGCACCGC 
369 F DR_1427 signal peptidase I 228 244 CGCCGGGGCGGCGCGGG 
370 F hisG 
ATP 
phosphoribosyltransferase 
catalytic subunit 
133 149 GGCGACGGCGGCGCGGG 
371 F DR_1449 hypothetical protein 226 242 GGGGACGGCGGGGCTGC 
372 R DR_1490 hypothetical protein 79 95 CGGCGCGGCGGCGCGGG 
373 F DR_1529 hypothetical protein 12 28 CGCTGCGGCGGCAGGGC 
374 F DR_1549 hypothetical protein 97 113 CGTCGCGGCGGTGCTGG 
375 F DR_1551 
carboxyl-terminal 
protease, putative 
122 138 GGGCGCGGCGGCAGGGG 
376 F DR_1565 hypothetical protein 153 169 GGTGACGGCGGTGGGGG 
377 F DR_1601 nodulin 21-related protein 58 74 GGCCGGGGCGGGAGCGG 
378 F DR_1623 hypothetical protein 65 81 CGGCGCGGCGGGGCTGG 
379 F DR_1631 hypothetical protein 157 173 CGGCGCGGCGGCAGCGG 
380 R DR_1694 hypothetical protein 269 285 GGTGACGGCGGGGCCGC 
381 F DR_1699 hypothetical protein 134 150 CGGCGCGGCGGCGCGGC 
382 R uvrA 
excinuclease ABC subunit 
A 
131 147 GGCGAGGGCGGCGTGGG 
383 F DR_1801 hypothetical protein 86 102 GGGCGCGGCGGCAGCGG 
384 F DR_1863 pilin biogenesis protein 69 85 GGCGGCGGCGGCGGGGC 
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385 F DR_1871 
chloromuconate 
cycloisomerase, putative 
283 299 GGGCGCGGCGGTGCGGG 
386 R DR_1938 
short chain 
dehydrogenase/reductase 
family oxidoreductase 
102 118 CGCCGGGGCGGGGGCGG 
387 R DR_1954 hypothetical protein 33 49 GGCGGCGGCGGGGGCGG 
388 F DR_1963 twitching mobility protein 17 33 CGCTGCGGCGGCACCGG 
389 F DR_1970 
transcription elongation 
factor 
41 57 GGCTGGGGCGGCGGGGC 
390 F DR_1972 
ATP-dependent Clp 
protease, proteolytic 
subunit ClpP 
155 171 GGGGGCGGCGGCGCTGC 
391 R DR_1989 hypothetical protein 144 160 CGGCAGGGCGGCGGTGG 
392 F DR_1993 hypothetical protein 157 173 GGTCGCGGCGGCGCTGC 
393 F rpmI 50S ribosomal protein L35 9 25 GGCTGGGGCGGCGCGGC 
394 R DR_2035 hypothetical protein 260 276 GGTGATGGCGGGGGCGC 
395 R DR_2076 hypothetical protein 179 195 CGCTGCGGCGGCGTCGC 
396 R rpsH 30S ribosomal protein S8 259 275 GGCGGGGGCGGTGTGGC 
397 F DR_2139 hypothetical protein 174 190 GGTCAGGGCGGCGCGGG 
398 F DR_2267 
DNA modification 
methyltransferase-related 
protein 
31 47 CGCGGCGGCGGCGTCGC 
399 R DR_2269 
molybdopterin 
biosynthesis MoeB 
1 17 GGGCGCGGCGGCGGCGG 
400 F DR_2271 hypothetical protein 29 45 GGGGGCGGCGGCATCGC 
401 F DR_2271 hypothetical protein 181 197 GGTGGTGGCGGTGCCGG 
402 F DR_2310 hypothetical protein 226 242 CGCGGCGGCGGCGGCGC 
403 F DR_2323 transposase, putative 163 179 GGCGACGGCGGCGGCGC 
404 R DR_2333 
NADH oxidase-related 
protein 
245 261 GGTCAGGGCGGTGGCGG 
405 R DR_2338 cinA protein 46 62 GGTGGCGGCGGGGCTGG 
406 R DR_2439 hypothetical protein 48 64 GGTCACGGCGGTGCGGC 
407 F DR_2502 transport protein, putative 66 82 CGCGGCGGCGGGGTCGG 
408 F DR_2503 prolyl endopeptidase 174 190 CGCGGTGGCGGGGTCGG 
409 R DR_2512 
protein translation 
inhibitor, putative 
166 182 GGGCGCGGCGGCGGCGC 
410 F DR_2530 hypothetical protein 124 140 GGGCACGGCGGCGCCGG 
411 R DR_2599 hypothetical protein 34 50 GGTCGTGGCGGCGGTGC 
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412 F DR_2603 
3-octaprenyl-4-
hydroxybenzoate carboxy-
lyase 
31 47 GGGCATGGCGGTGGCGC 
413 F DR_2620 
cytochrome c oxidase, 
subunit I 
58 74 GGCGGCGGCGGCGCTGC 
414 R DR_A0005 
alcohol dehydrogenase, 
zinc-containing 
258 274 GGTGAGGGCGGCGCGGC 
415 R DR_A0028 hypothetical protein 129 145 CGCCGGGGCGGTGGCGG 
416 F DR_A0050 photoreceptor 202 218 GGTCGTGGCGGGAGCGC 
417 R DR_A0144 hypothetical protein 119 135 GGCGGCGGCGGCGCTGC 
418 F DR_A0163 hypothetical protein 31 47 CGGCGTGGCGGTGCGGC 
419 R DR_A0179 hypothetical protein 192 208 CGGGGTGGCGGGGCTGG 
420 F DR_A0267 hypothetical protein 71 87 GGTGACGGCGGCGGCGC 
421 F DR_A0269 hypothetical protein 230 246 GGTGACGGCGGCGGCGC 
422 R DR_A0274 
flavin monoamine 
oxidase-related protein 
253 269 CGCTGTGGCGGCGCGGC 
423 F DR_A0323 
urea/short-chain amide 
ABC transporter, ATP-
binding protein, putative 
227 243 GGGGGTGGCGGGGCTGC 
424 R DR_A0332 protein kinase, putative 243 259 CGGCAGGGCGGCGTCGC 
425 R,F DR_0518 hypothetical protein 203 219 CGCGAGGGCG,GCGGTGCTGG 
426 F,R DR_2387 S-ribosylhomocysteinase 44 60 GGGCACGGCG,GCGGCAGCGC 
427 F,R DR_1950 ferredoxin, putative 157 173 GGCTACGGCG,GCGGGAGCGC 
428 F,R DR_2148 
TetR family 
transcriptional regulator 
159 175 TCGGTGCCGC,CGTGACGGCG 
429 F,R DR_A0351 hypothetical protein 223 239 CGTCAGGGCG,TCGGCGGCGC 
 
4. Small Angle Scattering Envelops 
 
 Complementary views to the constructs molecular envelopes shown in §4 of 
Chapter III. 
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Figure 6.17- SAXS derived molecular envelope of D. radiodurans PhoRFL superposed 
with the crystal structure of HK0853 of T. maritima.  
The SAXS envelope for D. radiodurans PhoRFL determined with DAMMIN was superposed using 
SUPCOM to the crystal structure of T. maritima HK0853. Images A, B, C and D show the superposition at 
different orientations, with rotation angles of 90º on the y axes. The top (Image E) and down (Image F) 
view of the superposition is accomplished through rotation on the x axes. 
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Figure 6.18- SAXS derived molecular envelope for D. radiodurans PhoRDHpD 
superposed with the crystal structure of HK0853DHpD of T. maritima.  
The SAXS envelope for D. radiodurans PhoRDHpD determined with DAMMIN was superposed using 
SUPCOM to the crysta structure of T. maritima HK0853DHpD. Images A, B, C and D show the superposition 
at different orientations, with rotation angles of 90º on the y axes. The top (Image E) and down (Image F) 
view of the superposition is accomplished through rotation on the x axes. 
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Figure 6.19- SAXS derived molecular envelope for D. radiodurans PhoRCAD superposed 
with crystal structure of PhoRCAD of D. radiodurans.  
The SAXS envelope for D. radiodurans PhoRCAD determined with DAMMIN was superposed using 
SUPCOM to the crystal structure of D. radiodurans PhoRCAD. Images A, B, C and D show the 
superposition at different orientations, with rotation angles of 90º on the y axes. The top (Image F) and 
down (Image E) view of the superposition is accomplished through rotation on the x axes. 
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Figure 6.20- SAXS derived molecular envelope for D. radiodurans PhoBFL superposed 
with the crystal structure of RegX3 of M. tuberculosis.  
The SAXS envelope for D. radiodurans PhoBFL determined with DAMMIN was superposed using 
SUPCOM to the crystal structure of M. tuberculosis RegX3. Images A, B, C and D show the superposition 
at different orientations, with rotations on the y axes of 90º each. The top (Image E) and down (Image F) 
view of the superposition is accomplished through rotation on the x axes. 
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Figure 6.21- SAXS derived molecular envelope for D. radiodurans PhoBRD superposed 
with crystal structure of RegX3RD from M. tuberculosis.  
The SAXS envelope for D. radiodurans PhoBRD determined with DAMMIN was superposed using 
SUPCOM to the crystal structure of M. tuberculosis RegX3RD. Images A, B, C and D show the 
superposition at different orientations, with rotations on the y axes of 90º each. The top (Image F) and down 
(Image E) view of the superposition is accomplished through rotation on the x axes. 
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Figure 6.22- SAXS envelope for D. radiodurans PhoBDBD superposed with crystal 
structure of RegX3DBD from M. tuberculosis.  
SAXS envelope for D. radiodurans PhoBDBD determined with DAMMIN was superposed using SUPCOM 
to the crysta structure of M. tuberculosis RegX3DBD. Images A, B, C and D show the superposition at 
different orientations, with rotations on the y axes of 90º each. The top (Image F) and down (Image E) view 
of the superposition is accomplished through rotation on the x axes. 
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5. Methods introduction 
 
5.1. Dynamic Light Scattering 
 
Dynamic Light Scattering (DLS) measures Brownian motion of particles in solution 
(caused by interaction of particles with the solvent) forming fluctuations in the measured 
intensity of the scattered light which are related the particles sizes. Measurement is 
achieved by illuminating the particles with a laser and analysing the intensity fluctuations 
in the scattered light (Figure 6.23). 
In the Malvern Instruments Zetasizer Nano S DLS apparatus the measurement of the 
intensity fluctuation is performed at an angle of 173 º. This is known as backscatter 
detection and presents advantages when compared with a measurement angle of 90 º. The 
main advantages are: 
 - The laser light does not to travel through the entire sample, reducing the multiple 
scattering effect (scattered light from one particle is further scattered by surrounding 
ones); 
- Reduction of dust particles effects. Dust particles, since being larger than the 
sample particles, usually scatter the light in the forward direction;  
 - Allows measurements using a higher protein concentration since it reduce 
multiple scattering. 
The determination of particle size is possible due to the fact that the scattering from 
a particle of diameter d, which is considerably smaller than the wavelength (λ) of the 
incident laser (d ≤ λ/10), results ij an isotropic scattering of the incident light. According 
to Rayleigh approximation, the intensity (I) of the scattered light detected is proportional 
to the diameter of the particle: 
6dI ∝      (Equation 6.2) 
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Figure 6.23- Schematics of a DLS setup based on the Malvern Instruments Zetasizer 
Nano S.  
Laser light contacts with the particles in the protein solution (cell), and is scattered in all directions. The 
detector is positioned in such way as to detect backscattered light only. The correlation function from 
intensities measured with small time intervals is determined in the correlator from the intensity of the 
scattered light detected. That function is then processed and analysed using the Zetasizer Nano S software 
(v5.03). 
 
The DLS instruments measure the intensities of the scattered light within small time 
interval (in the µs range), calculating a "correlation function" (Gτ) that allows the particle 
diameter determination: 
[ ]ττ Γ−+= 21)( BAG      (Equation 6.3) 
where τ is the time interval, A is the baseline, B the intercept of the correlation function 
and Γ another function, represented by: 
2Dq=Γ      (Equation 6.4) 
in which D is the translational diffusion coefficient and q is given by: 
2
sin4
0
θ
λ
pinq =      (Equation 6.5) 
where n is the refracting index of the solvent, λ0 is the wavelength of the incident laser  
light and θ the scattering angle. 
 The hydrodynamic diameter (d(H)) is extrapolated from a known D, with the 
following correlation: 
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D
kTHd
piη3
)( =      (Equation 6.6) 
in which k is the Boltzmann constant (1.38 x 10-23 JK-1), T is the temperature, D is the 
translational diffusion coefficient and η the viscosity coefficient of the solution. 
 
5.2.  Overview of protein crystallisation and Macromolecular 
Crystallography 
 
5.2.1. Protein crystallisation 
 
The major bottle neck in Macromolecular Crystallography is the necessity of 
producing diffraction quality crystals from macromolecules. This is difficult, mainly due 
the inherent flexibility of macromolecules. 
In order to find suitable crystallisation condition to a given macromolecule, an 
extensive screening is needed. For this commercial screens are used based on sparse-
matrixes so that many possible combinations can access (Berger et al., 1996, Wooh et al., 
2003, Thakur et al., 2007). 
Crystal formation is dependent on two steps: nucleation and growth. Nucleation is 
the formation of crystallisation nuclei and growth is the stage in which a crystal gets 
bigger (Chernov, 2003). 
Protein crystallisation occurs when there is a passage of the molecules from solution 
to an organised solid form. According to the phase diagram shown in Figure 6.24, for 
crystal formation the solution needs to reach a supersaturated state, in which proteins can 
give rise to an ordered crystallisation form. 
In many cases achieving the nucleation phase is complex since it is dependent upon 
several factors: 
 - precipitant compounds such as PEG or glycerol, that promote nuclei formation 
by removing water from solution; 
 - ionic agents that can either act as a precipitant compound or can affect the 
surface charges of the protein that may lead to a stabilisation of crystal packing contacts; 
 - temperature, which influences the solubility of the protein; 
 - pH, which can influence the charge of the protein thus influencing its solubility 
and packing ability; 
Supplementary Material 
Doctoral thesis of Sofia Caria 187 
 - ligands (nucleotides, substrates, cofactors) that can promote a stabilisation of the 
protein conformation upon binding reducing the protein flexibility. 
Crystallisation solution screens depend on the factors mentioned above. 
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Figure 6.24- Crystallisation phase diagram.  
Crystallisation phase diagram in which protein concentration is plotted against the precipitant concentration. 
Supersaturation conditions can be subdivided in three main phases: metastable, nucleation and precipitation. 
In the metastable phase there is no nuclei formation but if nuclei are present these can give rise to crystals. 
The nucleation phase is fundamental for crystal formation. In the precipitation phase the precipitant and/or 
the protein concentration is too high leading to the formation of disordered packing that originates from 
protein aggregation.  
 
Crystals of macromolecules are usually obtained using vapour diffusion technique 
(Figure 6.25). Here, a protein solution drop (of few µl) containing a insufficient 
concentration of precipitant/protein to induce crystallisation, but by equilibrating the drop 
with a much larger reservoir solution (large amount around 0.5- 1 ml) containing a higher 
precipitant concentration, water from the drop will diffuse to the reservoir solution, 
increasing the precipitant/protein concentrations in the drop to optimal values (Bergfors, 
1999). 
The vapour diffusion system which is the most commonly used, there other 
crystallisation setups, like dialysis, batch or microbatch (Bergfors, 1999). 
 
Chapter VI 
Doctoral thesis of Sofia Caria 188 
                      
Figure 6.25- Schematics of vapour diffusion in hanging and sitting drop crystallisation 
setups. 
A- hanging drops setup: here the protein contained on a drop is placed siliconized glass cover slide and 
equilibrated with the solution in the reservoir. B-sitting drop setup: in which the drop is placed on a support 
right above the reservoir solution. Both systems are sealed either by a glass cover slide (A) or using tape 
(B).  
 
5.2.2. X-ray diffraction 
 
A crystal consists in the repetition of the molecules in a highly organised fashion 
originating a lattice. The smallest motif block of the crystal is a unit cell (Figure 6.26), 
described by three vectors a, b and c and by three angles α, β and γ. In the unit cell 
molecules (or atoms) adopt a unique spacial arrangement. In a crystal this unit cell is then 
repeated many times in three dimensions. 
 
 
Figure 6.26- Schematics of a protein crystal composition.  
In this crystal form the monomeric protein is repeated in the lattice originating the crystal. The crystal is 
characterized by vectors a, b and c that form angles between them (α, β and  γ). 
 
A B 
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The diffraction of X-rays by crystals was discovered by Laue in 1914 and was later 
mathematically described by Bragg. Bragg's law states that a set of imaginary equivalent 
parallel planes in a crystal having a d distance, produce a diffracted beam at an angle 2θ 
to the incident beam with a wavelength λ: 
 
θλ 2sindn =      (Equation 6.7) 
  
According to Bragg's law a constructive interference would only be accomplished 
when the path length difference between the scattered beam from parallel crystal planes 
would be an integral number of wavelengths of the incident beam (Figure 6.27). 
 
 
Figure 6.27- Bragg's law representation. 
The diffracted X-rays beams exhibit a constructive interference when the distance between planes differs by 
an integer number of wavelengths (λ). 
 
Ewald used a geometric construct, a sphere, to demonstrate the relationship in 
equation 6.7. 
The Ewald construct consists of a sphere of radius 1/λ in which the crystal is in the 
centre; receiving X-rays and scattering that radiation. The diffraction obtained results 
from the crossing of the scattered radiation through the Ewald's sphere as represented in 
Figure 6.28, since only in those conditions the Bragg's law is satisfied. 
Ewald's construction also demonstrates the need to rotate the crystal in order to 
retrieve different reciprocal lattice points through the Ewald's sphere. By rotating the 
crystal diffraction from all the Bragg's planes contained in the crystal can be obtained. 
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Figure 6.28- The Ewald sphere construction.  
The crystal is at the centre of this construction, diffracting the incident radiation with a 2θ angle (scattered 
x-ray). The scattering vector describes the path difference between the incident and the scattered radiation. 
The origin of that vector is at reciprocal lattice origin the point on the sphere at which the radiation is 
undeflected. In order to obtain diffraction from all planes it is fundamental to rotate the crystal, satisfying 
the conditions for diffraction to occur. 
 
5.2.3. Crystal Symmetry and Space Groups 
 
A crystal is, as mentioned above, composed of unit cells repeated in an organised 
form. In the unit cell molecules and atoms adopt a unique spatial arrangement. The 
geometrical arrangement of the molecules is defined by three-dimensional symmetry 
operations such as rotations, inversions, reflections, screw axes, glide planes (mirror 
reflection in this plane with a translation) or translation.  
A crystallographic space group consists of the combination of these operations 
relating the molecules/atoms in the unit cell. In unit cells made up of protein molecules, 
five symmetry operations allowed are rotations and translations; since proteins are 
composed only by L-amino acids. Besides this requirement, the unit cell symmetry also 
imposes restrictions on the operations that are allowed. Only n-fold rotations (which n is 
an integer and integral fraction of 360 º), are allowed with 2-, 3-, 4- and 6-fold possible 
axes. Based on these requirements only 65 of the possible 230 space groups are possible 
for proteins crystals (Wondratschek, 2006). These are described in Table 6.2. 
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5.2.4. Diffraction data collection 
 
Diffraction data collection protocols usually consist of several steps. The first is the 
cryo-protection of the crystals which is fundamental for a inhibiting the crystal intrinsic 
decay when in the absence of mother liquor and also to attenuate radiation damage into 
the crystal. Cryo-protection is carried out by freezing the crystals in liquid nitrogen (100 
K) in the presence of cryo-protectant compounds which can required to prevent the 
formation of crystalline ice in the crystal (Garman et al., 2007). There are many possible 
cryo-protectants, and it may necessary to screen several of these in order to obtain the 
best diffraction (Garman et al., 2007). 
The crystal is frozen in a loop with a magnetic pin that is placed in the goniometer 
head with the help of the sample changer and in which a stream if liquid nitrogen is 
present. The goniometer allows the rotation of the crystal around an axis (Φ) the 
perpendicular to the incident x-ray beam. 
 
            
 
Figure 6.29- ID14-2 hutch beamline at ESRF.  
The several instruments present in ID14-2 beamline at ESRF that allow a crystal diffraction experiment (A) 
with special highlight to the goniometer where the crystal is placed (B). 
 
 
The position of the detector is dependent on the protein crystal unit cell. The bigger 
the unit cells the nearest are the diffraction spots, so to avoid overlapped reflections one 
can place the detector near. Another approach is to decrease the rotation series know as 
oscillations.  
Goniometer Cryostream CCD Detector 
Sample 
Changer 
Crystal pin 
holder 
A 
B 
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Table 6.2- The non-centrosymmetric space groups for protein crystals. 
Crystal System 
Axes of symmetry 
(rotational ) 
Geometrical  lattice constrains Possible Bravais Lattices 
Point 
groups 
Space groups 
Triclinic 
No axes of 
symmetry 
a≠b≠c α≠β≠γ 
P  
1 P1 
Monoclinic 
2-fold axis parallel 
to b 
a≠b≠c α=γ=90° ≠β 
P   C 
2 P2, P21, C2 
Orthorhombic 
3 orthogonal 2-fold 
axes 
a≠b≠c α=β=γ=90° 
P  C  I  F 
222 
P222, P212121, P21212, P2221, C222, 
C2221, I222, I212121, F222 
Tetragonal 
4-fold axis parallel 
to c 
a=b≠c α=β=γ=90° 
P    I 
4 
422 
P4, P41, P42, P43, I4, I41 
P422, P4212, P4122, P41212, P4222, 
P42212, P4322, P43212, I422, I4122 
Trigonal 
3-fold axis parallel 
to c 
a=b≠c α=β=90° γ=120° 
a=b=c α=β=γ<120°, ≠90° P   (or R) 
3 
32 
P3, P31, P32, R3 
P312, P321, P3121, P3112, P3212, 
P3221, R32 
Hexagonal 
6-fold axis parallel 
to c 
a=b≠c α=β=90° γ=120° 
P 
6 
622 
P6, P61, P62, P63, P64, P65 
P622, P6122, P6222, P6322, P6422, 
P6522 
Cubic 
four 3-fold axis 
along the diagonals 
of the cube 
a=b=c α=β=γ=90° 
P   I   F 
23 
432 
P23, F23, I23, P213, I213 
P432, P4132, P4232, P4332, F432, 
F4132, I432, I4132 
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For these reasons it is important to plan the full diffraction data collection properly. 
To achieve this, once it has been centered in the X-ray beam two diffraction images are 
collected 90 º apart. The images and then indexed in order to characterise the crystal 
properties such as space group and unit cell dimensions. In this thesis iMosflm (Leslie, 
2006) was used for indexing, although several other programs are available like Denzo 
(Rossmann et al., 1999) or XDS (Diederichs et al., 1997). Once the crystal space group is 
determined the minimum rotation range of diffraction data collection needed for a full 
data set is determinant being dependent on the degree of symmetry inside the crystal. To 
fully plan a data collection strategy several packages can be used such as iMOSFLM 
(Leslie, 2006) or DNA (http://www.esrf.eu/UsersAndScience/Experiments/MX/ 
How_to_use_our_beamlines/Run_Your_Experiment/Collecting_Data/DNA); but in this 
thesis EDNA (Bourenkov et al., 2006, http://www.edna-site.org/, 2009, Incardona et al., 
2009) was used as it accounts for radiation damage during data collection. At this point it 
is also possible to determine if the amount of radiation given to the crystal is too high 
since it that case it will originate overloads (maximum intensity measured by the detector 
is achieved), and to prevent that either decrease transmission or increase attenuation. 
Once a fully diffraction dataset has been collected the reflection intensities have to 
be integrated (using iMosflm), then scaled and merged in order to have averaged 
intensities for further analysis. This last step was carried out using Scala (Evans, 2006) 
from CCP4 suite (Collaborative Computational Project, 1994). The output from scaling 
and merging protocols can be used as a checkpoint to determine dataset quality, through 
the analysis of parameters such as the merging R-factor (Rmerge, Equation 6.8). 
 
∑ ∑
∑ ∑ −
= )(
)()((
hklI
hklIhklI
R
ihkl
iihkl
merge      (Equation 6.8) 
  
Another parameter to be checked is <I/σ(I)>, which is in the ratio between the intensity 
measured and its standard deviation. It also gives some hints about the existence of 
absence of twinning in the dataset by analysing the intensity distribution along the data 
collection. The program Truncate (French et al., 1978) was used to read the averaged 
intensities and derive mean factors amplitudes (|Fhkl|). 
 
5.2.5. Phase determination for structure solution 
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 During a diffraction experiment the only values recorded are the intensities of the 
diffracted radiation from the different reciprocal lattice planes of the crystal. The 
amplitude can be determined, since it is proportional to the square root of the intensity 
measured (Equation 6.9).  
 
hklhkl I  F α      (Equation 6.9) 
 
 However, the electron density distribution in the unit cell of a crystal is based on the 
following equation (Taylor, 2003): 
 
∑ ++−= )2()(
1 lzkyihxi
hkl eeFV
hkl piαρ      (Equation 6.10) 
 
where V is the volume of the unit cell in a diffraction experiment and αhkl is the phase 
associated with the amplitude structure factor |Fhkl|. As described above, the amplitude 
structure factors can be derived from the measured intensities, but the phase information 
is lost. Several methods have been developed to overcome this issue and thus enable the 
calculation of the electron density distribution that will allow model building:  
 
A. Molecular Replacement 
 
 Molecular Replacement (MR) is based on the availability of the previously 
determined crystal structure of a homologous protein. The homologous protein used 
should present usually a sequence identity higher than 25 % and a root mean square 
deviation between the Cα atoms position smaller than 2 Å compared to the structure we 
are trying to solve (Taylor, 2003). 
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 The principle of MR relies on the positioning of the unknown molecule within the 
unit cells by rotation and translation of the known search model (Figure 6.29). In the 
rotation, a Patterson map calculated from the intensities for the unknown protein is 
compared with Patterson maps derived from the diffraction of the known search model 
structures in different orientations. The translation function is then used to position the 
corrects oriented model in the asymmetric unit also using a Patterson map comparison. 
 
 
Figure 6.30-  Molecular Replacement procedure (courtesy of Dr. Garry Taylor). 
The structure of the homologous protein (Xmodel) is used as a search model to determine the unknown phases 
of the new structure. The determination of the new phase consists of finding the correct orientation of the 
search model in the unit cell, followed by the translation of the correctly oriented model relative the origin 
of the unit cell. 
 
 MR can be carried out in several software packages including AmoRe (Trapani et 
al., 2008), Molrep (Lebedev et al., 2008) or as most used during this thesis, Phaser 
(McCoy et al., 2007). In Phaser the scoring is based on the maximum likelihood statistical 
algorithm.  
 
txRx elmodnew +⋅=
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B. Isomorphous Replacement 
 
 This method is dependent on the existence of diffraction intensity measurements 
from a derivative crystal and the comparison of these with intensities measurements from 
a native crystal. The derivative crystals is obtained by soaking a crystal with a heavy atom 
compound such as mercury chloride, gadolinium (III) chloride hydrate, lanthanum (III) 
nitrate hexahydrate among others. 
 Isomorphous Replacement (IR) requires the collection of two diffraction data sets, 
one from the native crystal and another from the crystal containing heavy atoms. The 
structure factors amplitudes of the heavy atoms (|FH|) are determined from the 
approximated isomorphous differences between the amplitudes of the derived crystal 
(|FPH|) and the amplitudes measured for the native crystal (FP).  
 
|FH| ≈ |FPH| - |FP|     (Equation 6.11) 
 
 The best representation of Equation 6.11 is the Argand diagram shown in Figure 
6.31. 
αPH
|FPH|
|FP|
αP
|FH|
αH
 
Figure 6.31- Argand diagram of isomorphous replacement.  
|FP| is the amplitude of a reflection in a native crystal, |FPH| that obtained from a derivative crystal, |FH| is the 
heavy atom structure factor.  
 
 From the Patterson function 2PPH FF −  as coefficients the position of the heavy 
atoms is determined. These then allow the determination of the native protein phases 
(Taylor, 2003): 
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where αP and αH are the phases of the native and heavy atoms respectively. From 
equation 6.12, two solutions will be obtained, giving rise to the phase ambiguity. To solve 
this problem it may be necessary to use a second heavy atom derivate crystal in a 
technique known as Multiple Isomorphous Replacement (MIR). 
 
C. Single and Multiple Wavelength Anomalous Dispersion (SAD/MAD) 
 
 These methods require the presence of an element with appreciable anomalous 
scattering at wavelengths normally used for protein crystallography, in the protein crystal. 
Several approaches can be used to add that element, but one of the most common is the 
incorporation of selenium in the form of selenomethionine protein expression (Taylor, 
2003).  
 The scattering factor f of an atom is composed of the normal scattering form (f0), a 
dispersive term (f '(λ)) and the absorption term f '' (λ) as shown in the equation below. 
 
)('' )('  )(),( 0 λλθλθ iffff ++=      (Equation 6.13) 
 
When f '' is large, Friedel's law is no longer valid: 
Fhkl ≠ F-h-k-l 
 The anomalous difference is represented by the following equation: 
 
|F||F| |F| lkhhklano −−−−=∆      (Equation 6.14) 
 
if both |Fhkl| and |F-h-k-l| are measured the difference can be used for the determination of 
the position of the anomalous scatterers in the unit cell through the analysis of the Ewald's 
sphere, in which only two phase values are possible . 
Originating in anomalous differences, as is clear on the Argand diagram shown in 
Figure 6.32. 
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Figure 6.32- Argand diagram of single wavelength anomalous dispersion.  
The diagram shows the existence of anomalous scatters that induce the Fridel's law breakage.   
  
 Both f ' and f '' are wavelengths dependent (Figure 6.33) and in experiments 
exploiting anomalous scattering , the wavelengths of the incident X-ray is usually tuned 
to take this wavelength variation into account.. 
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Figure 6.33- General variation of the f ' and f '' for a anomalous scatterer.  
λ1 corresponds to the absorption edge peak of the scatterer, λ2 to the inflection point of the absorption edge, 
λ3 and λ4 correspond to the remote wavelengths. 
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 Two types of anomalous scattering experiments can be performed depending on the 
number wavelengths used for the measurements. When only a single wavelength (SAD) 
is used, the wavelength of choice for the experiment is usually the peak of the absorption 
edge (λ1) of the anomalous scatterer since there the anomalous differences are maximised 
(Figure 6.33). In a MAD experiment data are measured at three different wavelengths in 
order to maximise the absorption and dispersive effects. The wavelengths of choice are 
the peak in which f '' is maximum (λ1 in Figure 6.33), the inflection point in which f ' is at 
a minimum (λ2 in Figure 6.33) and one of the remote points (λ3 or λ4 in Figure 6.33) 
(Taylor, 2003). 
 Experimental phasing using this approach can be done in programs such as 
ShelXD/ShelXE (Sheldrick, 2008), Solve/Resolve (Terwilliger, 2004) and Sharp 
(Vonrhein et al., 2007). 
 
5.2.6. Phase Improvement 
 
 Once experimental phases are determined, the electron density map can be 
calculated from equation 6.9 previously described. The electron density obtained can be 
more or less interpretable depending on the phase quality. The quality is related to data 
quality, phase errors and resolution. However, there are mechanisms to improve 
experimentally derived phases and, as consequence, the electron density. These 
techniques are generally called density modification techniques.  
 
A. Solvent Flattening 
 
 Protein crystals usually contain 27 - 78 % of the unit cell volume as disordered 
solvent, that can be averaged and determined as solvent regions, originating a new 
electron density in which the solvent effect is minimised (Rupp, 2009). In the solvent 
flattening method, solvent regions are determined and the electron density in these 
regions set to a uniform value. This results in a new electron density map retrieving 
different phases. These are then combined with the experimental phases to produce 
modified phases and thus improve electron density map. 
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B. Histogram Matching 
 
 This technique is based on previous knowledge of the electron density distribution 
in protein crystals. Adjustments are made to the maximum, minimum and intermediate 
values of the electron density so that they correspond to the values expected for the same 
diffraction resolution. This results in a modified electron density map from which phases 
are retrieved, and used as described above to produce an improved electron density map. 
 
C. Non-crystallography Symmetry Averaging 
 
 This phase improvement method relies on the existence of several copies of the 
same molecule in the asymmetric unit of the crystal. Copies of molecules with an 
arrangement that is not described by the crystal symmetry are considered to be related by 
non-crystallographic symmetry (NCS). In this technique, the electron density of the 
different monomers inside the crystal asymmetric unit is averaged locally, leading to a 
modified electron density map. Modified phases are retrieved from the new electron 
density, and combined with experimental phases which are then used to produce new 
electron density maps. 
 The approaches mentioned above can be applied separately or in conjunction. 
Programs for density modification include: DM (Cowtan et al., 1998) and Resolve 
(Terwilliger, 2004). 
 
5.2.7. Model Building and Refinement 
 
 After the phase improvement step, an electron density map is calculated which 
usually allows the building of the protein model. This model can be built automatically 
using programs such as ArpWarp (Perrakis et al., 2001) or Resolve (Terwilliger, 2004). 
The capacity of these programs to yield a good model depends on several factors such as 
diffraction resolution or phase quality. 
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 In some cases a partial model is obtained and has to be improved manually using 
graphics software such as Coot (Emsley et al., 2004). Here, a first approach is to add 
poly-alanine trace to the unmodelled electron density, thus generating new phases that can 
be used to improve the electron density. This process is known as model building and is 
performed in iterative cycles together with structure refinement to improve the electron 
density maps. 
 Structure refinement consists on the modification of the protein model, atomic 
positions, atomic displacement parameters (Bfactors) and occupancy factor; in order to 
minimise the differences between the calculated structure factors (Fcalc) and the 
experimental ones (Fobs).  
 Due to the fact that usually protein crystals present a low diffraction resolution, a 
priori chemical information is used such as geometric information about bond lengths and 
angles in order to improve the model retrieved. 
 In other to access if the refinement quality, there are statistical parameters that can 
be used as guide lines such as the comparison between Rfactor and Rfree. The smaller 
difference between those two values indicates a better agreement between the model built 
and the experimental information. 
 There are several programs that can be used for structure refinement including 
Refmac (Murshudov et al., 1997) and Phenix.Refine (Afonine, 2005). 
 
5.3. Overview of protein small angle X-ray scattering 
 
Small-angle X-ray scattering (SAXS) is a technique in which the scattering of X-
rays (wavelength in a range of 0.1 to 0.2 nm) by a homogeneous sample is recorded at 
very low angles. This method provides information about the sample size and shape in 
solution, retrieving structural information of macromolecules at low resolution (1- 2 nm); 
and allows a reutilisation of the protein if radiation damage effects during this analysis are 
not great (Petoukhov et al., 2007). 
In a SAXS experiment, the scattered X-rays are recorded on a detector (Figure 6.34) 
and are radially integrated to give scattering curves. 
 
Chapter VI 
Doctoral thesis of Sofia Caria 202 
Distance: 35 to 350 cm
Beamstop
Vantec-2000
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q
Sample in capillary
Monochromatic beam
  
Figure 6.34- Schematic layout of a SAXS experimental setup in ESRF ID14-3. 
A- The monochromatic beam crosses the sample contained in a capillary and scattered radiation is 
registered in the 2-dimension detector. B- SAXS scattering pattern collected at ID14-3. 
 
Through the X-ray scattering curve (Figure 6.34) - intensity as a function of scattering 
angle - a low resolution model of a protein can be determined.  
The scattering of any matter is the result of the sum of waves generated by each 
electron in a given volume, within a specific distance. X-ray scattering amplitudes 
represent the Fourier transform of the electron density distribuition in the atom and are 
functions of the momentum transfer (q or s) (Koch et al., 2003): 
( )θ
λ
pi
= sin4s      (Equation 6.15) 
where λ is the wavelength of the incident beam and 2θ the scattering angle. 
 
5.3.1. Protein solutions 
 
Solutions of monodisperse non-aggregated proteins diluted in a buffer are randomly 
dispersed in solution with no position correlation between them. In this case scattering 
intensities can be added; originating in a function proportional to the scattering of a single 
molecule averaged in all orientations and where equation 6.15 is valid. 
In solution, the scattering length density distribution ρ(r) is equal to the total 
scattering length of the atoms per unit of volume (Svergun et al., 2003). This scattering 
distribution is affected by the solvent, but if ones assume the solvent as featureless matrix 
with a constant scattering density  ρs, this can be subtracted to give ρ(i) for the protein 
atoms alone. 
B A 
Supplementary Material 
Doctoral thesis of Sofia Caria 203 
For this reason, in SAXS experiments scattering curves are measured from both the 
protein solution and separately the buffer in which the protein is contained. The scattering 
effect of the solvent and other contributions are removed by the subtraction of the two 
scattering curves. A correct subtraction is fundamental for the determination of the 
scattering of the protein only. This is usually very small at high angles (Koch et al., 
2003). 
During a SAXS experiment the only value measured is the scattering intensity 
which is related to the scattering amplitude (A(s)) as shown in Equation 6.16 and is 
proportional to the number of photons in the s direction. 
 
)s(*A)s(A)s(I =       (Equation 6.16) 
 
 From SAXS scattering patterns measured in reciprocal space (qmáx), information can 
be retrieved about the real space particle with a resolution of q/2piδ = . When working 
with solutions scattering, one should keep in mind that I(s) is usually a fast decay function 
and only low resolution patterns are available (d >> λ), allowing for this reason low 
resolution models (Svergun et al., 2003). 
 
5.3.2. SAXS parameters during data processing 
 
 In a SAXS experiment the concentration of the protein sample and that of the 
standard (bovine serum albumin) sample must be accurately measured, so that the 
estimation of the molecular weight based on the intensity in the origin (I(0)) value is valid 
based on equation 6.17. 
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0IM
Ψρ
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−
=       (Equation 6.17) 
 
where M is the molecular weight of the particle, µ the number of electrons in the particle, 
ρ0 the average electron density of the solvent, ψ the ratio of volume of the particle and 
number of electrons contained within it and NA the Avogadro's number (6.022 x 1023  
mol-1).  
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Proteins are usually globular, and in homogeneous solutions non-aggregating 
spherical particles behave at low angles (s·Rg < 1) according to the Guinier approximation 
(Guinier et al., 1947). The following equation is then valid: 
 
( ) ( )
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⋅=      (Equation 6.18) 
 
where I(s) is the scattered intensity as a function of the momentum transfer (s) and Rg is 
the radius of gyration. 
 The Guinier plot, log I against s2, is an indicator of the homogeneity of the system; 
since in a ideal monodisperse system it originates a linear function, whose intercept gives 
I(0) and the slope yields the radius of gyration (Rg). Rg is the mean square distance from 
the centre of gravity of the electron shell formed by the particle. If one assumes the 
particle to be spherical the 22g r5
3R = , where r is the radius of the spherical particle and 
equation 6.18 can be rewritten as: 
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e )0(I)s(I −=      (Equation 6.19) 
 
 The Porod law is based in the assumption that protein particles have a sharp smooth 
surface resembling spheres and for that reason: 
 
4
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e
s
S
  2 I)s(I ρpi=      (Equation 6.20) 
 
in which S corresponds to the surface of the particle and Ie is a constant. Through this 
approximation is possible the calculation of the particle surface. 
 For processing the data and determine the parameters above mentioned, the 
PRIMUS program is used. This software allows the manipulation of experimental data, 
including subtraction (buffer solution scattering curves from protein solution scattering 
curves), merging (scattering curves from the protein solution at different concentrations), 
extrapolation to zero of the concentration and evaluating parameters from the Guinier and 
Porod approximations such as radius of gyration, Porod's volume, molecular weight and 
indication of the protein shape (Konarev, 2003) as described in Figure 6.35. 
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Figure 6.35- Scattering intensities and distance distribution functions of different 
geometrical shapes (courtesy of Dimitri Svergun).  
A- Geometrical shapes used for the analysis. B- X-ray scattering curve for the different shapes. C-Distance 
distribution for the different shapes (ρ(i) plot). In the graphs the curves are represented in the same colour 
as the geometrical shapes. 
 
5.3.3. Modelling 
 
From the x-ray scattering of the particle in solution one can access, as explained 
above, low resolution information about the particle. This allows an the modelling of an 
molecular envelope that represents the experimental scattering data. There are several 
programs and approaches for the envelope determination, depending on the amount of 
structural information one has about the particle in study. 
A 
B C 
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The approach to determine an ab initio model is based in bead models and uses a 
trial and error Debye modelling strategy to determine the particle shape. The search 
volume is confined to the maximum diameter dimension (Dmax) value of the particle that 
is estimated directly from the scattering pattern. Each bead inside the sphere can either 
belong to the protein (with an index (X) of 1), or to the solvent (with an index of 0). The 
randomisation of the indices of the beads inside the sphere (radius=Dmax/2) uses a Monte 
Carlo-like search to better fit the experimental data.  
Softwares used for envelope determination when no structural information is 
available, include the programs DAMMIN (Svergun, 1999), GASBOR (Svergun et al., 
2001) and CREDO (Svergun et al., 2001) 
If some structural information is known, such as domains of individual proteins or 
the different components of a complex, one can determine their positions in the envelope 
by using SASREF (Petoukhov et al., 2005).  
Crystal structure information, even of homologues can than be used to compare the 
fit of an envelope to a known crystal structure. For this the program CRYSOL (Svergun 
et al., 1995) allows a comparison between the calculated scattering curve of a known 
crystal structure protein and the experimentally observed data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
